Sentence,class,file
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e6/0d/main.PMC4324548.pdf
"84 (1),45–55.http://dx.doi.org/10.1007/s00223-008-9195-5 (PubMed PMID: 19067021).19 J.L.",OADS,/arxiv_data1/oa_pdf/e6/0d/main.PMC4324548.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by- nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e6/d5/ezu238.PMC4324609.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/50/cc/nihms652785.PMC4324680.pdf
"H3Africa Cardiovascular Diseases Workshop On May 30, 2014, in conjunction with the fourth annual meeting of the H3Africa  Consortium ( http://www.h3africa.org/component/content/article/8-events/156-fourth- h3africa-consortium-meeting ), the Cardiovascular Working Group held an inaugural  workshop in Cape Town, South Africa.",Non-OADS,/arxiv_data1/oa_pdf/50/cc/nihms652785.PMC4324680.pdf
Jan. 2011  Available at: URL: http://h3africa.org/images/PDF/h3africa_whitepaper.pdf 12.,Non-OADS,/arxiv_data1/oa_pdf/50/cc/nihms652785.PMC4324680.pdf
Available at http://healthaffairs.org/healthpolicybriefs/brief_pdfs/healthpolicybrief_65.pdf 3.,Non-OADS,/arxiv_data1/oa_pdf/70/9e/nihms661274.PMC4324751.pdf
Available at http://www.hospitalcompare.hhs.gov/ 6.,Non-OADS,/arxiv_data1/oa_pdf/70/9e/nihms661274.PMC4324751.pdf
Available at:  http://www.effectivehealthcare.ahrq.gov/ehc/products/343/1198/Evidencereport208_CQG- PublicReporting_ExecutiveSummary_20120724.pdfDahlke et al.,OADS,/arxiv_data1/oa_pdf/70/9e/nihms661274.PMC4324751.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution- Noncommercial 3.0 Unported License (http://creativecommons.org/licenses/by-nc/3.0/), permitting all non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Libyan J Med 2015, 10: 26930 - http://dx.doi.org/10.3402/ljm.v10.26930 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/ff/4c/LJM-10-26930.PMC4325084.pdf
"2 (page number not for citation purpose)Citation: Libyan J Med 2015, 10: 26930 - http://dx.doi.org/10.3402/ljm.v10.26930",Non-OADS,/arxiv_data1/oa_pdf/ff/4c/LJM-10-26930.PMC4325084.pdf
"The number of road trafﬁc accidents plotted against the months in 2010 and 2011.Road traffic accidents during the Libyan conflict Citation: Libyan J Med 2015, 10: 26930 - http://dx.doi.org/10.3402/ljm.v10.26930 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/ff/4c/LJM-10-26930.PMC4325084.pdf
"4 (page number not for citation purpose)Citation: Libyan J Med 2015, 10: 26930 - http://dx.doi.org/10.3402/ljm.v10.26930",Non-OADS,/arxiv_data1/oa_pdf/ff/4c/LJM-10-26930.PMC4325084.pdf
"Comparison between 2010 and 2011 on duration, role in the accident, method of discharge, and receiving department 2010 2011 n % n % Duration ( x2/C3022.268, pB0.001, df /C304) No Stay 194 7.3 243 10.91/C17 days 1,755 66.2 1,402 63.1 8/C114 days 402 15.2 349 15.7 15/C129 days 211 8.0 149 6.7 30/C27days 91 3.4 78 3.5 Role ( x 2/C3011.2, p/C300.024, df /C304) Pedestrian 677 25.5 521 23.5Driver 915 34.5 761 34.3Passenger 1,002 37.8 872 39.3Motorcycle 41 1.5 58 2.6Bicycle 18 0.7 9 0.4 Method of discharge ( x 2/C3048.882, pB0.001, df /C306) Transferred to another hospital 47 1.8 95 4.3 LAMA 243 9.2 169 7.6 Absconded 87 3.3 116 5.2Discharged to attend OPD 2,146 80.9 1,719 77.4Expired 115 4.3 106 4.8Unspecified 1 0.0 7 0.3Refused admission 14 0.5 9 0.4 Department ( x 2/C3036.808, pB0.001, df /C308) Chest Surgery 114 4.3 85 3.8 General Surgery 246 9.3 132 5.9 Hand Surgery 2 0.1 1 0.0ICU 179 6.7 193 8.7Neurosurgery 690 26.0 575 25.9Oromaxillofacial Surgery 76 2.9 79 3.6Orthopedic Surgery 1,211 45.6 1,012 45.6Plastic Surgery 135 5.1 137 6.2Unspecified 0 0.0 7 0.3Road traffic accidents during the Libyan conflict Citation: Libyan J Med 2015, 10: 26930 - http://dx.doi.org/10.3402/ljm.v10.26930 5 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/ff/4c/LJM-10-26930.PMC4325084.pdf
"6 (page number not for citation purpose)Citation: Libyan J Med 2015, 10: 26930 - http://dx.doi.org/10.3402/ljm.v10.26930",Non-OADS,/arxiv_data1/oa_pdf/ff/4c/LJM-10-26930.PMC4325084.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7b/4d/main.PMC4325087.pdf
http://dx.doi.org/10.1016/j.nicl.2015.01.015 2213-1582/© 2015 Published by Elsevier Inc.,Non-OADS,/arxiv_data1/oa_pdf/7b/4d/main.PMC4325087.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7b/4d/main.PMC4325087.pdf
"Subjects All patients were recruited from the stroke units of 12 hospitals in the West Midlands, UK, as part of the Birmingham University Cognitive Screen trial (BUCS; http://www.bucs.bham.ac.uk ).",Non-OADS,/arxiv_data1/oa_pdf/7b/4d/main.PMC4325087.pdf
"Behavioural measures The cognitive abilities of the patients were examined using the BCoS Cognitive Screen ( Humphreys et al., 2012 ) (see also Bickerton et al., 2014 ;http://www.cognitionmatters.org.uk ).",Non-OADS,/arxiv_data1/oa_pdf/7b/4d/main.PMC4325087.pdf
This is achieved by 27 paper and pencil tasks with each designed to tap into various cognitive processes under each domain ( http://www.cognitionmatters.org.uk/bcos.php ).,Non-OADS,/arxiv_data1/oa_pdf/7b/4d/main.PMC4325087.pdf
"Compared to the cut-off points established from the age- matched healthy controls ( http://www.bcos.bham.ac.uk ), 108 patients scored lower than the cut-off points and were classi ﬁed as impaired.",Non-OADS,/arxiv_data1/oa_pdf/7b/4d/main.PMC4325087.pdf
http://dx.doi.org/10.1007/s00429-010-0257-x20512374 .,Non-OADS,/arxiv_data1/oa_pdf/7b/4d/main.PMC4325087.pdf
http://dx.doi.org/10.1016/j.neuroimage.2005.02.01815955494 .,OADS,/arxiv_data1/oa_pdf/7b/4d/main.PMC4325087.pdf
http://dx.doi.org/10.1016/j.cortex.2012.03.,OADS,/arxiv_data1/oa_pdf/7b/4d/main.PMC4325087.pdf
http://dx.doi.org/10.1016/S0896-6273(01)00224-011239441 .,OADS,/arxiv_data1/oa_pdf/7b/4d/main.PMC4325087.pdf
http://dx.doi.org/10.1016/0093-934X(83)90057-36222782 .,OADS,/arxiv_data1/oa_pdf/7b/4d/main.PMC4325087.pdf
http://dx.doi.org/10.1037/0894-4105.15.4.,Non-OADS,/arxiv_data1/oa_pdf/7b/4d/main.PMC4325087.pdf
Neuropsychology http://dx.doi.org/10.1037/neu0000160 .,Non-OADS,/arxiv_data1/oa_pdf/7b/4d/main.PMC4325087.pdf
http://dx.doi.org/10.1002/hbm.460030206 .,Non-OADS,/arxiv_data1/oa_pdf/7b/4d/main.PMC4325087.pdf
http://dx.doi.org/ 10.1162/jocn.2006.18.10.164417014369 .,Non-OADS,/arxiv_data1/oa_pdf/7b/4d/main.PMC4325087.pdf
http://dx.doi.org/10.1016/j.neuropsychologia.,OADS,/arxiv_data1/oa_pdf/7b/4d/main.PMC4325087.pdf
http://dx.doi.org/10.1093/brain/ awu28625348632 .,Non-OADS,/arxiv_data1/oa_pdf/7b/4d/main.PMC4325087.pdf
"Neuropsychologia 54, 11 –17.http://dx.doi.org/10.1016/j.neuropsychologia.",OADS,/arxiv_data1/oa_pdf/7b/4d/main.PMC4325087.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/7b/4d/main.PMC4325087.pdf
http://dx.doi.org/10.1371/journal.pone.,Non-OADS,/arxiv_data1/oa_pdf/7b/4d/main.PMC4325087.pdf
http://dx.doi.org/10.1016/j.nicl.2013.01.01324179784 .,OADS,/arxiv_data1/oa_pdf/7b/4d/main.PMC4325087.pdf
http://dx.doi.org/10.1037/0033-295X.108.1.20411212628 .,Non-OADS,/arxiv_data1/oa_pdf/7b/4d/main.PMC4325087.pdf
http://dx.doi.org/10.1080/ 1368282080258597519294554 .,Non-OADS,/arxiv_data1/oa_pdf/7b/4d/main.PMC4325087.pdf
http://dx.doi.org/ 10.1016/j.bandl.2010.04.00120452661 .,OADS,/arxiv_data1/oa_pdf/7b/4d/main.PMC4325087.pdf
http://dx.doi.org/10.1038/ 380499a08606767 .,Non-OADS,/arxiv_data1/oa_pdf/7b/4d/main.PMC4325087.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/7b/4d/main.PMC4325087.pdf
http://dx.doi.org/10.1097/00001756-200203040-0001511930131 .,Non-OADS,/arxiv_data1/oa_pdf/7b/4d/main.PMC4325087.pdf
http://dx.doi.org/10.1093/brain/ awm01117337482 .,Non-OADS,/arxiv_data1/oa_pdf/7b/4d/main.PMC4325087.pdf
http://dx.doi.org/10.1016/S1364- 6613(98)01211-X21227232 .,OADS,/arxiv_data1/oa_pdf/7b/4d/main.PMC4325087.pdf
"Neuropsychologia 47 (1), 1 –16.http://dx.doi.org/10.1016/j.neuropsychologia.2008.",OADS,/arxiv_data1/oa_pdf/7b/4d/main.PMC4325087.pdf
http://dx.doi.org/10.1016/j.neuroimage.2012.06.01822728617 .,OADS,/arxiv_data1/oa_pdf/7b/4d/main.PMC4325087.pdf
http://dx.doi.org/10.1038/384159a08906789 .,Non-OADS,/arxiv_data1/oa_pdf/7b/4d/main.PMC4325087.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/7b/4d/main.PMC4325087.pdf
http://dx.doi.org/10.1093/brain/awp27119887506 .,Non-OADS,/arxiv_data1/oa_pdf/7b/4d/main.PMC4325087.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/7b/4d/main.PMC4325087.pdf
http://dx.doi.org/10.1523/JNEUROSCI.2307-05.200516135758 .,Non-OADS,/arxiv_data1/oa_pdf/7b/4d/main.PMC4325087.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/7b/4d/main.PMC4325087.pdf
http://dx.doi.org/10.1016/ S0042-6989(01)00073-611322983 .,OADS,/arxiv_data1/oa_pdf/7b/4d/main.PMC4325087.pdf
"5 (2), 84 –92.http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/7b/4d/main.PMC4325087.pdf
http://dx.doi.org/10.1038/nrn211317431404 .,Non-OADS,/arxiv_data1/oa_pdf/7b/4d/main.PMC4325087.pdf
http://dx.doi.org/10.1212/WNL.55.6.78210993996 .,Non-OADS,/arxiv_data1/oa_pdf/7b/4d/main.PMC4325087.pdf
http://dx.doi.org/10.1002/ana.126511706960 .,Non-OADS,/arxiv_data1/oa_pdf/7b/4d/main.PMC4325087.pdf
http://dx.doi.org/10.1093/brain/123.9.191310960055 .,Non-OADS,/arxiv_data1/oa_pdf/7b/4d/main.PMC4325087.pdf
http://dx.doi.org/10.1016/S1474- 4422(07)70266-117945154 .,OADS,/arxiv_data1/oa_pdf/7b/4d/main.PMC4325087.pdf
http://dx.doi.org/10.1016/ S0028-3932(01)00192-011900726 .,OADS,/arxiv_data1/oa_pdf/7b/4d/main.PMC4325087.pdf
http://dx.doi.org/10.1016/j.neuroimage.2007.07.05317931890 .,OADS,/arxiv_data1/oa_pdf/7b/4d/main.PMC4325087.pdf
http://dx.doi.org/10.1007/ s00426005004610472198 .,Non-OADS,/arxiv_data1/oa_pdf/7b/4d/main.PMC4325087.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/7b/4d/main.PMC4325087.pdf
http://dx.doi.org/10.1098/rstb.2006.193417118927 .,Non-OADS,/arxiv_data1/oa_pdf/7b/4d/main.PMC4325087.pdf
http://dx.doi.org/10.1093/cercor/bhh07615142954 .,Non-OADS,/arxiv_data1/oa_pdf/7b/4d/main.PMC4325087.pdf
http://dx.doi.org/10.1093/brain/ awh62916150848 .,Non-OADS,/arxiv_data1/oa_pdf/7b/4d/main.PMC4325087.pdf
"105 (1), 1 –17.http://dx.doi.org/10.1016/j.bandl.2007.11.00718237773 .",OADS,/arxiv_data1/oa_pdf/7b/4d/main.PMC4325087.pdf
http://dx.doi.org/10.1093/brain/ awr32522287382 .,Non-OADS,/arxiv_data1/oa_pdf/7b/4d/main.PMC4325087.pdf
http://dx.doi.org/10.1093/brain/ awm02517438021 .,Non-OADS,/arxiv_data1/oa_pdf/7b/4d/main.PMC4325087.pdf
http://dx.doi.org/10.1162/0898929015113739511371312 .,Non-OADS,/arxiv_data1/oa_pdf/7b/4d/main.PMC4325087.pdf
"Neuroimage 17 (1), 174 –183.http://dx.doi.org/10.1006/nimg.",OADS,/arxiv_data1/oa_pdf/7b/4d/main.PMC4325087.pdf
http://dx.doi.org/10.1017/ S0140525X9900177611301520 .,Non-OADS,/arxiv_data1/oa_pdf/7b/4d/main.PMC4325087.pdf
http://dx.doi.org/10.1016/S1364-6613(02)01870- 311912041 .,OADS,/arxiv_data1/oa_pdf/7b/4d/main.PMC4325087.pdf
http://dx.doi.org/10.1016/S0896-6273(03)00146- 612691670 .474 J.K.L.,OADS,/arxiv_data1/oa_pdf/7b/4d/main.PMC4325087.pdf
http://dx.doi.org/10.1016/S0010- 9452(79)80051-995004 .,OADS,/arxiv_data1/oa_pdf/7b/4d/main.PMC4325087.pdf
http://dx.doi.org/ 10.1016/S1364-6613(03)00134-712860187 .,OADS,/arxiv_data1/oa_pdf/7b/4d/main.PMC4325087.pdf
http://dx.doi.org/10.1162/jocn.,Non-OADS,/arxiv_data1/oa_pdf/7b/4d/main.PMC4325087.pdf
http://dx.doi.org/10.1093/brain/ awp13819506067 .,Non-OADS,/arxiv_data1/oa_pdf/7b/4d/main.PMC4325087.pdf
"Stroke 26 (5), 807 –812.http://dx.doi.org/10.1161/01.STR.26.",Non-OADS,/arxiv_data1/oa_pdf/7b/4d/main.PMC4325087.pdf
http://dx.doi.org/ 10.1212/WNL.28.4.311565019 .,Non-OADS,/arxiv_data1/oa_pdf/7b/4d/main.PMC4325087.pdf
http://dx.doi.org/10.1016/S0074-7742(08)60358- X9378596 .,OADS,/arxiv_data1/oa_pdf/7b/4d/main.PMC4325087.pdf
http://dx.doi.org/10.1006/nimg.,OADS,/arxiv_data1/oa_pdf/7b/4d/main.PMC4325087.pdf
http://dx.doi.org/10.1161/STROKEAHA.106.47548317615368 .,Non-OADS,/arxiv_data1/oa_pdf/7b/4d/main.PMC4325087.pdf
http://dx.doi.org/10.1080/02687030244000563 .,Non-OADS,/arxiv_data1/oa_pdf/7b/4d/main.PMC4325087.pdf
http://dx.doi.org/10.1177/ 026921550809471119052248 .,Non-OADS,/arxiv_data1/oa_pdf/7b/4d/main.PMC4325087.pdf
http://dx.doi.org/10.1093/brain/awl34417251241 .,Non-OADS,/arxiv_data1/oa_pdf/7b/4d/main.PMC4325087.pdf
"296 (1), 33 –36.http://dx.doi.org/10.1016/ S0304-3940(00)01612-811099827 .",Non-OADS,/arxiv_data1/oa_pdf/7b/4d/main.PMC4325087.pdf
http://dx.doi.org/10.1038/nrn227718026167 .,Non-OADS,/arxiv_data1/oa_pdf/7b/4d/main.PMC4325087.pdf
http://dx.doi.org/10.1073/ pnas.070738310418056637 .,Non-OADS,/arxiv_data1/oa_pdf/7b/4d/main.PMC4325087.pdf
http://dx.doi.org/10.1016/S1053-8119(03)00084-312880781 .,OADS,/arxiv_data1/oa_pdf/7b/4d/main.PMC4325087.pdf
"25 (1), 70 –82.http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/7b/4d/main.PMC4325087.pdf
http://dx.doi.org/10.1016/j.neuroimage.2005.07.04416137894 .,OADS,/arxiv_data1/oa_pdf/7b/4d/main.PMC4325087.pdf
http://dx.doi.org/10.1038/nn.233119471271 .,Non-OADS,/arxiv_data1/oa_pdf/7b/4d/main.PMC4325087.pdf
http://dx.doi.org/10.3758/CABN.6.3.20117243356 .,Non-OADS,/arxiv_data1/oa_pdf/7b/4d/main.PMC4325087.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/7b/4d/main.PMC4325087.pdf
http://dx.doi.org/10.1016/j.neuropsychologia.,OADS,/arxiv_data1/oa_pdf/7b/4d/main.PMC4325087.pdf
http://dx.doi.org/10.1093/brain/123.4.77010734008 .,Non-OADS,/arxiv_data1/oa_pdf/7b/4d/main.PMC4325087.pdf
http://dx.doi.org/10.1073/ pnas.93.1.3218552630 .,Non-OADS,/arxiv_data1/oa_pdf/7b/4d/main.PMC4325087.pdf
http://dx.doi.org/10.1162/jocn_a_0044123806177 .,Non-OADS,/arxiv_data1/oa_pdf/7b/4d/main.PMC4325087.pdf
http://dx.doi.org/10.1093/brain/awp28419942676 .,Non-OADS,/arxiv_data1/oa_pdf/7b/4d/main.PMC4325087.pdf
http://dx.doi.org/10.1016/j.neuroimage.2008.03.02818482850 .,OADS,/arxiv_data1/oa_pdf/7b/4d/main.PMC4325087.pdf
http://dx.doi.org/10.1001/archgenpsychiatry.2010.8520679585 .,Non-OADS,/arxiv_data1/oa_pdf/7b/4d/main.PMC4325087.pdf
http://dx.doi.org/10.1016/S0028-3932(01)00096-311684177 .,OADS,/arxiv_data1/oa_pdf/7b/4d/main.PMC4325087.pdf
http://dx.doi.org/10.1016/S0926-6410(97)00020-79593960 .,OADS,/arxiv_data1/oa_pdf/7b/4d/main.PMC4325087.pdf
http://dx.doi.org/10.1016/j.neuroimage.,OADS,/arxiv_data1/oa_pdf/7b/4d/main.PMC4325087.pdf
http://dx.doi.org/10.1136/jnnp.57.,Non-OADS,/arxiv_data1/oa_pdf/7b/4d/main.PMC4325087.pdf
http://dx.doi.org/10.1162/jocn.2009.2131519642885 .,Non-OADS,/arxiv_data1/oa_pdf/7b/4d/main.PMC4325087.pdf
http://dx.doi.org/10.1016/S0028- 3932(97)00085-79347478 .,OADS,/arxiv_data1/oa_pdf/7b/4d/main.PMC4325087.pdf
http://dx.doi.org/10.1006/nimg.2001.,OADS,/arxiv_data1/oa_pdf/7b/4d/main.PMC4325087.pdf
"7, 422. http://dx.doi.org/10.3389/ fnhum.2013.0042223986670 .",Non-OADS,/arxiv_data1/oa_pdf/7b/4d/main.PMC4325087.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/7b/4d/main.PMC4325087.pdf
http://dx.doi.org/10.1097/01.wnr.,Non-OADS,/arxiv_data1/oa_pdf/7b/4d/main.PMC4325087.pdf
"20 (1), 6 –11.http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/7b/4d/main.PMC4325087.pdf
"6, 85. http://dx.doi.org/10.3389/fnhum.2012.0008522529789 .",Non-OADS,/arxiv_data1/oa_pdf/7b/4d/main.PMC4325087.pdf
http://dx.doi.org/10.1006/nimg.1995.10239343600 .475 J.K.L.,OADS,/arxiv_data1/oa_pdf/7b/4d/main.PMC4325087.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/27/7a/main.PMC4325088.pdf
http://dx.doi.org/10.1016/j.nicl.2015.01.017 2213-1582/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/27/7a/main.PMC4325088.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/27/7a/main.PMC4325088.pdf
"Estimation of whole brain atrophy rate Whole brain atrophy rate was estimated with SIENA (Smith et al., 2001), part of the FSL software package ( http://fsl.fmrib.ox.ac.uk/fsl/ fslwiki/ ).",OADS,/arxiv_data1/oa_pdf/27/7a/main.PMC4325088.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/27/7a/main.PMC4325088.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/27/7a/main.PMC4325088.pdf
http://dx.doi.org/10.1006/nimg.2002.119712377138 .,Non-OADS,/arxiv_data1/oa_pdf/27/7a/main.PMC4325088.pdf
http://dx.doi.org/10.1002/mds.2065216116613 .,Non-OADS,/arxiv_data1/oa_pdf/27/7a/main.PMC4325088.pdf
http://dx.doi.org/10.1016/j.pscychresns.2011.02.01221764565 .,OADS,/arxiv_data1/oa_pdf/27/7a/main.PMC4325088.pdf
http://dx.doi.org/10.1523/JNEUROSCI.3252-09.,Non-OADS,/arxiv_data1/oa_pdf/27/7a/main.PMC4325088.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/27/7a/main.PMC4325088.pdf
http://dx.doi.org/10.1212/01.wnl.0000344568.09360.3119289740 .,Non-OADS,/arxiv_data1/oa_pdf/27/7a/main.PMC4325088.pdf
http://dx.doi.org/10.1038/nrn340623254192 .,Non-OADS,/arxiv_data1/oa_pdf/27/7a/main.PMC4325088.pdf
"20 (1), 29 –33.http://dx.doi.org/10.1177/089198870629708617341768 .McKeith, I.G., Ballard, C.G., Perry, R.H., Ince, P.G., O 3Brien, J.T., Neill, D., Lowery, K., Jaros, E., Barber, R., Thompson, P., Swann, A., Fairbairn, A.F., Perry, E.K., 2000.",Non-OADS,/arxiv_data1/oa_pdf/27/7a/main.PMC4325088.pdf
http://dx.doi.org/ 10.1212/01.wnl.0000187889.17253.b116237129 .,Non-OADS,/arxiv_data1/oa_pdf/27/7a/main.PMC4325088.pdf
http://dx.doi.org/10.1212/wnl.34.7.,Non-OADS,/arxiv_data1/oa_pdf/27/7a/main.PMC4325088.pdf
http://dx.doi.org/10.1002/mds.1047312815652 .,Non-OADS,/arxiv_data1/oa_pdf/27/7a/main.PMC4325088.pdf
http://dx.doi.org/ 10.1007/s00415-010-5630-420563821 .,Non-OADS,/arxiv_data1/oa_pdf/27/7a/main.PMC4325088.pdf
http://dx.doi.org/10.1212/01.wnl.0000167542.89697.,Non-OADS,/arxiv_data1/oa_pdf/27/7a/main.PMC4325088.pdf
http://dx.doi.org/10.1148/ radiol.248207093818574133 .,Non-OADS,/arxiv_data1/oa_pdf/27/7a/main.PMC4325088.pdf
http://dx.doi.org/10.1212/WNL.0b013e31822b000421832223 .,Non-OADS,/arxiv_data1/oa_pdf/27/7a/main.PMC4325088.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/27/7a/main.PMC4325088.pdf
http://dx.doi.org/10.1017/s104161021100217122126938 .,Non-OADS,/arxiv_data1/oa_pdf/27/7a/main.PMC4325088.pdf
http://dx.doi.org/10.1093/brain/ awm02117347250 .,Non-OADS,/arxiv_data1/oa_pdf/27/7a/main.PMC4325088.pdf
http://dx.doi.org/10.1212/01.wnl.0000247041.63081.9817159097 .,Non-OADS,/arxiv_data1/oa_pdf/27/7a/main.PMC4325088.pdf
http://dx.doi.org/10.1001/archneur.57.6.,Non-OADS,/arxiv_data1/oa_pdf/27/7a/main.PMC4325088.pdf
"Imaging 20 (1), 45 –57.http://dx.doi.org/10.1109/42.90642411293691 .462 E. Mak et al.",OADS,/arxiv_data1/oa_pdf/27/7a/main.PMC4325088.pdf
"Keywords:  Exome; Genotype; Lymph nodes; Predictive value of tests; Prostate neoplasms This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Korean J Urol 2015;56:109-116. http://dx.doi.org/10.4111/kju.2015.56.2.109 pISSN 2005-6737  •  eISSN 2005-6745Original Article - Genomics/Stem Cells in Urology Received:  28 November, 2014   •  Accepted:  30 December, 2014 Corresponding Author:  Seok-Soo Byun Department of Urology, Seoul National University Bundang Hospital, 82 Gumi-ro 173beon-gil, Bundang-gu, Seongnam 463-707, Korea TEL: +82-31-787-7342, FAX: +82-31-787-4057, E-mail: ssbyun@snubh.org ⓒ The Korean Urological Association, 2015 Recently, the incidence of this disease has significantly  increased in Asian countries, including Korea, owing to the  reported widespread use of prostate-specific antigen (PSA)  testing and downward stage migration [1,2].",Non-OADS,/arxiv_data1/oa_pdf/60/5c/kju-56-109.PMC4325114.pdf
"org http://dx.doi.org/10.4111/kju.2015.56.2.109 Oh et al patients still harbor lymph node invasion (LNI) at  extended pelvic lymph node dissection (PLND) in PCa  [3,4].",Non-OADS,/arxiv_data1/oa_pdf/60/5c/kju-56-109.PMC4325114.pdf
The effective number of  independent  marker loci was calculated by using SNPSpD software  (http://www.genepi.qimr.edu.au/general/daleN/SNPSpD/)  [ 20 ].,OADS,/arxiv_data1/oa_pdf/60/5c/kju-56-109.PMC4325114.pdf
org http://dx.doi.org/10.4111/kju.2015.56.2.109 Oh et al Table 1.,OADS,/arxiv_data1/oa_pdf/60/5c/kju-56-109.PMC4325114.pdf
"org http://dx.doi.org/10.4111/kju.2015.56.2.109 Oh et al PCa after RP, 3 of 20 SNPs were significantly associated  with BCR (p<0.02) after ad  j u st ment for clinicopathological  factors such as age, pre   operative PSA, pathologic stage,  and surgical margin.",Non-OADS,/arxiv_data1/oa_pdf/60/5c/kju-56-109.PMC4325114.pdf
org http://dx.doi.org/10.4111/kju.2015.56.2.109 Oh et al cancer susceptibility loci using the iCOGS custom genotyping  array.,OADS,/arxiv_data1/oa_pdf/60/5c/kju-56-109.PMC4325114.pdf
"Keywords:  Complementary therapies; Cryosurgery; Kidney neoplasmsKorean J Urol 2015;56:117-124. http://dx.doi.org/10.4111/kju.2015.56.2.117 pISSN 2005-6737  •  eISSN 2005-6745Original Article - Urological Oncology Received:  2 September, 2014   •  Accepted:  29 November, 2014 Corresponding Author:  Seok Ho Kang Department of Urology, Korea University College of Medicine, 73 Inchon-ro, Seongbuk-gu, Seoul 136-705, Korea TEL: +82-2-920-5367, FAX: +82-2-928-7864, E-mail: mdksh@korea.ac.kr ⓒ The Korean Urological Association, 2015 This is an increase of  about 6.2% per year, an increase  that is higher than in the United States and Europe [1] .",Non-OADS,/arxiv_data1/oa_pdf/d3/c2/kju-56-117.PMC4325115.pdf
"For the management of these This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d3/c2/kju-56-117.PMC4325115.pdf
"org http://dx.doi.org/10.4111/kju.2015.56.2.117 Kim et al masses, partial nephrectomy (PN) is considered the gold  standard of care [3] .",Non-OADS,/arxiv_data1/oa_pdf/d3/c2/kju-56-117.PMC4325115.pdf
org http://dx.doi.org/10.4111/kju.2015.56.2.117 Kim et al The pathologic findings are summarized in Table 4.,OADS,/arxiv_data1/oa_pdf/d3/c2/kju-56-117.PMC4325115.pdf
org http://dx.doi.org/10.4111/kju.2015.56.2.117 Kim et al local recurrence.,OADS,/arxiv_data1/oa_pdf/d3/c2/kju-56-117.PMC4325115.pdf
org http://dx.doi.org/10.4111/kju.2015.56.2.117 Kim et al REFERENCES 1.,OADS,/arxiv_data1/oa_pdf/d3/c2/kju-56-117.PMC4325115.pdf
"Keywords:  Penile neoplasms; Survival; Treatment outcome This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Korean J Urol 2015;56:125-130. http://dx.doi.org/10.4111/kju.2015.56.2.125 pISSN 2005-6737  •  eISSN 2005-6745Original Article - Urological Oncology Received:  4 November, 2014   •  Accepted:  5 December, 2014 Corresponding Author:  Eric Chung Department of Urology, Princess Alexandra Hospital, Brisbane, QLD 4103, Australia TEL: +61-7-33242468, FAX: +61-7-33242546, E-mail: ericchg@hotmail.com ⓒ The Korean Urological Association, 2015 penile cancer at 0.6–0.9 per 100,000 population and only  82 cases of  penile cancer was diagnosed in 2009 [1].",Non-OADS,/arxiv_data1/oa_pdf/46/f8/kju-56-125.PMC4325116.pdf
orgChung et al http://dx.doi.org/10.4111/kju.2015.56.2.125 and inflammation as well as smoking.,OADS,/arxiv_data1/oa_pdf/46/f8/kju-56-125.PMC4325116.pdf
orgChung et al http://dx.doi.org/10.4111/kju.2015.56.2.125 significant between pT2 and pT3; p=0.038) (Fig.,OADS,/arxiv_data1/oa_pdf/46/f8/kju-56-125.PMC4325116.pdf
"orgChung et al http://dx.doi.org/10.4111/kju.2015.56.2.125 berger KH, Stief CG, et al.",OADS,/arxiv_data1/oa_pdf/46/f8/kju-56-125.PMC4325116.pdf
"Keywords:  Prostate; Prostate neoplasms; Prostatectomy; Robotics; Surgery This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Korean J Urol 2015;56:131-137. http://dx.doi.org/10.4111/kju.2015.56.2.131 pISSN 2005-6737  •  eISSN 2005-6745Original Article - Laparoscopy/Robotics Received:  17 December, 2014   •  Accepted:  13 January, 2015 Corresponding Author:  Mahmoud Mustafa Department of Urology, An-Najah National University Hospital, Nablus, Palestine TEL: +972-92389687, FAX: +972-92389683, E-mail: mmustafa@najah.edu ⓒ The Korean Urological Association, 2015 this region can result in fibrous scaring that alters tissue  layers, thus making it more difficult to perform RP [2] .",Non-OADS,/arxiv_data1/oa_pdf/39/74/kju-56-131.PMC4325117.pdf
orgMustafa et al http://dx.doi.org/10.4111/kju.2015.56.2.131 et al.,OADS,/arxiv_data1/oa_pdf/39/74/kju-56-131.PMC4325117.pdf
"orgMustafa et al http://dx.doi.org/10.4111/kju.2015.56.2.131 robotic RP and 12 (12/13, 92.3%) had undergone open RP.",OADS,/arxiv_data1/oa_pdf/39/74/kju-56-131.PMC4325117.pdf
orgMustafa et al http://dx.doi.org/10.4111/kju.2015.56.2.131 undergo robotic or open RP without previous pelvic  surgery.,Non-OADS,/arxiv_data1/oa_pdf/39/74/kju-56-131.PMC4325117.pdf
"Keywords:  Kidney pelvis; Ureteroscopy; Urolithiasis  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Korean J Urol 2015;56:138-143. http://dx.doi.org/10.4111/kju.2015.56.2.138 pISSN 2005-6737  •  eISSN 2005-6745Original Article - Endourology/Urolithiasis Received:  4 September, 2014   •  Accepted:  10 December, 2014                 See Editorial on page 142.",Non-OADS,/arxiv_data1/oa_pdf/ea/b2/kju-56-138.PMC4325118.pdf
"orgSüer et al http://dx.doi.org/10.4111/kju.2015.56.2.138 Postoperatively, there were 3 minor complications.",Non-OADS,/arxiv_data1/oa_pdf/ea/b2/kju-56-138.PMC4325118.pdf
orgSüer et al http://dx.doi.org/10.4111/kju.2015.56.2.138 may decrease the use and increase the availability of the  ureteroscope.,Non-OADS,/arxiv_data1/oa_pdf/ea/b2/kju-56-138.PMC4325118.pdf
"Keywords:  Doppler ultrasonography; Valsalva maneuver; Varicocele This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Korean J Urol 2015;56:144-149. http://dx.doi.org/10.4111/kju.2015.56.2.144 pISSN 2005-6737  •  eISSN 2005-6745Original Article - Sexual Dysfunction/Infertility Received:  8 October, 2014   •  Accepted:  3 November, 2014 Corresponding Author:  Seung Ki Min Department of Urology, National Police Hospital, 123 Songi-ro, Songpa-gu, Seoul 138-708, Korea TEL: +82-2-3400-1263, FAX: +82-2-431-3192, E-mail: drmsk@korea.com ⓒ The Korean Urological Association, 2015 affects 15% of the general population and is especially  common among teenagers and young adults [4].",Non-OADS,/arxiv_data1/oa_pdf/7c/1b/kju-56-144.PMC4325119.pdf
"org http://dx.doi.org/10.4111/kju.2015.56.2.144 Kim et al By use of scrotal CDU in the supine position at rest,  the mMVD of varicocele testis units was 1.8 mm (grade  I), 2.0 mm (grade II), and 2.5 mm (grade III), respectively,  and that of normal testis units was 1.2 mm.",OADS,/arxiv_data1/oa_pdf/7c/1b/kju-56-144.PMC4325119.pdf
org http://dx.doi.org/10.4111/kju.2015.56.2.144 Kim et al the supine position.,OADS,/arxiv_data1/oa_pdf/7c/1b/kju-56-144.PMC4325119.pdf
"Keywords:  Abscess; Holmium; Prostate; Transurethral resection of prostate This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Korean J Urol 2015;56:150-156. http://dx.doi.org/10.4111/kju.2015.56.2.150 pISSN 2005-6737 • eISSN 2005-6745Original Article - Infection/Inflammation Received:  16 September, 2014  • Accepted:  2 December, 2014 Corresponding Author:  Dong Gil Shin Department of Urology, Pusan National University Hospital, 179 Gudeok-ro, Seo-gu, Busan 602-739, Korea TEL: +82-51-240-7351, FAX: +82-51-247-5443, E-mail: shindong16@hanmail.net ⓒ The Korean Urological Association, 2015treatment is needed when the disease is diagnosed [2].",Non-OADS,/arxiv_data1/oa_pdf/f3/5f/kju-56-150.PMC4325120.pdf
"Scan this QR code to see the ac - companying video, or visit www.kjurology.org or http://youtu.be/zSq-kk7dQ_E.",Non-OADS,/arxiv_data1/oa_pdf/f3/5f/kju-56-150.PMC4325120.pdf
org http://dx.doi.org/10.4111/kju.2015.56.2.150 Lee et al Table 1.,OADS,/arxiv_data1/oa_pdf/f3/5f/kju-56-150.PMC4325120.pdf
org http://dx.doi.org/10.4111/kju.2015.56.2.150 Lee et al abscess has been used.,OADS,/arxiv_data1/oa_pdf/f3/5f/kju-56-150.PMC4325120.pdf
"1 of this article, or  be available on YouTube (http://youtu.be/zSq-kk7dQ_E).",Non-OADS,/arxiv_data1/oa_pdf/f3/5f/kju-56-150.PMC4325120.pdf
org http://dx.doi.org/10.4111/kju.2015.56.2.150 Lee et al REFERENCES 1.,OADS,/arxiv_data1/oa_pdf/f3/5f/kju-56-150.PMC4325120.pdf
"Keywords:  Hydronephrosis; Radioisotope renography; Treatment failure This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Korean J Urol 2015;56:157-163. http://dx.doi.org/10.4111/kju.2015.56.2.157 pISSN 2005-6737  •  eISSN 2005-6745Original Article - Pediatric Urology Received:  8 October, 2014   •  Accepted:  12 November, 2014                 See Editorial on page 163.",Non-OADS,/arxiv_data1/oa_pdf/8c/c2/kju-56-157.PMC4325121.pdf
"org http://dx.doi.org/10.4111/kju.2015.56.2.157 Chung et al requiring secondary surgical intervention [2,3] .",OADS,/arxiv_data1/oa_pdf/8c/c2/kju-56-157.PMC4325121.pdf
org http://dx.doi.org/10.4111/kju.2015.56.2.157 Chung et al 3.,OADS,/arxiv_data1/oa_pdf/8c/c2/kju-56-157.PMC4325121.pdf
org http://dx.doi.org/10.4111/kju.2015.56.2.157 Chung et al These factors may reflect a reduced resilience of the  pelvis.,OADS,/arxiv_data1/oa_pdf/8c/c2/kju-56-157.PMC4325121.pdf
"Keywords:  Buccal mucosa; Reconstructive surgical procedure; Urethral stricture  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Korean J Urol 2015;56:164-167. http://dx.doi.org/10.4111/kju.2015.56.2.164 pISSN 2005-6737  •  eISSN 2005-6745Case Report Received:  3 November, 2014   •  Accepted:  10 December, 2014 Corresponding Author:  Robert Caleb Kovell Department of Urology, Wake Forest Baptist Medical Center, Wake Forest School of Medicine, Medical Center Boulevard, Winston Salem, NC 27157, USA TEL: +1-336-716-9601, FAX: +1-336-716-5711, E-mail: rkovell@wakehealth.edu ⓒ The Korean Urological Association, 2015 gout, and hypertension.",Non-OADS,/arxiv_data1/oa_pdf/bd/26/kju-56-164.PMC4325122.pdf
"orgKovell and Terlecki http://dx.doi.org/10.4111/kju.2015.56.2.164 Through the dorsal urethrotomy, the ventral urethral  plate was sharply incised in the midline without signifi - cant violation of the spongiosum.",Non-OADS,/arxiv_data1/oa_pdf/bd/26/kju-56-164.PMC4325122.pdf
"Whole-genome sequencing (also known as full-genome  sequencing, complete genome sequencing, or entire genome  sequencing) is a laboratory process that determines the  complete DNA sequence of a sample's genome at a single Next generation sequencing and urologic cancer Seon-Kyu Kim, Wun-Jae Kim1 Medical Genomics Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon, 1Department of Urology, Chungbuk National University College  of Medicine, Cheongju, Korea This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Korean J Urol 2015;56:87-89. http://dx.doi.org/10.4111/kju.2015.56.2.87 pISSN 2005-6737  •  eISSN 2005-6745Editorial Corresponding Author:  Wun-Jae Kim Department of Urology, Chungbuk National University College of Medicine, 410 Sunbong-ro, Heungdeok-gu, Cheongju 361-763, Korea TEL: +82-43-269-6371, FAX: +82-43-269-6144, E-mail: wjkim@chungbuk.ac.kr ⓒ The Korean Urological Association, 2015 time.",Non-OADS,/arxiv_data1/oa_pdf/ab/5d/kju-56-87.PMC4325123.pdf
org http://dx.doi.org/10.4111/kju.2015.56.2.87 Kim and Kim skim the surface of what NGS can offer to translational  researchers and clinicians.,OADS,/arxiv_data1/oa_pdf/ab/5d/kju-56-87.PMC4325123.pdf
"Keywords:  Biological markers; Molecular biology; Prostate neoplasms; Translations  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Korean J Urol 2015;56:90-98. http://dx.doi.org/10.4111/kju.2015.56.2.90 pISSN 2005-6737  •  eISSN 2005-6745Review Article Received:  26 November, 2014   •  Accepted:  23 December, 2014 Corresponding Author:  Yuri Tolkach Urology and Urologic Oncology Clinic, Hannover Medical School, Carl-Neuberg-Str.",Non-OADS,/arxiv_data1/oa_pdf/1b/24/kju-56-90.PMC4325124.pdf
org http://dx.doi.org/10.4111/kju.2015.56.2.90 Tolkach et al known [29].,OADS,/arxiv_data1/oa_pdf/1b/24/kju-56-90.PMC4325124.pdf
org http://dx.doi.org/10.4111/kju.2015.56.2.90 Tolkach et al influence the clinical application of genetic analyses are  as follows: how many clones can reside within one tumor  focus?,Non-OADS,/arxiv_data1/oa_pdf/1b/24/kju-56-90.PMC4325124.pdf
"org http://dx.doi.org/10.4111/kju.2015.56.2.90 Tolkach et al malin fixed, paraffin embedded tissues.",OADS,/arxiv_data1/oa_pdf/1b/24/kju-56-90.PMC4325124.pdf
http://dx.doi.org/10.1111/bju.12789.,Non-OADS,/arxiv_data1/oa_pdf/1b/24/kju-56-90.PMC4325124.pdf
org http://dx.doi.org/10.4111/kju.2015.56.2.90 Tolkach et al Cancer 2014;50:852-61.,OADS,/arxiv_data1/oa_pdf/1b/24/kju-56-90.PMC4325124.pdf
"Keywords:  Erectile dysfunction; Penis erection; Prostatectomy This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Korean J Urol 2015;56:99-108 http://dx.doi.org/10.4111/kju.2015.56.2.99 pISSN 2005-6737  •  eISSN 2005-6745Review Article  Received:  17 October, 2014   •  Accepted:  12 December, 2014 Corresponding Author:  Seung Wook Lee Department of Urology, Hanyang University Guri Hospital, 153 Gyeongchun-ro, Guri 471-701, Korea TEL: +82-31-560-2374, FAX: +82-31-560-2372, E-mail: swleepark@hanyang.ac.kr ⓒ The Korean Urological Association, 2015 many patients face the distress of sexual difficulties such  as loss of erectile function and, in some cases, pain related  to sexual activity [2] .",Non-OADS,/arxiv_data1/oa_pdf/99/3c/kju-56-99.PMC4325125.pdf
"org http://dx.doi.org/10.4111/kju.2015.56.2.99 Kim and Lee increase in medical coverage [1,2,7,8] .",OADS,/arxiv_data1/oa_pdf/99/3c/kju-56-99.PMC4325125.pdf
"org http://dx.doi.org/10.4111/kju.2015.56.2.99 Kim and Lee risk (age≤65 years, IIEF-EF score≥26, and CCI score≤1) for  postoperative ED.",Non-OADS,/arxiv_data1/oa_pdf/99/3c/kju-56-99.PMC4325125.pdf
org http://dx.doi.org/10.4111/kju.2015.56.2.99 Kim and Lee treatment [65].,OADS,/arxiv_data1/oa_pdf/99/3c/kju-56-99.PMC4325125.pdf
org http://dx.doi.org/10.4111/kju.2015.56.2.99 Kim and Lee pertension; potential treatments for the common problem of  endothelial dysfunction.,OADS,/arxiv_data1/oa_pdf/99/3c/kju-56-99.PMC4325125.pdf
org http://dx.doi.org/10.4111/kju.2015.56.2.99 Kim and Lee male partner.,OADS,/arxiv_data1/oa_pdf/99/3c/kju-56-99.PMC4325125.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/12/a6/main.PMC4325126.pdf
Contents lists available at ScienceDirect NeuroImage: Clinical journal homepage: www.elsevier.com/locate/ynicl http://dx.doi.org/10.1016/j.nicl.2015.01.016 2213-1582/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/12/a6/main.PMC4325126.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/12/a6/main.PMC4325126.pdf
"Finally, ‘DTIFit ’(http://www.fmrib.ox.ac.uk/ fsl) was used to ﬁt diffusion tensors to the eddy- and EPI-corrected data to generate FA values for each subject using standard formulas in FSL.",OADS,/arxiv_data1/oa_pdf/12/a6/main.PMC4325126.pdf
"The investigators also acknowledge the ﬁnancial support of National Health Service (NHS) Research, Scotland, through the Scottish Mental Health Research Network ( http://www.smhrn.org.uk ) who provided assistance with subject recruitment and cognitive assessments.",Non-OADS,/arxiv_data1/oa_pdf/12/a6/main.PMC4325126.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2014-007023).,Non-OADS,/arxiv_data1/oa_pdf/2f/0e/bmjopen-2014-007023.PMC4325127.pdf
Secondary placental abruption: clinical features anddiagnosis 2014. http://www.uptodate.com/contents/placental-abruption-clinical-features-and-diagnosis28.,Non-OADS,/arxiv_data1/oa_pdf/2f/0e/bmjopen-2014-007023.PMC4325127.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2014-005839).,Non-OADS,/arxiv_data1/oa_pdf/21/f8/bmjopen-2014-005839.PMC4325128.pdf
"28Food items were calculated into grams per day using assumptions on stand-ard portion sizes, and nutrient intake was quanti ﬁed using the National Food Institute ’s Food Composition Databank V .6.02 (http://www.foodcomp.dk).",OADS,/arxiv_data1/oa_pdf/21/f8/bmjopen-2014-005839.PMC4325128.pdf
"Competing interests All authors have completed the Unified Competing Interests form at http://www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: AA reports personal fees from Global Dairy Platform, USA, Jenny Craig, USA, McCain Foods Limited, USA,and from McDonald ’s, USA, outside the submitted work.",Non-OADS,/arxiv_data1/oa_pdf/21/f8/bmjopen-2014-005839.PMC4325128.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/21/f8/bmjopen-2014-005839.PMC4325128.pdf
Data sharing statement Extra data can be accessed via the Dryad data repository at http://datadryad.org/ with the http://dx.doi.org/10.5061/dryad.,OADS,/arxiv_data1/oa_pdf/b7/c5/bmjopen-2014-006762.PMC4325129.pdf
http://www.nimh.nih.gov/health/publications/suicide-in-the-us-statistics-and-prevention/index.shtml (accessed 24Jul 2013).,Non-OADS,/arxiv_data1/oa_pdf/b7/c5/bmjopen-2014-006762.PMC4325129.pdf
http://www.stats-sd.gov.cn/disp/tjgb.asp?aa=4220100001 (accessed 14 Jun 2013).,OADS,/arxiv_data1/oa_pdf/b7/c5/bmjopen-2014-006762.PMC4325129.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2014-006014).,Non-OADS,/arxiv_data1/oa_pdf/22/a5/bmjopen-2014-006014.PMC4325130.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/61/e6/main.PMC4325131.pdf
"Both methods use widely available equipment and low-cost chemicals, yet produce highly accurate and reproducible results in high-throughput http://dx.doi.org/10.1016/j.fob.2015.01.003 2211-5463/ /C2112015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/61/e6/main.PMC4325131.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).⇑Corresponding author.,Non-OADS,/arxiv_data1/oa_pdf/61/e6/main.PMC4325131.pdf
"Supplementary data Supplementary data associated with this article can be found, in the online version, at http://dx.doi.org/10.1016/j.fob.2015.01.003 .020406080100120viability % of control Control  Arrayscan  CellTiter GloMTS MultitoxCRC29 CRC47 020406080100120 Fig.",OADS,/arxiv_data1/oa_pdf/61/e6/main.PMC4325131.pdf
This is an open access article under the CC BY license ( http://creativecommons.org/licenses/by/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7d/1a/main.PMC4325132.pdf
"In the mean time, http://dx.doi.org/10.1016/j.fob.2015.01.001 2211-5463/ /C2112015 The Authors.",OADS,/arxiv_data1/oa_pdf/7d/1a/main.PMC4325132.pdf
"This is an open access article under the CC BY license ( http://creativecommons.org/licenses/by/4.0/ ).Abbreviations: TnC, troponin C; BSA, bovine serum albumin; ELISA, enzyme linked immunosorbent assay; McTnI, wild type mouse cardiac TnI; McTnI A117G , mouse cardiac TnI A117G mutation; McTnI K118C , mouse cardiac TnI K118C mutation; McTnI-ND, N-terminal truncated mouse cardiac TnI; McTnI-ND A117G , N-terminal truncated McTnI A117G ; McTnI-ND K118C , N-terminal truncated McTnI K118C ; PKA, protein kinase A; TnI, troponin I; TnT, troponin T ⇑Corresponding author.",Non-OADS,/arxiv_data1/oa_pdf/7d/1a/main.PMC4325132.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/59/b5/main.PMC4325133.pdf
"RutR was originally identiﬁed as the regulator of a novel path- way for pyrimidine utilization, encoded by the rutABCDEFG operon [1,9,10] ; later on its genome-wide binding proﬁle was determined http://dx.doi.org/10.1016/j.fob.2015.01.002 2211-5463/ /C2112015 The Authors.",OADS,/arxiv_data1/oa_pdf/59/b5/main.PMC4325133.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).⇑Corresponding author at: Research Group of Microbiology, Department of Bio- engineering Sciences, Vrije Universiteit Brussel (VUB), Pleinlaan 2, B-1050 Brussel,Belgium.",Non-OADS,/arxiv_data1/oa_pdf/59/b5/main.PMC4325133.pdf
§Calculated using Molprobity server ( http://molprobity.biochem.duke.edu/ ).80 P. Nguyen Le Minh et al.,OADS,/arxiv_data1/oa_pdf/59/b5/main.PMC4325133.pdf
"Supplementary data Supplementary data associated with this article can be found, in the online version, at http://dx.doi.org/10.1016/j.fob.2015.01.002 .",OADS,/arxiv_data1/oa_pdf/59/b5/main.PMC4325133.pdf
*Correspondence: niels-bjarne.woods@med.lu.se http://dx.doi.org/10.1016/j.stemcr.2015.01.009 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/70/ee/main.PMC4325193.pdf
SUPPLEMENTAL INFORMATION Supplemental Information includes three ﬁgures and one tableand can be found with this article online at http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/70/ee/main.PMC4325193.pdf
"Stem Cell Reports Resource Large-Scale Hematopoietic Differentiation of Human Induced Pluripotent Stem Cells Provides Granulocytes or Macrophages for Cell ReplacementTherapies Nico Lachmann,1,2,10Mania Ackermann,1,2,10Eileen Frenzel,3,9Stefﬁ Liebhaber,1,2Sebastian Brennig,1,2 Christine Happle,4,9Dirk Hoffmann,2Olga Klimenkova,5Doreen Lu ¨ttge,1,2Theresa Buchegger,1,2 Mark Philipp Ku ¨hnel,6Axel Schambach,2,7Sabina Janciauskiene,3,9Constanca Figueiredo,8 Gesine Hansen,4,9Julia Skokowa,5,11and Thomas Moritz1,2,* 1RG Reprogramming and Gene Therapy, REBIRTH Cluster of Excellence, Hannover Medical School, Hannover 30625, Germany 2Institute of Experimental Hematology, Hannover Medical School, Hannover 30625, Germany 3Department of Respiratory Medicine, Hannover Medical School, Hannover 30625, Germany 4Department of Pediatric Pneumology, Allergology and Neonatology, Hannover Medical School, Hannover 30625, Germany 5Department of Molecular Hematopoiesis, Hannover Medical School, Hannover 30625, Germany 6Institute of Functional and Applied Anatomy, Hannover Medical School, Hannover 30625, Germany 7Division of Pediatric Hematology/Oncology, Boston Children’s Hospital, Harvard Medical School, Boston, MA 02115, USA 8Institute for Transfusion Medicine, Hannover Medical School, Hannover 30625, Germany 9Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), Member of the German Center for Lung Research (DZL), Hannover 30625, Germany 10Co-ﬁrst author 11Present address: Department of Oncology, Hematology, Immunology, Rheumatology and Pulmonology, University Hospital of Tu ¨bingen, Tu ¨bingen 72074, Germany*Correspondence: moritz.thomas@mh-hannover.de http://dx.doi.org/10.1016/j.stemcr.2015.01.005 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/d6/6f/main.PMC4325194.pdf
SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental Experimental Procedures and seven ﬁgures and can be found with this article on- line at http://dx.doi.org/10.1016/j.stemcr.2015.01.005 .,Non-OADS,/arxiv_data1/oa_pdf/d6/6f/main.PMC4325194.pdf
"Stem Cell Reports Report Use of RUNX2 Expression to Identify Osteogenic Progenitor Cells Derived from Human Embryonic Stem Cells Li Zou,1Fahad K. Kidwai,2Ross A. Kopher,1Jason Motl,1Cory A. Kellum,1Jennifer J. Westendorf,3 and Dan S. Kaufman1,* 1Department of Medicine, University of Minnesota, Minneapolis, MN 55455, USA 2Diagnostic/Biological Sciences, School of Dentistry, University of Minnesota, Minneapolis, MN 55455, USA 3Department of Orthopedic Surgery, Mayo Clinic, Rochester, MN 55905, USA *Correspondence: kaufm020@umn.edu http://dx.doi.org/10.1016/j.stemcr.2015.01.008 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/92/5d/main.PMC4325195.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental ExperimentalProcedures, four ﬁgures, and one table and can be found withthis article online at http://dx.doi.org/10.1016/j.stemcr.2015.",OADS,/arxiv_data1/oa_pdf/92/5d/main.PMC4325195.pdf
"Bhat,3 Anna Elisabetta Salcini,5and Ichiro Nakano1,* 1Department of Neurological Surgery, The James Comprehensive Cancer Center, The Ohio State University, Columbus, OH 43210, USA 2Department of Radiation Oncology, The University of Texas, MD Anderson Cancer Center, Houston, TX 77030, USA 3Department of Pathology, The University of Texas, MD Anderson Cancer Center, Houston, TX 77030, USA 4Department of Stem Cell Biology and Regenerative Medicine, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195, USA 5Biotech Research and Innovation Centre (BRIC), University of Copenhagen, Ole Maaløes Vej 5, 2200 Copenhagen, Denmark *Correspondence: ichiro.nakano@osumc.edu http://dx.doi.org/10.1016/j.stemcr.2014.12.006 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/7a/b8/main.PMC4325196.pdf
"A strong correlation between MELK and EZH2 was also observed when they were examined in three gliomadata sets ( Freije et al., 2004; Sun et al., 2006; Verhaak et al., 2010 ;https://tcga-data.nci.nih.gov/docs/publications/ gbm_exp/ )(Figure S1 B).",OADS,/arxiv_data1/oa_pdf/7a/b8/main.PMC4325196.pdf
"Intriguingly, when expression of MELK and EZH2 was compared between newly diagnosed, untreated GBM tumors and recurrent GBM tumors afterfailed radiation and chemotherapy, both of these proteinswere markedly upregulated in recurrent tumors ( Mao et al., 2013; Phillips et al., 2006 ;http://www.ncbi.nlm.",Non-OADS,/arxiv_data1/oa_pdf/7a/b8/main.PMC4325196.pdf
"The presence of pig-1 transcripts in the germline, as revealed by in situ hybridization (NEXTdatabase, http://nematode.lab.nig.ac.jp/ ) and quantitative RT-PCR (qRT-PCR) analysis ( Figure S4 ), suggests that pig-1 is expressed in the germline.",OADS,/arxiv_data1/oa_pdf/7a/b8/main.PMC4325196.pdf
"The statistically signiﬁcant correlation of FOXM1 and EZH2 expression in glioma tumors was also observed in other three data sets ( Freije et al., 2004; Sun et al., 2006; Ver- haak et al., 2010 ;https://tcga-data.nci.nih.gov/docs/ publications/gbm_exp/ )(Figure S5 ).",OADS,/arxiv_data1/oa_pdf/7a/b8/main.PMC4325196.pdf
SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental ExperimentalProcedures and ﬁve ﬁgures and can be found with this article on- line at http://dx.doi.org/10.1016/j.stemcr.2014.12.006 .,Non-OADS,/arxiv_data1/oa_pdf/7a/b8/main.PMC4325196.pdf
"Stem Cell Reports Report Nonirradiated NOD,B6.SCID Il2rg/C0//C0KitW41/W41(NBSGW) Mice Support Multilineage Engraftment of Human Hematopoietic Cells Brian E. McIntosh,1Matthew E. Brown,2Bret M. Dufﬁn,1John P. Maufort,1David T. Vereide,1,3 Igor I. Slukvin,4,5and James A. Thomson1,6,7,* 1Morgridge Institute for Research, Madison, WI 53715, USA 2Department of Surgery, University of Wisconsin, Madison, WI 53715, USA 3Biotechnology Center, University of Wisconsin, Madison, WI 53706, USA 4Wisconsin National Primate Research Center, University of Wisconsin, Madison, WI 53715, USA 5Department of Pathology and Laboratory Medicine, University of Wisconsin, Madison, WI 53715, USA 6Department of Cell and Regenerative Biology, University of Wisconsin School of Medicine and Public Health, Madison, WI 53706, USA 7Department of Molecular, Cellular, and Developmental Biology, University of California, Santa Barbara, Santa Barbara, CA 93106, USA *Correspondence: jthomson@morgridgeinstitute.org http://dx.doi.org/10.1016/j.stemcr.2014.12.005 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/ee/2a/main.PMC4325197.pdf
Statistics A two-sided Wilcoxon rank-sum test was performed using the sta-tistical software program MStat 5.5 ( http://mcardle.oncology.wisc.,OADS,/arxiv_data1/oa_pdf/ee/2a/main.PMC4325197.pdf
SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental ExperimentalProcedures and one table and can be found with this article onlineathttp://dx.doi.org/10.1016/j.stemcr.2014.12.005 .,OADS,/arxiv_data1/oa_pdf/ee/2a/main.PMC4325197.pdf
"Stem Cell Reports Report Stable X Chromosome Reactivation in Female Human Induced Pluripotent Stem Cells Tahsin Stefan Barakat,1,5,6Mehrnaz Ghazvini,1,2,5Bas de Hoon,1,4Tracy Li,1,2Bert Eussen,3Hannie Douben,3 Reinier van der Linden,2Nathalie van der Stap,1,2Marjan Boter,3Joop S. Laven,4Robert-Jan Galjaard,3 J. Anton Grootegoed,1Annelies de Klein,3and Joost Gribnau1,* 1Department of Developmental Biology 2Erasmus Stem Cell and Regenerative Medicine Institute 3Department of Clinical Genetics 4Department of Obstetrics and Gynecology Erasmus MC, University Medical Center, 3015 CE Rotterdam, the Netherlands 5Co-ﬁrst author 6Present address: MRC Centre of Regenerative Medicine, University of Edinburgh, Edinburgh EH16 4UU, UK *Correspondence: j.gribnau@erasmusmc.nl http://dx.doi.org/10.1016/j.stemcr.2014.12.012 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/fa/ad/main.PMC4325229.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental ExperimentalProcedures, four ﬁgures, and two tables and can be found with this article online at http://dx.doi.org/10.1016/j.stemcr.2014.12.",OADS,/arxiv_data1/oa_pdf/fa/ad/main.PMC4325229.pdf
"Published online June 14, 2014. http://dx.doi.org/10.3791/ 51628.",Non-OADS,/arxiv_data1/oa_pdf/fa/ad/main.PMC4325229.pdf
"Stem Cell Reports Report Endothelial Cells Control Pancreatic Cell Fate at Deﬁned Stages through EGFL7 Signaling Der-I Kao,1Lauretta A. Lacko,2Bi-Sen Ding,3Chen Huang,4Kathleen Phung,1Guoqiang Gu,4Shahin Raﬁi,3 Heidi Stuhlmann,2and Shuibing Chen1,* 1Departments of Surgery and Biochemistry 2Department of Cell and Developmental Biology 3Howard Hughes Medical Institute, Ansary Stem Cell Institute, Department of Genetic Medicine Weill Cornell Medical College, New York, NY 10065, USA 4Vanderbilt University Medical Center, Nashville, TN 37232, USA *Correspondence: shc2034@med.cornell.edu http://dx.doi.org/10.1016/j.stemcr.2014.12.008 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/94/20/main.PMC4325230.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental Experimental Procedures, four ﬁgures, and two tables and can be found with this article online at http://dx.doi.org/10.1016/j.stemcr.2014.12.",OADS,/arxiv_data1/oa_pdf/94/20/main.PMC4325230.pdf
http://dx.doi.org/10.3791/3759 .,Non-OADS,/arxiv_data1/oa_pdf/94/20/main.PMC4325230.pdf
http://dx.doi.org/10.1016/j.stemcr.2014.12.009 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/38/cb/main.PMC4325231.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental ExperimentalProcedures, six ﬁgures, and seven tables and can be found with this article online at http://dx.doi.org/10.1016/j.stemcr.2014.12.",OADS,/arxiv_data1/oa_pdf/38/cb/main.PMC4325231.pdf
"Stem Cell Reports Article Activated STAT5 Confers Resistance to Intestinal Injury by Increasing Intestinal Stem Cell Proliferation and Regeneration Shila Gilbert,1,8Harini Nivarthi,6,8Christopher N. Mayhew,2,8Yuan-Hung Lo,1Taeko K. Noah,1 Jefferson Vallance,1Thomas Ru ¨licke,6,7Mathias Mu ¨ller,6,7Anil G. Jegga,3Wenjuan Tang,1 Dongsheng Zhang,1Michael Helmrath,4Noah Shroyer,1,2Richard Moriggl,5,6,7and Xiaonan Han1,* 1Division of Gastroenterology, Hepatology and Nutrition 2Division of Developmental Biology 3Division of Biomedical Informatics 4Division of Pediatric Surgery Cincinnati Children’s Hospital Medical Center, Cincinnati, OH 45229, USA 5Ludwig Boltzmann Institute for Cancer Research, 1090 Vienna, Austria 6Institute of Animal Breeding and Genetics, Biomodels Austria, Institute of Laboratory Animal Science, University of Veterinary Medicine, 1210 Vie nna, Austria 7Medical University of Vienna, 1090 Vienna, Austria 8Co-ﬁrst author *Correspondence: xiaonan.han@cchmc.org http://dx.doi.org/10.1016/j.stemcr.2014.12.004 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/26/b1/main.PMC4325270.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental Experimental Procedures, six ﬁgures, and three tables and can be found with this article online at http://dx.doi.org/10.1016/j.stemcr.",OADS,/arxiv_data1/oa_pdf/26/b1/main.PMC4325270.pdf
"Stem Cell Reports Article Disequilibrium of BMP2 Levels in the Breast Stem Cell Niche Launches Epithelial T ransformation by Overamplifying BMPR1B Cell Response Marion Chapellier,1,2,3,4,5Elodie Bachelard-Cascales,6Xenia Schmidt,1,2,3,4,5Flora Cle ´ment,1,2,3,4,5 Isabelle Treilleux,1,2,3,4,5,7Emmanuel Delay,1,2,3,4,5,7Alexandre Jammot,1,2,3,4,5 Christine Me ´ne´trier-Caux,1,2,3,4,5,7Gae¨tan Pochon,1,2,3,4,5Roger Besanc ¸on,1,2,3,4,5Thibault Voeltzel,1,2,3,4,5 Claude Caron de Fromentel,1,2,3,4,5Christophe Caux,1,2,3,4,5,7Jean-Yves Blay,1,2,3,4,5,7Richard Iggo,6 and Ve ´ronique Maguer-Satta1,2,3,4,5,* 1CNRS UMR5286, Centre de Recherche en Cance ´rologie de Lyon, 69000 Lyon, France 2Inserm U1052, Centre de Recherche en Cance ´rologie de Lyon, 69000 Lyon, France 3Universite ´de Lyon, 69000 Lyon, France 4Department of Immunity, Virus, and Microenvironment, 69000 Lyon, France 5Universite ´de Lyon 1, ISPB, 69000 Lyon, France 6Inserm U916, Institut Bergonie ´, University of Bordeaux, 33076 Bordeaux, France 7Centre Le ´on Be ´rard, 69000 Lyon, France *Correspondence: veronique.maguer-satta@lyon.unicancer.fr http://dx.doi.org/10.1016/j.stemcr.2014.12.007 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/c2/22/main.PMC4325271.pdf
SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental Experimental Procedures and ﬁve ﬁgures and can be found with this article on- line at http://dx.doi.org/10.1016/j.stemcr.2014.12.007 .,Non-OADS,/arxiv_data1/oa_pdf/c2/22/main.PMC4325271.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/7a/ac/srep08431.PMC4325316.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 5 : 8431 | DOI: 10.1038/srep08431 4",Non-OADS,/arxiv_data1/oa_pdf/7a/ac/srep08431.PMC4325316.pdf
"directed the work, contributed to the analysis and the manuscript writing.Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.",Non-OADS,/arxiv_data1/oa_pdf/69/73/srep08426.PMC4325329.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 5 : 8426 | DOI: 10.1038/srep08426 7",Non-OADS,/arxiv_data1/oa_pdf/69/73/srep08426.PMC4325329.pdf
"Spike detection was performed with the use of a pattern recognition algorithm (an automatic spike detection program coded in MATLAB,http://www.mathworks.com/matlabcentral/fileexchange/25500-peakfinder) and also by visual inspection of all the data sets.",OADS,/arxiv_data1/oa_pdf/4d/e9/srep08423.PMC4325330.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 5 : 8423 | DOI: 10.1038/srep08423 7",Non-OADS,/arxiv_data1/oa_pdf/4d/e9/srep08423.PMC4325330.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/71/08/srep08421.PMC4325332.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 5 : 8421 | DOI: 10.1038/srep08421 8",Non-OADS,/arxiv_data1/oa_pdf/71/08/srep08421.PMC4325332.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/cc/7c/srep08429.PMC4325339.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 5 : 8429 | DOI: 10.1038/srep08429 8",Non-OADS,/arxiv_data1/oa_pdf/cc/7c/srep08429.PMC4325339.pdf
Available from: http://umoomi.sbmu.ac.ir.servercms1.com/uploads/tamas_ba_jame.pdf 2013 [last accessed on 2014 Sep 21].,Non-OADS,/arxiv_data1/oa_pdf/21/16/IJNMR-20-113.PMC4325402.pdf
Available from: http://www.dx.doi.org/10.1016/j.midw.,OADS,/arxiv_data1/oa_pdf/21/16/IJNMR-20-113.PMC4325402.pdf
Available from: http://www.who.int/sdhconference/resources/Conference_Report.pdf [Last accessed on 2014 Aug 07].,Non-OADS,/arxiv_data1/oa_pdf/21/16/IJNMR-20-113.PMC4325402.pdf
Available from: http://www.who.int/socialdeterminants/resources/csdhframeworkaction0507.pdf [Last accessed on 2011 Oct 19-21].,OADS,/arxiv_data1/oa_pdf/21/16/IJNMR-20-113.PMC4325402.pdf
"In order to calculate Kt/V, blood samples were obtained  before and after hemodialysis, urea tests were performed, and the ratios were calculated using the dialysis adequacy calculation software available online (http://www.merah.ir/home/index.php?option=com_wrapperandview=wrapperandItemid=15).",Non-OADS,/arxiv_data1/oa_pdf/03/71/IJNMR-20-12.PMC4325403.pdf
Available  from: http://www.lilakelly.com.,Non-OADS,/arxiv_data1/oa_pdf/47/fc/IJNMR-20-17.PMC4325409.pdf
Available from: http://www.imamreza.net/eng/imamreza.php?id=1275.,Non-OADS,/arxiv_data1/oa_pdf/86/a6/IJNMR-20-25.PMC4325410.pdf
Available from: http://www.ejbiotechnology.info/content/vol8/issue3/full/9/bip/.,Non-OADS,/arxiv_data1/oa_pdf/bc/89/IJNMR-20-40.PMC4325412.pdf
Available at: http://scholarworks.montana.edu/xmlui/bitstream/handle/1/919/BeselJ0506.pdf 2013.,Non-OADS,/arxiv_data1/oa_pdf/9f/09/IJNMR-20-63.PMC4325415.pdf
Available at: http://www.diva-portal.org/smash/get/diva2:5595/FULLTEXT01.pdf 2013.,Non-OADS,/arxiv_data1/oa_pdf/9f/09/IJNMR-20-63.PMC4325415.pdf
Available at: http://www.kb.psu.ac.th/psukb/bitstream/2010/7097/1/320171.pdf 2013.,Non-OADS,/arxiv_data1/oa_pdf/9f/09/IJNMR-20-63.PMC4325415.pdf
Available from; http://www.WHO.org/.,Non-OADS,/arxiv_data1/oa_pdf/7b/7f/IJNMR-20-7.PMC4325417.pdf
Available from: http://www.diabetes.org/udeocumentations/nationaldiabetes fact sheetRev.pdf  [Last accessed on 2005 May 22].,Non-OADS,/arxiv_data1/oa_pdf/ba/ad/IJNMR-20-75.PMC4325418.pdf
Available from: http://www.dx.doi.org/.,Non-OADS,/arxiv_data1/oa_pdf/27/52/IJNMR-20-99.PMC4325422.pdf
"To see more or order reprints or permissions, see http://ijssurgery.com.",Non-OADS,/arxiv_data1/oa_pdf/d9/97/IJSS-8-14444-1035.PMC4325480.pdf
"To see more or order reprints or permissions, see http://ijssurgery.com.",Non-OADS,/arxiv_data1/oa_pdf/87/28/IJSS-8-14444-1005.PMC4325481.pdf
"To see more or order reprints or permissions, see http://ijssurgery.com.",Non-OADS,/arxiv_data1/oa_pdf/48/19/IJSS-8-14444-1018.PMC4325482.pdf
"To see more or order reprints or permissions, see http://ijssurgery.com.",Non-OADS,/arxiv_data1/oa_pdf/c6/2a/IJSS-8-14444-1026.PMC4325483.pdf
"Peroneal neuropathy misdiagnosed as L5 radiculopathy: a case report Michael D Reife12 and Christopher M Coulis345 Chiropractic & Manual Therapies 2013, 21:12 http://www.chiromt.com/content/21/1/12",Non-OADS,/arxiv_data1/oa_pdf/5e/f4/IJSS-8-14444-1015.PMC4325484.pdf
"To see more or order reprints or permissions, see http://ijssurgery.com.",Non-OADS,/arxiv_data1/oa_pdf/5e/f4/IJSS-8-14444-1015.PMC4325484.pdf
"To see more or order reprints or permissions, see http://ijssurgery.com.",Non-OADS,/arxiv_data1/oa_pdf/d1/c0/IJSS-8-14444-1032.PMC4325485.pdf
"To see more or order reprints or permissions, see http://ijssurgery.com.",Non-OADS,/arxiv_data1/oa_pdf/0d/ae/IJSS-8-14444-1007.PMC4325486.pdf
"To see more or order reprints or permissions, see http://ijssurgery.com.",Non-OADS,/arxiv_data1/oa_pdf/b9/8f/IJSS-8-14444-1027.PMC4325487.pdf
"To see more or order reprints or permissions, see http://ijssurgery.com.",Non-OADS,/arxiv_data1/oa_pdf/5d/2d/IJSS-8-14444-1010.PMC4325488.pdf
"To see more or order reprints or permissions, see http://ijssurgery.com.",Non-OADS,/arxiv_data1/oa_pdf/0e/75/IJSS-8-14444-1004.PMC4325489.pdf
"To see more or order reprints or permissions, see http://ijssurgery.com.",Non-OADS,/arxiv_data1/oa_pdf/16/c4/IJSS-8-14444-1030.PMC4325490.pdf
"To see more or order reprints or permissions, see http://ijssurgery.com.",Non-OADS,/arxiv_data1/oa_pdf/54/7a/IJSS-8-14444-1019.PMC4325491.pdf
"To see more or order reprints or permissions, see http://ijssurgery.com.",Non-OADS,/arxiv_data1/oa_pdf/dc/78/IJSS-8-14444-1021.PMC4325492.pdf
"To see more or order reprints or permissions, see http://ijssurgery.com.",Non-OADS,/arxiv_data1/oa_pdf/be/fe/IJSS-8-14444-1011.PMC4325493.pdf
"To see more or order reprints or permissions, see http://ijssurgery.com.",Non-OADS,/arxiv_data1/oa_pdf/0d/58/IJSS-8-14444-1020.PMC4325494.pdf
"To see more or order reprints or permissions, see http://ijssurgery.com.",Non-OADS,/arxiv_data1/oa_pdf/54/1e/IJSS-8-14444-1034.PMC4325495.pdf
"To see more or order reprints or permissions, see http://ijssurgery.com.",Non-OADS,/arxiv_data1/oa_pdf/8c/ee/IJSS-8-14444-1014.PMC4325496.pdf
"To see more or order reprints or permissions, see http://ijssurgery.com.",Non-OADS,/arxiv_data1/oa_pdf/ee/1c/IJSS-8-14444-1031.PMC4325497.pdf
"To see more or order reprints or permissions, see http://ijssurgery.com.",Non-OADS,/arxiv_data1/oa_pdf/ff/d1/IJSS-8-14444-1008.PMC4325498.pdf
"To see more or order reprints or permissions, see http://ijssurgery.com.",Non-OADS,/arxiv_data1/oa_pdf/8f/f5/IJSS-8-14444-1001.PMC4325499.pdf
"To see more or order reprints or permissions, see http://ijssurgery.com.",Non-OADS,/arxiv_data1/oa_pdf/76/17/IJSS-8-14444-1024.PMC4325500.pdf
"To see more or order reprints or permissions, see http://ijssurgery.com.",Non-OADS,/arxiv_data1/oa_pdf/c3/0f/IJSS-8-14444-1003.PMC4325501.pdf
"To see more or order reprints or permissions, see http://ijssurgery.com.",Non-OADS,/arxiv_data1/oa_pdf/c0/98/IJSS-8-14444-1029.PMC4325502.pdf
"To see more or order reprints or permissions, see http://ijssurgery.com.",Non-OADS,/arxiv_data1/oa_pdf/12/3e/IJSS-8-14444-1017.PMC4325503.pdf
"To see more or order reprints or permissions, see http://ijssurgery.com.",Non-OADS,/arxiv_data1/oa_pdf/0a/96/IJSS-8-14444-1023.PMC4325504.pdf
"To see more or order reprints or permissions, see http://ijssurgery.com.",Non-OADS,/arxiv_data1/oa_pdf/35/05/IJSS-8-14444-1002.PMC4325505.pdf
"To see more or order reprints or permissions, see http://ijssurgery.com.",Non-OADS,/arxiv_data1/oa_pdf/bd/68/IJSS-8-14444-1009.PMC4325506.pdf
"To see more or order reprints or permissions, see http://ijssurgery.com.",Non-OADS,/arxiv_data1/oa_pdf/19/62/IJSS-8-14444-1022.PMC4325507.pdf
A.T. Yeung #453 Intra-operative Neuromonitoring in Percutaneous Transforaminal Surgery MIS Techniques and Results http://www.isass.org/abstracts/ isass12_regular_posters/isass12-453-Intra-operative-Neuromonitoring-in- Percutaneous-Transforaminal-Surgery.html 93.,Non-OADS,/arxiv_data1/oa_pdf/1c/5e/IJSS-8-14444-1028.PMC4325508.pdf
"To see more or order reprints or permissions, see http://ijssurgery.com.",Non-OADS,/arxiv_data1/oa_pdf/1c/5e/IJSS-8-14444-1028.PMC4325508.pdf
"To see more or order reprints or permissions, see http://ijssurgery.com.",Non-OADS,/arxiv_data1/oa_pdf/64/a2/IJSS-8-14444-1016.PMC4325509.pdf
"To see more or order reprints or permissions, see http://ijssurgery.com.",Non-OADS,/arxiv_data1/oa_pdf/c5/41/IJSS-8-14444-1025.PMC4325510.pdf
Available at: http://thejns.org/doi/abs/10.3171/spi.2003.98.2.0156 .,Non-OADS,/arxiv_data1/oa_pdf/32/0e/IJSS-8-14444-1033.PMC4325511.pdf
Available at: http://thejns.org/doi/abs/ 10.3171/2014.1.FOCUS13565.,Non-OADS,/arxiv_data1/oa_pdf/32/0e/IJSS-8-14444-1033.PMC4325511.pdf
"Available at: http://journals.lww.com/spinejournal/Abstract/ 2001/08010/A_Multicenter,_... .",OADS,/arxiv_data1/oa_pdf/32/0e/IJSS-8-14444-1033.PMC4325511.pdf
Available at: http://www.ajnr.org/content/22/5/997.short .,Non-OADS,/arxiv_data1/oa_pdf/32/0e/IJSS-8-14444-1033.PMC4325511.pdf
Available at: http://www.ncbi.nlm.nih.gov/pubmed/24070089 .,Non-OADS,/arxiv_data1/oa_pdf/32/0e/IJSS-8-14444-1033.PMC4325511.pdf
Available at: http://www.ajnr.org/content/20/5/757.short .,Non-OADS,/arxiv_data1/oa_pdf/32/0e/IJSS-8-14444-1033.PMC4325511.pdf
Available at: http://www.tumorionline.it/r.php?v=611&a=7141&l=10027&f=allegati/00611_2... (66-73).pdf.,OADS,/arxiv_data1/oa_pdf/32/0e/IJSS-8-14444-1033.PMC4325511.pdf
Available at: http://www.ncbi.nlm.nih.gov/ entrez/query.fcgi?cmd=Retrieve&db=PubMed&dop... .,OADS,/arxiv_data1/oa_pdf/32/0e/IJSS-8-14444-1033.PMC4325511.pdf
Available at: http://journals.lww.com/spinejournal/Abstract/2006/10010/How_Many_Ligati... .,OADS,/arxiv_data1/oa_pdf/32/0e/IJSS-8-14444-1033.PMC4325511.pdf
Available at: http://journals.lww.com/spinejournal/Abstract/ 2008/06150/Effects_on_Spinal_Cord_Blood_Flow_and_Neurologic.7.aspx.,OADS,/arxiv_data1/oa_pdf/32/0e/IJSS-8-14444-1033.PMC4325511.pdf
Available at: http://journals.lww.com/ spinejournal/Abstract/2010/10150/Does_Interrupti... .,Non-OADS,/arxiv_data1/oa_pdf/32/0e/IJSS-8-14444-1033.PMC4325511.pdf
"To see more or order reprints or permissions, see http://ijssurgery.com.",Non-OADS,/arxiv_data1/oa_pdf/32/0e/IJSS-8-14444-1033.PMC4325511.pdf
"To see more or order reprints or permissions, see http://ijssurgery.com.",Non-OADS,/arxiv_data1/oa_pdf/8b/b9/IJSS-8-14444-1006.PMC4325512.pdf
"To see more or order reprints or permissions, see http://ijssurgery.com.",Non-OADS,/arxiv_data1/oa_pdf/3c/38/IJSS-8-14444-1013.PMC4325513.pdf
http://www.bbraun.com/cps/rde/xchg/ bbraun-com/hs.xsl/products.html?prid=... .,OADS,/arxiv_data1/oa_pdf/fc/9e/IJSS-8-14444-1012.PMC4325514.pdf
http://www.mediform.cz/ Data/files/odborne_studie/ldr/MOBIDISC%20prosthes... .,Non-OADS,/arxiv_data1/oa_pdf/fc/9e/IJSS-8-14444-1012.PMC4325514.pdf
"To see more or order reprints or permissions, see http://ijssurgery.com.",Non-OADS,/arxiv_data1/oa_pdf/fc/9e/IJSS-8-14444-1012.PMC4325514.pdf
"Sao Paulo 57(1):1-13, January-February, 2015 http://dx.doi.org/10.1590/S0036-46652015000100001 (1) Universidade Federal de Alagoas.",Non-OADS,/arxiv_data1/oa_pdf/a7/57/0036-4665-rimtsp-57-01-01.PMC4325517.pdf
Available from:   http://www12.statcan.gc.ca/nhs-enm/2011/as-sa/99-011-x/99-011-x2011001- eng.pdf  2.,Non-OADS,/arxiv_data1/oa_pdf/a7/57/0036-4665-rimtsp-57-01-01.PMC4325517.pdf
Available from:   http://www.infoplease.com/spot/aihmcensus1.html.,Non-OADS,/arxiv_data1/oa_pdf/a7/57/0036-4665-rimtsp-57-01-01.PMC4325517.pdf
Available  from: http://dx.doi.org/10.4172/2332-0877.1000108.,Non-OADS,/arxiv_data1/oa_pdf/a7/57/0036-4665-rimtsp-57-01-01.PMC4325517.pdf
Publications from 1984 to the present data are now available on: http://www.scielo.br/rimtsp PAST ISSUES FROM 1959 ON (PDF) www.imt.usp.br/portal/  SciELO  – The Scientific Electronic Library OnLine - SciELO is an electronic virtual covering a selected    collection of Brazilian scientific journals.,Non-OADS,/arxiv_data1/oa_pdf/a7/57/0036-4665-rimtsp-57-01-01.PMC4325517.pdf
"Sao Paulo 57(1):15-20, January-February, 2015 http://dx.doi.org/10.1590/S0036-46652015000100002 Financial Support:  This research was supported by the Brazilian Research Council (Conselho Nacional de Desenvolvimento Científico e Tecnológico, CNPq, Brazil, Protocol 475040/2011-2).",Non-OADS,/arxiv_data1/oa_pdf/3b/57/0036-4665-rimtsp-57-01-15.PMC4325518.pdf
"Sao Paulo 57(1):21-26, January-February, 2015 http://dx.doi.org/10.1590/S0036-46652015000100003 (1) Departamento de Biología de Organismos, Universidad Simón Bolívar, Caracas, Venezuela.",Non-OADS,/arxiv_data1/oa_pdf/29/2f/0036-4665-rimtsp-57-01-21.PMC4325519.pdf
"Sao Paulo 57(1):27-32, January-February, 2015 http://dx.doi.org/10.1590/S0036-46652015000100004 *The authors contributed equally to this work.",Non-OADS,/arxiv_data1/oa_pdf/d1/68/0036-4665-rimtsp-57-01-27.PMC4325520.pdf
"Sao Paulo 57(1):33-38, January-February, 2015 http://dx.doi.org/10.1590/S0036-46652015000100005 (1) Specialist in Health Sciences from the University of Health Sciences of Alagoas-UNCISAL.",Non-OADS,/arxiv_data1/oa_pdf/12/6c/0036-4665-rimtsp-57-01-33.PMC4325521.pdf
"Sao Paulo 57(1):39-46, January-February, 2015 http://dx.doi.org/10.1590/S0036-46652015000100006 (1) Faculdade São Lucas.",Non-OADS,/arxiv_data1/oa_pdf/13/60/0036-4665-rimtsp-57-01-39.PMC4325522.pdf
"Sao Paulo 57(1):47-55, January-February, 2015 http://dx.doi.org/10.1590/S0036-46652015000100007 (1) Laboratorio de Inmunología de Enfermedades Infecciosas, Instituto de Biomedicina, Universidad Central de Venezuela, Caracas, Venezuela.",Non-OADS,/arxiv_data1/oa_pdf/99/c3/0036-4665-rimtsp-57-01-47.PMC4325523.pdf
"Sao Paulo 57(1):57-61, January-February, 2015 http://dx.doi.org/10.1590/S0036-46652015000100008 (1) Department of Dermatology, Medical School, University of Sao Paulo, São Paulo, SP, Brazil.",Non-OADS,/arxiv_data1/oa_pdf/70/ee/0036-4665-rimtsp-57-01-57.PMC4325524.pdf
"Sao Paulo 57(1):63-72, January-February, 2015 http://dx.doi.org/10.1590/S0036-46652015000100009 (1) Facultad de Ecología y Recursos Naturales, Universidad Andres Bello, Av.",Non-OADS,/arxiv_data1/oa_pdf/db/a9/0036-4665-rimtsp-57-01-63.PMC4325525.pdf
"Source: SIEPI-PANAFTOSA/PAHO-WHO, data available on http://siepi.panaftosa.org.br/",OADS,/arxiv_data1/oa_pdf/db/a9/0036-4665-rimtsp-57-01-63.PMC4325525.pdf
Available from: http://www.iucnredlist.org/  37.,Non-OADS,/arxiv_data1/oa_pdf/db/a9/0036-4665-rimtsp-57-01-63.PMC4325525.pdf
"Sao Paulo 57(1):73-76, January-February, 2015 http://dx.doi.org/10.1590/S0036-46652015000100010 (1) Facultad de Ciencias Exactas y Naturales y Agrimensura, Universidad Nacional del Nordeste, Corrientes, Corrientes, Argentina.",Non-OADS,/arxiv_data1/oa_pdf/7b/e7/0036-4665-rimtsp-57-01-73.PMC4325526.pdf
Available from: http://www.smn.gov.ar/  17.,Non-OADS,/arxiv_data1/oa_pdf/7b/e7/0036-4665-rimtsp-57-01-73.PMC4325526.pdf
"Sao Paulo 57(1):77-80, January-February, 2015 http://dx.doi.org/10.1590/S0036-46652015000100011 (1) Instituto de Medicina Tropical de São Paulo, USP, São Paulo, SP, Brazil.",Non-OADS,/arxiv_data1/oa_pdf/6a/f1/0036-4665-rimtsp-57-01-77.PMC4325527.pdf
"Sao Paulo 57(1):81-83, January-February, 2015 http://dx.doi.org/10.1590/S0036-46652015000100012 Departamento de Microbiologia, Imunologia e Parasitologia.",Non-OADS,/arxiv_data1/oa_pdf/6c/7e/0036-4665-rimtsp-57-01-81.PMC4325528.pdf
"Analysis of the DNA sequences was performed  with the Chromas Lite program and compared to those present in  GenBank (http://blast.ncbi.nlm.nih.gov/).In the present study, all isolates of Acanthamoeba showed  internalized bacteria when primers are used to amplify the Bacteria  domain and all isolates showed the genus Pseudomonas  spp.",OADS,/arxiv_data1/oa_pdf/6c/7e/0036-4665-rimtsp-57-01-81.PMC4325528.pdf
"Sao Paulo 57(1):85-87, January-February, 2015 http://dx.doi.org/10.1590/S0036-46652015000100013 (1) Post-Graduate Program in Health Sciences - Parasitology Laboratory, Universidade Federal do Rio Grande (FURG), Academic Area of the University Hospital, FURG.",Non-OADS,/arxiv_data1/oa_pdf/38/d7/0036-4665-rimtsp-57-01-85.PMC4325529.pdf
"Sao Paulo 57(1):88, January-February, 2015 http://dx.doi.org/10.1590/S0036-46652015000100014 CORRESPONDENCE NEUROCYSTICERCOSIS AND AFEBRILE SEIZURE Sir, The report on “neurocysticercosis and afebrile seizure3” is very interesting.",Non-OADS,/arxiv_data1/oa_pdf/3e/49/0036-4665-rimtsp-57-01-88.PMC4325530.pdf
"Sao Paulo 57(1):89-91, January-February, 2015 http://dx.doi.org/10.1590/S0036-46652015000100015 LETTER TO THE EDITOR LOOSE AND COMPACT AGGLOMERATES OF 50 NM MICROVESICLES DERIVED FROM   GOLGI AND ENDOPLASMIC RETICULUM MEMBRANES IN PRE- AND IN -APOPTOTIC   MYCOPLASMA INFECTED HELA CELLS: HOST-PARASITE INTERACTIONS   UNDER THE TRANSMISSION ELECTRON MICROSCOPE São Paulo, November 17, 2014 Dear Editor  The fine structure of apoptotic HeLa cells from cultures contaminated  with mycoplasma in early and in advanced stages of the cell demise  process differs from those so far described in apoptotic cells.",Non-OADS,/arxiv_data1/oa_pdf/20/eb/0036-4665-rimtsp-57-01-89.PMC4325531.pdf
"Sao Paulo 57(1):92, January-February, 2015 http://dx.doi.org/10.1590/S0036-46652015000100016 LETTER TO THE EDITOR INFLUENZA VIRUS SURVEILLANCE BY THE INSTITUTO ADOLFO LUTZ,   INFLUENZA SEASON 2014: ANTIVIRAL RESISTANCE São Paulo, August 4, 2014 Dear Sir, Neuraminidase (NA) inhibitors (NAIs) are the only antivirals that  are effective for prophylaxis and the treatment of seasonal influenza  A and B infections.",Non-OADS,/arxiv_data1/oa_pdf/5a/02/0036-4665-rimtsp-57-01-92.PMC4325532.pdf
The code used by team IGB is provided under http://github.com/uci-igb/improver2013.,Non-OADS,/arxiv_data1/oa_pdf/31/17/btu407.PMC4325536.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/31/17/btu407.PMC4325536.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/98/ea/btu611.PMC4325540.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9b/53/btu647.PMC4325541.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a3/39/pgpm-8-001.PMC4325625.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pPharmacogenomics and Personalized Medicine 2015:8 1–7Pharmacogenomics and Personalized Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  1Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PGPM.S5550 1Targeted treatment for chronic lymphocytic  leukemia: clinical potential of obinutuzumab Lukáš Smolej 4th Department of internal   Medicine – Hematology, University  Hospital Hradec Králové and Charles  University in Prague, Faculty of  Medicine in Hradec Králové, Hradec  Králové, Czech Republic Correspondence: Lukáš Smolej   4th Department of internal Medicine –   Hematology, University Hospital   and Charles University in Prague,   Faculty of Medicine in Hradec Králové,   Sokolská 581, 50005 Hradec Králové,   Czech Republic   Tel +420 49 583 2649, +420 49 583 4688   Fax +420 49 583 2011   email lukas.smolej@fnhk.c zAbstract:  Introduction of targeted agents revolutionized the treatment of chronic lymphocytic  leukemia (CLL) in the past decade.",Non-OADS,/arxiv_data1/oa_pdf/a3/39/pgpm-8-001.PMC4325625.pdf
"Available from: http://www.ema.europa.eu/docs/en_GB/ document_library/EPAR_-_Public_assessment_ report/human/002799/ WC500171596.pd f. Accessed October 17, 2014.",Non-OADS,/arxiv_data1/oa_pdf/a3/39/pgpm-8-001.PMC4325625.pdf
"Pharmacogenomics and Personalized Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/pharmacogenomics-and-personalized-medicine-journa lPharmacogenomics and Personalized Medicine is an international, peer- reviewed, open access journal characterizing the influence of genotype  on pharmacology leading to the development of personalized treatment  programs and individualized drug selection for improved safety, efficacy  and sustainability.",Non-OADS,/arxiv_data1/oa_pdf/a3/39/pgpm-8-001.PMC4325625.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/a3/39/pgpm-8-001.PMC4325625.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/56/10/pgpm-8-009.PMC4325626.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pPharmacogenomics and Personalized Medicine 2015:8 9–22Pharmacogenomics and Personalized Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  9Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PGPM.S5284 6Asthma pharmacogenetics and the development  of genetic profiles for personalized medicine victor e Ortega Deborah A Meyers eugene R Bleecker Center for Genomics and  Personalized Medicine Research,    Pulmonary Medicine, wake Forest  School of Medicine, winston-Salem,   NC, USA Correspondence: eugene R Bleecker   Center for Genomics and Personalized  Medicine Research, Pulmonary Medicine,  wake Forest School of Medicine, Medical  Center Boulevard, winston-Salem,   NC 27157, USA   T el +1 336 713 7521   Fax +1 336 713 7566   email ebleeck@wakehealth.ed uAbstract:  Human genetics research will be critical to the development of genetic profiles for  personalized or precision medicine in asthma.",Non-OADS,/arxiv_data1/oa_pdf/56/10/pgpm-8-009.PMC4325626.pdf
"Available from: http://www.fda.gov/Drugs/ DrugSafety /ucm251512.ht m. Accessed July 10, 2012.",Non-OADS,/arxiv_data1/oa_pdf/56/10/pgpm-8-009.PMC4325626.pdf
"Pharmacogenomics and Personalized Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/pharmacogenomics-and-personalized-medicine-journa lPharmacogenomics and Personalized Medicine is an international, peer- reviewed, open access journal characterizing the influence of genotype  on pharmacology leading to the development of personalized treatment  programs and individualized drug selection for improved safety, efficacy  and sustainability.",Non-OADS,/arxiv_data1/oa_pdf/56/10/pgpm-8-009.PMC4325626.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/56/10/pgpm-8-009.PMC4325626.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/9e/99/pgpm-8-023.PMC4325627.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pPharmacogenomics and Personalized Medicine 2015:8 23–33Pharmacogenomics and Personalized Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  23Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PGPM.S3908 5Targeted treatments for multiple myeloma:  specific role of carfilzomib Dhivya Sugumar1 Jesse Keller2 Ravi vij2 1Department of internal Medicine,   St Mary’s Health Center, 2Department  of Medicine, Division of Oncology,   washington University in St Louis,   St Louis, USA Correspondence: Ravi vij   Department of Medicine, Division of  Oncology, washington University in St  Louis, 660 South euclid Avenue, St Louis,  MO 63110, USA   email rvij@dom.wustl.ed uAbstract:  Carfilzomib is a selective, irreversible proteasome inhibitor, initially approved in the  US in 2012 as single-agent therapy for relapsed and refractory multiple myeloma.",Non-OADS,/arxiv_data1/oa_pdf/9e/99/pgpm-8-023.PMC4325627.pdf
"August 10, 2014];  Available from: http://www.cancer.org/cancer/multiplemyeloma /.",Non-OADS,/arxiv_data1/oa_pdf/9e/99/pgpm-8-023.PMC4325627.pdf
"August 10, 2014 Available from: http://www.nccn.org/ professionals /physician_gls/pdf/myeloma.pd f.  3. van de Donk NW, et  al.",Non-OADS,/arxiv_data1/oa_pdf/9e/99/pgpm-8-023.PMC4325627.pdf
"August 12, 2014]; Available from: http://www.amgen.",Non-OADS,/arxiv_data1/oa_pdf/9e/99/pgpm-8-023.PMC4325627.pdf
"August 4, 2014; Available from: http://www.amgen.co m.  26.",Non-OADS,/arxiv_data1/oa_pdf/9e/99/pgpm-8-023.PMC4325627.pdf
Available  from: http://clinicaltrials.gov/show/NCT0156886 6.,Non-OADS,/arxiv_data1/oa_pdf/9e/99/pgpm-8-023.PMC4325627.pdf
Available from:  http://clinicaltrials.gov/ct2/show/NCT0200259 8.,Non-OADS,/arxiv_data1/oa_pdf/9e/99/pgpm-8-023.PMC4325627.pdf
"Pharmacogenomics and Personalized Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/pharmacogenomics-and-personalized-medicine-journa lPharmacogenomics and Personalized Medicine is an international, peer- reviewed, open access journal characterizing the influence of genotype  on pharmacology leading to the development of personalized treatment  programs and individualized drug selection for improved safety, efficacy  and sustainability.",Non-OADS,/arxiv_data1/oa_pdf/9e/99/pgpm-8-023.PMC4325627.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/9e/99/pgpm-8-023.PMC4325627.pdf
Available from:   http://clinicaltrials.gov/ct2/show/NCT0181697 1.,Non-OADS,/arxiv_data1/oa_pdf/9e/99/pgpm-8-023.PMC4325627.pdf
Available  from: http://clinicaltrials.gov/show/NCT0157248 0.,Non-OADS,/arxiv_data1/oa_pdf/9e/99/pgpm-8-023.PMC4325627.pdf
Available from: http://clinicaltrials.gov/ct2/show/ NCT0177555 3.,Non-OADS,/arxiv_data1/oa_pdf/9e/99/pgpm-8-023.PMC4325627.pdf
Available  from: http://clinicaltrials.gov/ct2/show/NCT0196279 2.,Non-OADS,/arxiv_data1/oa_pdf/9e/99/pgpm-8-023.PMC4325627.pdf
Available from: http://clinicaltrials.gov/ct2/show/ NCT0190381 1.,Non-OADS,/arxiv_data1/oa_pdf/9e/99/pgpm-8-023.PMC4325627.pdf
Available from: http://clinicaltrials.gov/ ct2/show/NCT0154943 1.,Non-OADS,/arxiv_data1/oa_pdf/9e/99/pgpm-8-023.PMC4325627.pdf
Available from: http://clinicaltrials.gov/ct2/show/ NCT0166579 4.,Non-OADS,/arxiv_data1/oa_pdf/9e/99/pgpm-8-023.PMC4325627.pdf
Available  from: http://clinicaltrials.gov/ct2/show/NCT0129776 4.,Non-OADS,/arxiv_data1/oa_pdf/9e/99/pgpm-8-023.PMC4325627.pdf
Available from: http://clinicaltrials.gov/ct2/show/ NCT0124606 3.,Non-OADS,/arxiv_data1/oa_pdf/9e/99/pgpm-8-023.PMC4325627.pdf
Available from: http://clinicaltrials.gov/ct2/show/ NCT0179210 2.,Non-OADS,/arxiv_data1/oa_pdf/9e/99/pgpm-8-023.PMC4325627.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/27/96/pgpm-8-035.PMC4325628.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pPharmacogenomics and Personalized Medicine 2015:8 35–41Pharmacogenomics and Personalized Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  35Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/PGPM.S7181 3awareness regarding clinical application of  pharmacogenetics among Japanese pharmacists Taku Obara1–3 shinya abe4 Michihiro satoh1 sergio ramón gutiérrez  Ubeda5 shoko Y oshimachi4 T eruaki goto4 1Department of Pharmacy, Tohoku  University hospital, sendai,   2Division of Molecular epidemiology,   environment and genome research  center, T ohoku University graduate  school of Medicine, sendai,   3Department of Preventive Medicine  and epidemiology, Tohoku Medical  Megabank Organization, Tohoku  University, sendai, 4Tsuruha holdings,   sapporo, 5Department of geriatric  Behavioral neurology, T ohoku  University graduate school of  Medicine, sendai, Japan correspondence: Taku Obara   Department of Pharmacy, Tohoku  University hospital, 1-1 seiryo-cho,  aoba-ku, sendai, Miyagi 980-8575, Japan   Tel +81 22 717 8104   Fax +81 22 717 8106   email obara-t@hosp.tohoku.ac.j pAbstract:  Advances in pharmacogenetic analysis technology have accelerated the movement  to incorporate pharmacogenetic analysis data into medicine.",Non-OADS,/arxiv_data1/oa_pdf/27/96/pgpm-8-035.PMC4325628.pdf
"Many cases have been reported in which  analyses of gene polymorphisms related to drug-metabolizing enzymes would be useful  for predicting efficacy and adverse reactions.1 In Shinshu University Hospital (Japan),  gene diagnostics are done with mitochondrial deoxyribonucleic acid for preventing  deafness caused by aminoglycoside antibiotics, and drug cards are distributed to the  relevant patients in clinical settings ( http://www.shinshu-u.ac.jp/faculty/medicine/chair/ ent/nonsyndromic/Mit1555.htm l, http://www.pharm.tohoku.ac.jp/ ∼seikatsu/mysite1/ sub3.htm l).",Non-OADS,/arxiv_data1/oa_pdf/27/96/pgpm-8-035.PMC4325628.pdf
"In Japan, a UGT1A1  gene polymorphism diagnostic agent for use before  irinotecan was allowed under insurance coverage in 2009 ( http://www.info.pmda.go.jp/ go/pack/4240404A1091_1_08 /).",Non-OADS,/arxiv_data1/oa_pdf/27/96/pgpm-8-035.PMC4325628.pdf
"Materials and methods Pharmacists employed by the Tsuruha Group, a Japanese  drugstore chain, were surveyed using a self-administered  questionnaire on their awareness of the Japanese Ethical  Guidelines for Human Genome/Gene Analysis Research  (http://www.meti.go.jp/policy/mono_info_service/mono/ bio/Seimeirinnri/shishinnhonbun.pd f), awareness of the  terms “pharmacogenomics” and “pharmacogenetics”, the  status of the clinical use of insurance-covered pharmacog - enomic tests when dispensing drugs in Japan, their ability  to perform such duties as raising pharmaceutical questions  regarding prescriptions based on patients’ pharmacogenomic  information, and preferences for undertaking pharmacog - enomic tests for predicting efficacy and adverse reactions.",OADS,/arxiv_data1/oa_pdf/27/96/pgpm-8-035.PMC4325628.pdf
"Pharmacogenomics and Personalized Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/pharmacogenomics-and-personalized-medicine-journa lPharmacogenomics and Personalized Medicine is an international, peer- reviewed, open access journal characterizing the influence of genotype  on pharmacology leading to the development of personalized treatment  programs and individualized drug selection for improved safety, efficacy  and sustainability.",Non-OADS,/arxiv_data1/oa_pdf/27/96/pgpm-8-035.PMC4325628.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/27/96/pgpm-8-035.PMC4325628.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/34/f8/sccaa-8-027.PMC4325629.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pStem Cells and Cloning: Advances and Applications 2015:8 27–38Stem Cells and Cloning: Advances and Applications Dove press submit your manuscript | www.dovepress.co m Dove press  27Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/SCCAA.S5861 3Hedgehog signaling in cancer stem cells: a focus  on hematological cancers victoria Campbell Mhairi Copland Paul O’Gorman Leukaemia Research  Centre, institute of Cancer Sciences,   College of Medical, veterninary and  Life Sciences, University of Glasgow,   Glasgow, UK Correspondence: Mhairi Copland   Paul O’Gorman Leukaemia Research  Centre, institute of Cancer Sciences,  College of Medical, veterinary and  Life Sciences, University of Glasgow,  Gartnavel General Hospital, 1053 Great  western Road, Glasgow, G12 0YN, UK   Tel +44 141 301 7872/7880   Fax +44 141 301 7898   email mhairi.copland@glasgow.ac.u kAbstract:  The stem cell paradigm was first demonstrated in hematopoietic stem cells.",Non-OADS,/arxiv_data1/oa_pdf/34/f8/sccaa-8-027.PMC4325629.pdf
"Stem Cells and Cloning: Advances and Applications Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/stem-cells-and-cloning-advances-and-applications-journa lStem Cells and Cloning: Advances and Applications is an international,  peer-reviewed, open access journal.",Non-OADS,/arxiv_data1/oa_pdf/34/f8/sccaa-8-027.PMC4325629.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/34/f8/sccaa-8-027.PMC4325629.pdf
"Copyright © 2015  Korean Stroke Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which  permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/26/a2/jos-17-7.PMC4325630.pdf
"pISSN: 2287-6391 • eISSN: 2287-6405 http://j-stroke.org  7Genetics of Cerebral Small Vessel Disease Jay Chol Choi Department of Neurology, Jeju National University, Jeju, Korea Correspondence:  Jay Chol Choi Department of Neurology, Jeju National  University, 15 Aran 13-gil, Jeju 690-767,  Korea Tel: +82-64-754-8160  Fax: +82-64-717-1131 E-mail: jaychoi@jejunu.ac.kr Received: November 18, 2014 Revised: December 26, 2014 Accepted: December 29, 2014 The author has no financial conflict of  interest.Cerebral small vessel disease (SVD) is an important cause of stroke and cognitive impairment  among the elderly and is a more frequent cause of stroke in Asia than in the US or Europe.",Non-OADS,/arxiv_data1/oa_pdf/26/a2/jos-17-7.PMC4325630.pdf
"Keywords Cerebral small vessel diseases; Genetic association study; Genome-wide associa - tion study; CADASIL; Fabry diseaseSpecial Review Small Vessel Disease IJournal of Stroke  201 5;17(1):7-16 http://dx.doi.org/10.5853/jos.2015.17.1.7 Introduction Cerebral small vessel disease (SVD) is an important cause of  stroke, cognitive impairment, and mood disorder among the el - derly.1 It accounts for 15% to 26% of ischemic stroke in the US  and Europe.2-6 In Asia, cerebral SVD is responsible for an even  greater proportion of ischemic stroke, ranging from 25% to  54%.7-11 In addition, it is the most important cause of intracere - bral hemorrhage (ICH)12 and contributes to a substantial pro - portion of vascular dementia.13Although traditional risk factors are important in the devel - opment of cerebral SVD14 the exact cause is still uncertain be - cause not all individuals with those risk factors develop the dis - ease and often, known risk factors are absent in patients with  cerebral SVD.15 Ischemic stroke is possibly a complex genetic  disorder in which interactions between candidate genes and en - vironmental factors or established risk factors are important in  the development of clinical phenotypes.16 Therefore, genetics  may play an important role in understanding the pathophysiol - ogy of sporadic cerebral SVD.",Non-OADS,/arxiv_data1/oa_pdf/26/a2/jos-17-7.PMC4325630.pdf
"Choi Genetics of Small Vessel Disease http://dx.doi.org/10.5853/jos.2015.17.1.7 8 http://j-stroke.orgodology such as genome-wide association study (GWAS) and  meta-analysis of individual candidate gene study, both, exten - sive and in-depth information on the susceptible genetic loci  associated with sporadic cerebral SVD (T able 1) is now avail - able.",Non-OADS,/arxiv_data1/oa_pdf/26/a2/jos-17-7.PMC4325630.pdf
"1 / January 2015 http://dx.doi.org/10.5853/jos.2015.17.1.7 http://j-stroke.org  9stroke, a family history of stroke was a significant risk factor for  large vessel disease (odds ratio [OR], 2.24 to 2.54) and for SVD  (OR, 1.93 to 2.62) but not for cardioembolic stroke.18,19 Cere - bral white matter hyperintensities (WMH) are one of the main  imaging features of SVD, and they are frequently found in pa - tients with lacunar stroke on brain magnetic resonance imaging  (MRI).14 Twin studies also indicate a genetic contribution to  WMH with concordance rates of 61% in monozygotic pairs and  that of 38% in dizygotic pairs for large proportion of WMH.20  The findings were also replicated in the family-based Framing - ham study, with an overall heritability of approximately 52% to  78%.21 ICH, especially nonlobar ICH, results from the rupture  of small penetrating arteries of the brain and is another impor - tant clinical manifestation of cerebral SVD.12 Heritability of non - lobar or primary ICH was suggested by case-control studies  showing associations between family history and an increased  risk of ICH (adjusted OR, 2.1 to 6.3).18,22 Candidate gene studies Candidate gene study is an approach involving exploring the ge - netic influences on a complex trait by identifying candidate genes  that might have a role in the etiology of the disease and this meth - od has been widely used for the study of complex diseases.23 In a  comprehensive meta-analysis of 187 candidate genetic polymor - phism in 37,481 stroke patients, 6 polymorphisms, namely, factor  V Leiden, angiotensin converting enzyme (ACE) insertion/dele - tion (I/D), methylene tetrahydrofolate reductase (MTHFR)  C677T , prothrombin G20210A, plasminogen activator inhibi - tor-1 4G/5G allele, and glycoprotein IIIa L33P , were found to  have an association with increased risk of stroke.",Non-OADS,/arxiv_data1/oa_pdf/26/a2/jos-17-7.PMC4325630.pdf
"Choi Genetics of Small Vessel Disease http://dx.doi.org/10.5853/jos.2015.17.1.7 10 http://j-stroke.orgThe polymorphism may also contribute to a higher proportion  of both, lacunar stroke and primary ICH in the Asian population  rather than Caucasians, as the minor allele is rarely found in Eu - ropean descendants.32  However, European large-scale collaborative studies applying  GWAS technique have confirmed subtype-specific associations  for cardioembolic stroke only near PITX2  and ZFHX3  and for  large vessel disease at a 9p21 locus and HDAC9 , but not for SVD.35  In addition, heritability estimates calculated by genome-wide com - plex trait analysis were 40.3% for large vessel disease, 32.6% for car - dioembolic stroke but only 16.1% for SVD.36 In a meta-analysis of  GWAS in Caucasian participants in 6 studies comprising the Co - horts for Heart and Aging Research in Genomic Epidemiology  (CHARGE) consortium, the most significant association was  found on chromosome 20p12 with rs2208454 for silent infarcts  found on brain MRI.",Non-OADS,/arxiv_data1/oa_pdf/26/a2/jos-17-7.PMC4325630.pdf
1 / January 2015 http://dx.doi.org/10.5853/jos.2015.17.1.7 http://j-stroke.org  11dues.,OADS,/arxiv_data1/oa_pdf/26/a2/jos-17-7.PMC4325630.pdf
"Choi Genetics of Small Vessel Disease http://dx.doi.org/10.5853/jos.2015.17.1.7 12 http://j-stroke.orgas a common feature, the disorders present with various combi - nations of Raynaud phenomenon, migraine, cranial pseudotu - mor, and mild kidney or liver dysfunction.",Non-OADS,/arxiv_data1/oa_pdf/26/a2/jos-17-7.PMC4325630.pdf
"1 / January 2015 http://dx.doi.org/10.5853/jos.2015.17.1.7 http://j-stroke.org  13At present, the available data suggest that enzyme replacement  therapy, either agalsidase α or β, is possibly effective only for re - ducing neuropathic pain but not for preventing cerebrovascular  complications in patients with FD.89 Conclusion and future perspective Although several epidemiological studies suggest the herita - bility of sporadic cerebral SVD, candidate gene studies have  been disappointing in identifying specific genes causing the dis - order.",Non-OADS,/arxiv_data1/oa_pdf/26/a2/jos-17-7.PMC4325630.pdf
"Several important genetic loci have been identified for  cerebral SVD by using the GWAS technique; nevertheless, sec - ond-generation GWAS would need an even larger sample size  (e.g., 100,000 to 200,000 for a complex disease such as stroke),  because undiscovered susceptibility loci are expected to have  smaller effect size than the loci that are known.90 T o obtain such  a large sample size, stroke researchers from various regions of  the world have set up the International Stroke Genetics Con - sortium (ISGC, http://www.strokegenetics.org).",Non-OADS,/arxiv_data1/oa_pdf/26/a2/jos-17-7.PMC4325630.pdf
Choi Genetics of Small Vessel Disease http://dx.doi.org/10.5853/jos.2015.17.1.7 14 http://j-stroke.orgcerebral small-vessel disease.,Non-OADS,/arxiv_data1/oa_pdf/26/a2/jos-17-7.PMC4325630.pdf
1 / January 2015 http://dx.doi.org/10.5853/jos.2015.17.1.7 http://j-stroke.org  15Cerebral autosomal dominant arteriopathy with subcortical in - farcts and leukoencephalopathy.,Non-OADS,/arxiv_data1/oa_pdf/26/a2/jos-17-7.PMC4325630.pdf
Choi Genetics of Small Vessel Disease http://dx.doi.org/10.5853/jos.2015.17.1.7 16 http://j-stroke.orgby in situ hybridization.,Non-OADS,/arxiv_data1/oa_pdf/26/a2/jos-17-7.PMC4325630.pdf
"Copyright © 2015  Korean Stroke Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which  permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4d/df/jos-17-91.PMC4325631.pdf
"pISSN: 2287-6391 • eISSN: 2287-6405 http://j-stroke.org  91Stroke Genetics: A Review and Update  Arne Lindgrena,b aDepartment of Clinical Sciences Lund, Neurology, Lund University, Lund, Sweden bDepartment of Neurology and Rehabilitation Medicine, Skane University Hospital, Lund, SwedenJournal of Stroke  201 5;17(1):91- 91 http://dx.doi.org/10.5853/jos.2015.17.1.91 ERRATUM: Corrected Figure Legend Journal of Stroke  2014;16(3):114-123 http://dx.doi.org/10.5853/jos.2014.16.3.114 An error was found in the following published article: Lindgren A. Stroke Genetics: A Review and Update.",Non-OADS,/arxiv_data1/oa_pdf/4d/df/jos-17-91.PMC4325631.pdf
"60 http://j-stroke.orgCopyright © 2015  Korean Stroke Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which  permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d2/3f/jos-17-60.PMC4325632.pdf
"Keywords Ischemic stroke; White matter hyperintensity; Leukoaraiosis; MRI, progression;  Regression Original ArticleJournal of Stroke  201 5;17(1):60- 66 http://dx.doi.org/10.5853/jos.2015.17.1.60 Introduction White matter hyperintensities (WMH) are frequently observed  on T2- or fluid-attenuated inverse recovery (FLAIR) MRI in isch - emic stroke patients as well as in normal elderly individuals.",Non-OADS,/arxiv_data1/oa_pdf/d2/3f/jos-17-60.PMC4325632.pdf
1 / January 2015 http://dx.doi.org/10.5853/jos.2015.17.1.60 http://j-stroke.org  61marker for research.2 The probable pathogenesis reported up to  now has mostly involved ischemic pathogenesis.,Non-OADS,/arxiv_data1/oa_pdf/d2/3f/jos-17-60.PMC4325632.pdf
White Matter Hyperintensity in Ischemic Stroke http://dx.doi.org/10.5853/jos.2015.17.1.60 62 http://j-stroke.org9.2 version was used.,Non-OADS,/arxiv_data1/oa_pdf/d2/3f/jos-17-60.PMC4325632.pdf
1 / January 2015 http://dx.doi.org/10.5853/jos.2015.17.1.60 http://j-stroke.org  63progression was 3.32 cc (0.92-4.05) and that in patients with  regression was -1.87 cc (-4.61- -0.73).,OADS,/arxiv_data1/oa_pdf/d2/3f/jos-17-60.PMC4325632.pdf
White Matter Hyperintensity in Ischemic Stroke http://dx.doi.org/10.5853/jos.2015.17.1.60 64 http://j-stroke.orgstroke patients.,Non-OADS,/arxiv_data1/oa_pdf/d2/3f/jos-17-60.PMC4325632.pdf
1 / January 2015 http://dx.doi.org/10.5853/jos.2015.17.1.60 http://j-stroke.org  65studies.,OADS,/arxiv_data1/oa_pdf/d2/3f/jos-17-60.PMC4325632.pdf
White Matter Hyperintensity in Ischemic Stroke http://dx.doi.org/10.5853/jos.2015.17.1.60 66 http://j-stroke.org16.,Non-OADS,/arxiv_data1/oa_pdf/d2/3f/jos-17-60.PMC4325632.pdf
"Copyright © 2015  Korean Stroke Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which  permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d8/76/jos-17-31.PMC4325633.pdf
"pISSN: 2287-6391 • eISSN: 2287-6405 http://j-stroke.org  31Cerebral Small Vessel Disease and Chronic Kidney  Disease Kazunori T oyoda Department of Cerebrovascular Medicine, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan Correspondence:  Kazunori Toyoda Department of Cerebrovascular  Medicine, National Cerebral and  Cardiovascular Center, 5-7-1 Fujishiro-dai, Suita, Osaka  565-8565, Japan Tel: +81-6-6833-5012 Fax: +81-6-6835-5267 E-mail: toyoda@ncvc.go.jp Received: August 25, 2014 Revised: November 24, 2014 Accepted: November 24, 2014 The author has no financial conflicts of  interest.Chronic kidney disease, defined by a decreased glomerular filtration rate or albuminuria, is  recognized as a major global health burden, mainly because it is an established risk factor  for cardiovascular and cerebrovascular diseases.",Non-OADS,/arxiv_data1/oa_pdf/d8/76/jos-17-31.PMC4325633.pdf
"Keywords Acute stroke; Asian; Cognitive impairment; Dementia; Lacunar infarction; RetinopathySpecial Review Small Vessel Disease IJournal of Stroke  201 5;17(1):31- 37 http://dx.doi.org/10.5853/jos.2015.17.1.31 Introduction Chronic kidney disease (CKD) is defined by a decreased esti - mated glomerular filtration rate (eGFR) below 60 mL/min/1.73  m2 or albuminuria as a marker of an increased glomerular per - meability.1 Beyond the original meaning of CKD as a high-risk  state for future dialysis, CKD is now recognized as a significant  and rapidly growing global health burden, mainly because it is an  established risk factor for cardiovascular diseases, including  stroke.2,3 The impact of CKD on incident stroke differs among  regions and races and is higher in Asian people.4 The glomerular  afferent arterioles of the juxtamedullary nephrons and the cere - bral small vessels have anatomical and functional features in  common.5 Thus, cerebral small vessel disease (SVD) and CKD  seem to have a strong relationship.",Non-OADS,/arxiv_data1/oa_pdf/d8/76/jos-17-31.PMC4325633.pdf
Toyoda  Cerebral Small Vessel Disease and Chronic Kidney Disease http://dx.doi.org/10.5853/jos.2015.17.1.31 32 http://j-stroke.orghigher than that in the general population (4.4% to 11%) and  similar to that in the elderly general population aged 70 years or  older (19% to 38%).13-15 Stroke occurs much more commonly in  dialysis patients than in the general population or CKD patients  without need for dialysis.,Non-OADS,/arxiv_data1/oa_pdf/d8/76/jos-17-31.PMC4325633.pdf
"1 / January 2015 http://dx.doi.org/10.5853/jos.2015.17.1.31 http://j-stroke.org  33kuoka Stroke Registry, a 73% (95% CI 3%-190%) greater risk of  recurrence of noncardioembolic stroke in CKD patients was also  reported.20 The China National Stroke Registry, involving 4,836  diabetic patients with acute stroke and transient ischemic attack  (TIA) showed that eGFR < 45 mL/min/1.73 m2 was indepen - dently associated with risks of all-cause death, recurrent stroke,  combined endpoint of stroke or death, and stroke disability in  patients with overall stroke/TIA and those with ischemic  stroke/TIA.21  We determined the safety and feasibility of systolic blood pres - sure reduction initiated within 3 hours from onset to < 160 mmHg  using intravenous nicardipine in 211 patients with acute spontane - ous intracerebral hemorrhage (ICH) in the prospective, multi - center, observational Stroke Acute Management with Urgent Risk- factor Assessment and Improvement (SAMURAI)-ICH Study.22  In its subanalysis, eGFR < 60 mL/min/1.73 m2 was positively as - sociated with mRS score 5-6 (OR 5.87, 95% CI 1.87-19.34) and  negatively associated with mRS score 0-2 (OR 0.21, 95% CI 0.07-  0.54) at 3 months, after adjustment for known prognostic predic - tors including the initial NIH Stroke Scale score and hematoma  volume.12 In several other studies, the effects of CKD on neurologi - cal severity and outcomes of ischemic and hemorrhagic stroke  were clarified.2,3 Resistance to and limitations of stroke therapies appear to part - ly cause the poorer stroke outcomes of CKD patients.",Non-OADS,/arxiv_data1/oa_pdf/d8/76/jos-17-31.PMC4325633.pdf
"Toyoda  Cerebral Small Vessel Disease and Chronic Kidney Disease http://dx.doi.org/10.5853/jos.2015.17.1.31 34 http://j-stroke.orgChronic kidney disease and white matter  lesions Like SBIs, white matter lesions have often been studied to  clarify their association with CKD.",Non-OADS,/arxiv_data1/oa_pdf/d8/76/jos-17-31.PMC4325633.pdf
"1 / January 2015 http://dx.doi.org/10.5853/jos.2015.17.1.31 http://j-stroke.org  35Substitution T est.47 In the 14-year follow-up study of 803 partici - pants from the Atherosclerosis Risk in the Community (ARIC)  cohort, subjects with retinopathy showed more rapid decline of  the scores of the Word Fluency test and the Digit Symbol Substi - tution test than those without retinopathy.48 In the CRIC study  involving 588 participants, retinopathy was independently asso - ciated with cognitive impairment on the T rail-Making T est,  Forms A (OR 3.4, 95% CI 2.0-6.0), Forms B (3.0, 1.8-4.9), and  the Boston Naming T est (2.1, 1.2-3.4).49 The relationship be - tween retinopathy and CKD seems to be stronger in patients  with type 2 diabetes.",Non-OADS,/arxiv_data1/oa_pdf/d8/76/jos-17-31.PMC4325633.pdf
Toyoda  Cerebral Small Vessel Disease and Chronic Kidney Disease http://dx.doi.org/10.5853/jos.2015.17.1.31 36 http://j-stroke.orgFSR Investigators.,Non-OADS,/arxiv_data1/oa_pdf/d8/76/jos-17-31.PMC4325633.pdf
"1 / January 2015 http://dx.doi.org/10.5853/jos.2015.17.1.31 http://j-stroke.org  37tion, and dementia in older persons: the Cardiovascular Health  Study.",Non-OADS,/arxiv_data1/oa_pdf/d8/76/jos-17-31.PMC4325633.pdf
"54 http://j-stroke.orgCopyright © 2015  Korean Stroke Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which  permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/27/53/jos-17-54.PMC4325634.pdf
"Keywords Cerebral infarction; Calcium; Patient outcome assessmentOriginal ArticleJournal of Stroke  201 5;17(1):54- 59 http://dx.doi.org/10.5853/jos.2015.17.1.54 Introduction The calcium ion (Ca2+) is a ubiquitous intracellular messen - ger during and immediately after an ischemic period, and it in - fluences the cascade of events that lead to subsequent neuronal injury.1 Under ischemic conditions, release of glutamate from  the neurons and glia activates the N-methyl-D-aspartate (NMDA)  receptor and triggers the rapid translocation of Ca2+ from extra - cellular to intracellular spaces in cerebral tissues.2,3 Experimental  results indicate that Ca2+ can have a harmful effect on neurons",Non-OADS,/arxiv_data1/oa_pdf/27/53/jos-17-54.PMC4325634.pdf
1 / January 2015 http://dx.doi.org/10.5853/jos.2015.17.1.54 http://j-stroke.org  55under acute ischemic conditions.,Non-OADS,/arxiv_data1/oa_pdf/27/53/jos-17-54.PMC4325634.pdf
"Elevated Calcium in Acute Ischemic Stroke http://dx.doi.org/10.5853/jos.2015.17.1.54 56 http://j-stroke.org(n = 232), transient ischemic attack (n = 124), and those without  information on important clinical variables (n = 15) or functional  outcomes (n = 27).",Non-OADS,/arxiv_data1/oa_pdf/27/53/jos-17-54.PMC4325634.pdf
1 / January 2015 http://dx.doi.org/10.5853/jos.2015.17.1.54 http://j-stroke.org  57the albumin-corrected calcium level as independent risk factors  for a poor discharge outcome.,Non-OADS,/arxiv_data1/oa_pdf/27/53/jos-17-54.PMC4325634.pdf
"Elevated Calcium in Acute Ischemic Stroke http://dx.doi.org/10.5853/jos.2015.17.1.54 58 http://j-stroke.orgicity, such as calmodulin,21 calcineurin,22 or neuronal nitric oxide  synthase,23 protects neurons against the toxic effects of excitato - ry amino acids.",Non-OADS,/arxiv_data1/oa_pdf/27/53/jos-17-54.PMC4325634.pdf
1 / January 2015 http://dx.doi.org/10.5853/jos.2015.17.1.54 http://j-stroke.org  5964:1287-1291.,OADS,/arxiv_data1/oa_pdf/27/53/jos-17-54.PMC4325634.pdf
"2 http://j-stroke.orgCopyright © 2015  Korean Stroke Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which  permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/78/8f/jos-17-2.PMC4325635.pdf
Keywords Cerebral small vessel diseases; CADASIL; Cerebral amyloid angiopathy; Patho - physiologySpecial Review Small Vessel Disease IJournal of Stroke  201 5;17(1):2-6 http://dx.doi.org/10.5853/jos.2015.17.1.2 Pathology Vascular pathology Two major vascular pathologies underlie brain damage in pa - tients who have important abnormalities involving small size  penetrating brain arteries and arterioles; 1) thickening of the ar - terial media with encroachment on the arterial lumens and 2)  obstruction of the origins of penetrating arteries by parent large  intracranial artery intimal plaques.,Non-OADS,/arxiv_data1/oa_pdf/78/8f/jos-17-2.PMC4325635.pdf
1 / January 2015 http://dx.doi.org/10.5853/jos.2015.17.1.2 http://j-stroke.org  3sion.,OADS,/arxiv_data1/oa_pdf/78/8f/jos-17-2.PMC4325635.pdf
Caplan  SVD Pathology http://dx.doi.org/10.5853/jos.2015.17.1.2 4 http://j-stroke.orgby atherosclerotic plaque lesions.,Non-OADS,/arxiv_data1/oa_pdf/78/8f/jos-17-2.PMC4325635.pdf
1 / January 2015 http://dx.doi.org/10.5853/jos.2015.17.1.2 http://j-stroke.org  5volved.,Non-OADS,/arxiv_data1/oa_pdf/78/8f/jos-17-2.PMC4325635.pdf
Caplan  SVD Pathology http://dx.doi.org/10.5853/jos.2015.17.1.2 6 http://j-stroke.org7.,Non-OADS,/arxiv_data1/oa_pdf/78/8f/jos-17-2.PMC4325635.pdf
"Copyright © 2015  Korean Stroke Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which  permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9a/e3/jos-17-17.PMC4325636.pdf
"pISSN: 2287-6391 • eISSN: 2287-6405 http://j-stroke.org  17Cerebral Amyloid Angiopathy: Emerging Concepts Masahito Yamada Department of Neurology and Neurobiology of Aging, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Japan Correspondence:  Masahito Yamada   Department of Neurology and  Neurobiology of Aging, Kanazawa  University Graduate School of Medical  Sciences, Kanazawa 920-8640, Japan Tel: +81-76-265-2290 Fax: +81-76-234-4253 E-mail: m-yamada@med.kanazawa-u.",Non-OADS,/arxiv_data1/oa_pdf/9a/e3/jos-17-17.PMC4325636.pdf
Keywords Cerebral amyloid angiopathy; Amyloid β-protein; Cerebrovascular disorders; MRI;  PET; Cerebrospinal fluidSpecial Review Small Vessel Disease IJournal of Stroke  201 5;17(1):17- 30 http://dx.doi.org/10.5853/jos.2015.17.1.17 Introduction Cerebral amyloid angiopathy (CAA) involves cerebrovascu - lar amyloid deposition.,Non-OADS,/arxiv_data1/oa_pdf/9a/e3/jos-17-17.PMC4325636.pdf
"Yamada  Cerebral Amyloid Angiopathy  http://dx.doi.org/10.5853/jos.2015.17.1.17 18 http://j-stroke.orgtin (ATTR), gelsolin (AGel), and immunoglobulin light chain  amyloid (AL); among these, sporadic CAA of the Aβ type is  most commonly found in older individuals as well as in patients  with AD [see review5].",Non-OADS,/arxiv_data1/oa_pdf/9a/e3/jos-17-17.PMC4325636.pdf
1 / January 2015 http://dx.doi.org/10.5853/jos.2015.17.1.17 http://j-stroke.org  19and CAA-related vascular lesions (Figure 1).,Non-OADS,/arxiv_data1/oa_pdf/9a/e3/jos-17-17.PMC4325636.pdf
"Yamada  Cerebral Amyloid Angiopathy  http://dx.doi.org/10.5853/jos.2015.17.1.17 20 http://j-stroke.orgNational T aiwan University Hospital Stroke Registry.21 CAA- related ICH was the second most common cause of ICH fol - lowing hypertensive angiopathy in these studies.20,21 The inci - dence of lobar ICH in the elderly has been increasing recently,  in which CAA is strongly implicated.22 CAA-related lobar ICH  is often multiple and recurrent, and clinical manifestations in - clude motor paresis, disturbance of consciousness, abnormali - ties in higher brain functions, such as aphasia, visual loss, with  headache at the acute stage, and dementia and seizures during  chronic stages.9 Headache with meningeal signs is likely caused  by subarachnoid hemorrhage (SAH) accompanying lobar  ICH.23-25 Cortical microhemorrhages  Cerebral microhemorrhages (microbleeds) were noted in  16.7%-32% of AD patients, which is higher than in the general  population (5%-6%), when examined by gradient-echo T2*  MRI,26-30 and in 78% of patients with AD or mild cognitive im - pairment (MCI) on ultra-high field strength 7T MRI.31 Micro - hemorrhages were found in 47.4% of patients with pathologi - cally confirmed CAA cases.32 CAA-related microhemorrhages  are frequently lobar in distribution (Figure 4B).",Non-OADS,/arxiv_data1/oa_pdf/9a/e3/jos-17-17.PMC4325636.pdf
1 / January 2015 http://dx.doi.org/10.5853/jos.2015.17.1.17 http://j-stroke.org  21sodes (TFNEs); TFNEs are a clinical marker of cSS and may  be caused by cSS through cortical spreading depression or focal  seizure activity.45-49 Anti-platelet or anticoagulant therapies  based on the misdiagnosis of CAA-related TFNE as a transient  ischemic attack may induce CAA-related ICH.,Non-OADS,/arxiv_data1/oa_pdf/9a/e3/jos-17-17.PMC4325636.pdf
Yamada  Cerebral Amyloid Angiopathy  http://dx.doi.org/10.5853/jos.2015.17.1.17 22 http://j-stroke.orgmicroinfarcts is underrecognized.,Non-OADS,/arxiv_data1/oa_pdf/9a/e3/jos-17-17.PMC4325636.pdf
"1 / January 2015 http://dx.doi.org/10.5853/jos.2015.17.1.17 http://j-stroke.org  23Amyloid PET Amyloid imaging with the PET ligand, PiB, revealed an in - crease of PiB binding that often shows greater occipital uptake  in CAA-related ICH (Figure 5).75-77 Microhemorrhages are as - sociated with PiB retention,33,34 and new CAA-related hemor - rhages preferentially occur at sites of PiB retention.35 As a fre - quent occurrence of high PiB uptake in healthy elderly individ - uals reflects incipient AD, PiB PET has low specificity for CAA;  however, a negative PiB scan rules out CAA with excellent sen - sitivity.78 Amyloid imaging with such PET ligands as PiB cannot  discriminate vascular from parenchymal deposition or Aβ from  other amyloid proteins; reagents specific for vascular Aβ depo - sition are favorable candidates for amyloid imaging specific for  Aβ-type CAA.79 Biochemical markers A significant decrease in cerebrospinal fluid (CSF) levels of  Aβ40 as well as Aβ42 was reported in patients with probable  CAA, which suggests trapping of Aβ40 and Aβ42 in the cere - bral vasculature.",Non-OADS,/arxiv_data1/oa_pdf/9a/e3/jos-17-17.PMC4325636.pdf
"Yamada  Cerebral Amyloid Angiopathy  http://dx.doi.org/10.5853/jos.2015.17.1.17 24 http://j-stroke.orgGenetic risk factors Apolipoprotein E gene  In addition to hereditary cases of AD/CAA associated with  mutations of the AβPP or presenilin genes [see review5], the  ApoE gene ( ApoE ) has been reported to be risk factor for spo - radic CAA as well as AD; the ε4 allele for CAA itself, and the ε2  allele for CAA-related ICH85-87 and hematoma expansion.88  Carriers of the ApoE  ε2 or ε4 allele, particularly, of the ApoE  ε2/ ε4 genotype were associated with early recurrence of lobar ICH  in patients who survived a lobar ICH.89 The ApoE  ε4 allele con - stitutes a risk factor for capillary CAA (CAA-Type 1),11 CAA- related inflammation,63 and brain microhemorrhages.90 Further - more, ApoE  ε2 was overrepresented in patients with cSS.41 The  presence of CAA in head injury cases was significantly associat - ed with the ApoE  ε4 allele, suggesting an interaction between  gene and environment in the development of CAA.91 Other genetic factors T ransforming growth factor (TGF)-β1 is another CAA-related  gene reported by more than one research group.92,93 In addition,  CAA was reported to be associated with other gene polymor - phisms, including the presenilin 1 (PS1), α1-antichymotrypsin  (ACT), neprilysin, low-density lipoprotein-receptor related pro - tein (LRP-1), and angiotensin-converting enzyme (ACE)  genes.8,94-100 Furthermore, a CR1 gene polymorphism, reported  to increase the risk of AD, was also reported to be associated with  increased risk of CAA-ICH and CAA.101 Non-genetic risk factors Hypertension  Lowering of blood pressure reduced the risk of CAA-related  ICH, suggesting that high blood pressure could be a factor in - ducing ICH in patients with CAA.102 Hypertension could con - tribute to progression of CAA-associated vasculopathies, par - ticularly fibrinoid necrosis, leading to the development of CAA- related ICH.",Non-OADS,/arxiv_data1/oa_pdf/9a/e3/jos-17-17.PMC4325636.pdf
1 / January 2015 http://dx.doi.org/10.5853/jos.2015.17.1.17 http://j-stroke.org  25or more risk factors suggest the future development of CAA-re - lated disorders.,Non-OADS,/arxiv_data1/oa_pdf/9a/e3/jos-17-17.PMC4325636.pdf
Yamada  Cerebral Amyloid Angiopathy  http://dx.doi.org/10.5853/jos.2015.17.1.17 26 http://j-stroke.orgConflict of interest The author declares that the research was conducted in the  absence of any commercial or financial relationships that could  be construed as a potential conflict of interest.,Non-OADS,/arxiv_data1/oa_pdf/9a/e3/jos-17-17.PMC4325636.pdf
"1 / January 2015 http://dx.doi.org/10.5853/jos.2015.17.1.17 http://j-stroke.org  27hof F, Scheltens P .",Non-OADS,/arxiv_data1/oa_pdf/9a/e3/jos-17-17.PMC4325636.pdf
Yamada  Cerebral Amyloid Angiopathy  http://dx.doi.org/10.5853/jos.2015.17.1.17 28 http://j-stroke.orgden associated with leukoaraiosis: a positron emission tomog - raphy/magnetic resonance imaging study.,Non-OADS,/arxiv_data1/oa_pdf/9a/e3/jos-17-17.PMC4325636.pdf
1 / January 2015 http://dx.doi.org/10.5853/jos.2015.17.1.17 http://j-stroke.org  29amyloid angiopathy-related hemorrhage.,Non-OADS,/arxiv_data1/oa_pdf/9a/e3/jos-17-17.PMC4325636.pdf
Yamada  Cerebral Amyloid Angiopathy  http://dx.doi.org/10.5853/jos.2015.17.1.17 30 http://j-stroke.orgamyloid angiopathy: the PROGRESS trial.,Non-OADS,/arxiv_data1/oa_pdf/9a/e3/jos-17-17.PMC4325636.pdf
https://clinicaltrials.gov.,Non-OADS,/arxiv_data1/oa_pdf/9a/e3/jos-17-17.PMC4325636.pdf
"Copyright © 2015  Korean Stroke Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which  permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2c/a1/jos-17-67.PMC4325637.pdf
"pISSN: 2287-6391 • eISSN: 2287-6405 http://j-stroke.org  67Cerebral Arterial Calcification Is an Imaging  Prognostic Marker for Revascularization Treatment  of Acute Middle Cerebral Arterial Occlusion Seong-Joon Lee,a Ji Man Hong,a Manyong Lee,a Kyoon Huh,a Jin Wook Choi,b Jin Soo Leea Departments of aNeurology and bRadiology, Ajou University School of Medicine, Ajou University Medical Center, Suwon, Korea Correspondence:  Jin Soo Lee Department of Neurology, Ajou  University School of Medicine,  164 Worldcup-ro, Yeongtong-gu  Suwon 443-380, Korea Tel: +82-31-219-5175 Fax: +82-31-219-5178 E-mail: jinsoo22@gmail.com Received: October 8, 2014 Revised: December 15, 2014 Accepted: December 18, 2014 This work was supported by the new faculty  research fund of the Ajou University School  of Medicine.",Non-OADS,/arxiv_data1/oa_pdf/2c/a1/jos-17-67.PMC4325637.pdf
"Keywords Vascular calcification; Middle cerebral artery infarction; Intracranial embolism;  Intracranial thrombosis; Thrombolytic therapy; Risk factorsOriginal ArticleJournal of Stroke  201 5;17(1):67- 75 http://dx.doi.org/10.5853/jos.2015.17.1.67 Introduction Intracranial calcified arteries are encountered in approximate - ly 85% of patients with acute ischemic stroke.1 Intra-arterial cal - cification is usually accompanied by coronary atherosclerosis,  and is frequently observed in the intracranial arteries.2,3 Recent studies have indicated that intracranial arterial calcification (IAC)  is associated with a poor outcome in acute ischemic stroke.4,5 In  the case of coronary disease, high coronary artery calcification  scores can predict future ischemic coronary syndromes.6 In pa - tients with acute coronary syndromes that received urgent inter - vention, moderate to severe calcification was significantly associ -",Non-OADS,/arxiv_data1/oa_pdf/2c/a1/jos-17-67.PMC4325637.pdf
"Cerebral Arterial Calcification in Acute Ischemic Stroke http://dx.doi.org/10.5853/jos.2015.17.1.67 68 http://j-stroke.orgated with higher mortality rates 1 year after the intervention.7 The higher mortality rates are thought to be associated with  complexity of coronary interventions, procedure related com - plications, and major adverse cardiac events such as target lesion  revascularization, and non-target lesion revascularization.8,9 The significance of IAC in ischemic stroke, however, has not  yet been determined.",Non-OADS,/arxiv_data1/oa_pdf/2c/a1/jos-17-67.PMC4325637.pdf
"1 / January 2015 http://dx.doi.org/10.5853/jos.2015.17.1.67 http://j-stroke.org  69Clinical and imaging data Patient demographics, vascular risk factors, stroke etiology and  laboratory results, and critical pathway data were retrieved from  our Acute Ischemic Stroke and Thrombolysis databases.",OADS,/arxiv_data1/oa_pdf/2c/a1/jos-17-67.PMC4325637.pdf
Cerebral Arterial Calcification in Acute Ischemic Stroke http://dx.doi.org/10.5853/jos.2015.17.1.67 70 http://j-stroke.orgusing a χ2 test for categorical variables and Student’s t-test for  continuous variables.,Non-OADS,/arxiv_data1/oa_pdf/2c/a1/jos-17-67.PMC4325637.pdf
1 / January 2015 http://dx.doi.org/10.5853/jos.2015.17.1.67 http://j-stroke.org  71performed in 12 (80.0%) patients in the HCB group and in 55  (84.6%) patients in the LCB group ( P= 0.255).,Non-OADS,/arxiv_data1/oa_pdf/2c/a1/jos-17-67.PMC4325637.pdf
Cerebral Arterial Calcification in Acute Ischemic Stroke http://dx.doi.org/10.5853/jos.2015.17.1.67 72 http://j-stroke.orginfluences poor outcomes in a homogenous population of pa - tients with acute ischemic stroke.,Non-OADS,/arxiv_data1/oa_pdf/2c/a1/jos-17-67.PMC4325637.pdf
1 / January 2015 http://dx.doi.org/10.5853/jos.2015.17.1.67 http://j-stroke.org  73There are several limitations to our study.,Non-OADS,/arxiv_data1/oa_pdf/2c/a1/jos-17-67.PMC4325637.pdf
Cerebral Arterial Calcification in Acute Ischemic Stroke http://dx.doi.org/10.5853/jos.2015.17.1.67 74 http://j-stroke.org19.,Non-OADS,/arxiv_data1/oa_pdf/2c/a1/jos-17-67.PMC4325637.pdf
1 / January 2015 http://dx.doi.org/10.5853/jos.2015.17.1.67 http://j-stroke.org  75in octogenarians.,Non-OADS,/arxiv_data1/oa_pdf/2c/a1/jos-17-67.PMC4325637.pdf
"90 http://j-stroke.orgCopyright © 2015  Korean Stroke Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which  permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/cc/cb/jos-17-90.PMC4325638.pdf
"pISSN: 2287-6391 • eISSN: 2287-6405Aortic Stiffness in Patients with Deep and Lobar  Intracerebral Hemorrhage: Role of Antihypertensive  Drugs and Statins Maurizio Acampa, Francesca Guideri, Rossana T assi, Giuseppe Martini Stroke Unit, Department of Neurological and Sensorineural Sciences, Azienda Ospedaliera Universitaria Senese, “Santa Maria alle Scotte” General  Hospital, Siena, ItalyResponse to LetterJournal of Stroke  201 5;17(1):90- 90 http://dx.doi.org/10.5853/jos.2015.17.1.90 Correspondence: Maurizio Acampa U.O.C.",Non-OADS,/arxiv_data1/oa_pdf/cc/cb/jos-17-90.PMC4325638.pdf
"Copyright © 2015  Korean Stroke Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which  permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/da/e3/jos-17-1.PMC4325639.pdf
"pISSN: 2287-6391 • eISSN: 2287-6405 http://j-stroke.org  1Small Vessel Disease: Not a Small Problem Jong S. Kim Editor-in-Chief, Journal of StrokeEditorialJournal of Stroke  201 5;17(1):1-1 http://dx.doi.org/10.5853/jos.2015.17.1.1 Small infarcts in the subcortical area (lacunar infarction) have  been considered a relatively simple condition.",Non-OADS,/arxiv_data1/oa_pdf/da/e3/jos-17-1.PMC4325639.pdf
"Copyright © 2015  Korean Stroke Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which  permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/cd/7d/jos-17-89.PMC4325640.pdf
"pISSN: 2287-6391 • eISSN: 2287-6405 http://j-stroke.org  89Aortic Stiffness in Patients with Deep and Lobar  Intracerebral Hemorrhage: Role of Antihypertensive  Drugs and Statins Ercan Varol, Mehmet Ozaydin Department of Cardiology, Suleyman Demirel University, Faculty of Medicine, Isparta, TurkeyLetter to the EditorJournal of Stroke  201 5;17(1):89- 89 http://dx.doi.org/10.5853/jos.2015.17.1.89 Dear Sir: Acampa et al.1 investigated arterial stiffness in patients with  deep intracerebral hemorrhage (ICH) in comparison with that  in patients with lobar ICH.",Non-OADS,/arxiv_data1/oa_pdf/cd/7d/jos-17-89.PMC4325640.pdf
"84 http://j-stroke.orgCopyright © 2015  Korean Stroke Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which  permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c9/3a/jos-17-84.PMC4325641.pdf
"Rita Maciel,a,b Raquel Palma,b,c Pedro Sousa,d Fátima Ferreira,b,c Hipólito Nzwalob,c,e aDepartment of Internal Medicine, Centro Hospitalar do Algarve (CHA), Faro, Portugal bStroke Unit, Centro Hospitalar do Algarve (CHA), Faro, Portugal cDepartment of Neurology, Centro Hospitalar do Algarve (CHA), Faro, Portugal  dDepartment of Cardiology, Centro Hospitalar do Algarve (CHA), Faro, Portugal  eDepartment of Biomedical Sciences and Medicine, University of Algarve, Faro, PortugalLetter to the EditorJournal of Stroke  201 5;17(1):84- 86 http://dx.doi.org/10.5853/jos.2015.17.1.84 Dear Sir: Concomitant occurrence of acute myocardial infarction (MI)  and stroke is infrequently encountered in emergent patients.",Non-OADS,/arxiv_data1/oa_pdf/c9/3a/jos-17-84.PMC4325641.pdf
1 / January 2015 http://dx.doi.org/10.5853/jos.2015.17.1.84 http://j-stroke.org  85he resumed his normal life ( Rankin 2 ).,Non-OADS,/arxiv_data1/oa_pdf/c9/3a/jos-17-84.PMC4325641.pdf
"Thrombolysis for Concomitant Stroke and MI http://dx.doi.org/10.5853/jos.2015.17.1.84 86 http://j-stroke.orgof patients with concomitant acute MI and acute stroke, nor are  there published clinical studies addressing the decision-making  process in such cases.",Non-OADS,/arxiv_data1/oa_pdf/c9/3a/jos-17-84.PMC4325641.pdf
"76 http://j-stroke.orgCopyright © 2015  Korean Stroke Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which  permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f0/0e/jos-17-76.PMC4325642.pdf
"Keywords Ischemic stroke; Thrombolysis; Collateral circulation; Recanalization; Clinical out - comeOriginal ArticleJournal of Stroke  201 5;17(1):76- 83 http://dx.doi.org/10.5853/jos.2015.17.1.76 Introduction Successful arterial recanalization is critical for improving im - mediate and long-term outcomes after thrombolytic therapy.1,2 Intraarterial thrombolysis (IAT) is considered to increase the re - canalization rate, particularly when using mechanical devices.3-5  However, fewer patients achieve good clinical outcomes after  primary or bridging IAT for acute ischemia than after intrave -",Non-OADS,/arxiv_data1/oa_pdf/f0/0e/jos-17-76.PMC4325642.pdf
"1 / January 2015 http://dx.doi.org/10.5853/jos.2015.17.1.76 http://j-stroke.org  77nous thrombolysis (IVT).6-8 In addition to the time from symp - tom onset to recanalization (onset-to-recanalization time), the  presence of collateral circulation is important for the achieve - ment of good clinical outcomes after IAT .9,10 The onset-to-recan - alization time window to achieve good clinical outcomes may be  largely dependent on the degree of collateral circulation.",Non-OADS,/arxiv_data1/oa_pdf/f0/0e/jos-17-76.PMC4325642.pdf
Importance of Rapid Recanalization and Collaterals http://dx.doi.org/10.5853/jos.2015.17.1.76 78 http://j-stroke.orgUnadjusted fitted regression analysis was subsequently per - formed to determine whether onset-to-recanalization time and  the presence of collateral circulation predict the probability of a  good clinical outcome in patients with successful angiographic  recanalization.,Non-OADS,/arxiv_data1/oa_pdf/f0/0e/jos-17-76.PMC4325642.pdf
1 / January 2015 http://dx.doi.org/10.5853/jos.2015.17.1.76 http://j-stroke.org  79shown in Figure 1 and Supplementary T able I.,Non-OADS,/arxiv_data1/oa_pdf/f0/0e/jos-17-76.PMC4325642.pdf
"Importance of Rapid Recanalization and Collaterals http://dx.doi.org/10.5853/jos.2015.17.1.76 80 http://j-stroke.orgcanalized > 6 hours and those who did not undergo recanaliza - tion than in those recanalized < 6 hours ( P< 0.001) (Figure 3);  symptomatic ICH was also more frequent in the latter patients  ( < 4.5, 4.5-6, > 6 hours, and non-recanalization groups: 2.4%,  2.7%, 18.8%, and 13%, respectively, P= 0.028).",Non-OADS,/arxiv_data1/oa_pdf/f0/0e/jos-17-76.PMC4325642.pdf
1 / January 2015 http://dx.doi.org/10.5853/jos.2015.17.1.76 http://j-stroke.org  816 hours after IAT and those who did not achieve recanalization.,Non-OADS,/arxiv_data1/oa_pdf/f0/0e/jos-17-76.PMC4325642.pdf
Importance of Rapid Recanalization and Collaterals http://dx.doi.org/10.5853/jos.2015.17.1.76 82 http://j-stroke.orgaemic stroke.,Non-OADS,/arxiv_data1/oa_pdf/f0/0e/jos-17-76.PMC4325642.pdf
1 / January 2015 http://dx.doi.org/10.5853/jos.2015.17.1.76 http://j-stroke.org  83Supplementary Table I. Probability of a good clinical outcome owing to technically successful angiographic recanalization according to collateral circulation status  before intraarterial thrombolysis  Probability of good     clinical outcomeCollateral circulation status Good Poor EstimatedConfidence interval EstimatedConfidence interval 95% 90% 80% 70% 95% 90% 80% 70% 0.8 147.56 - - - 32.568 - - - - - 0.7 225.28 - 57.107 126.801 156.131 - - - - - 0.6 288.99 159.713 203.168 232.105 246.271 - - - - - 0.5 347.46 274.959 288.513 301.996 310.497 - - - - - 0.4 405.93 331.795 341.5 353.124 361.456 30.19 - - - - 0.3 469.64 377.426 387.87 401.212 411.251 93.90 - - - - 0.2 547.36 426.679 439.471 456.268 469.182 171.62 - - - 31.942 0.1 664.29 496.487 513.641 536.497 554.274 288.55 9.165 94.807 156.037 187.416 A good clinical outcome was defined as a modified Rankin scale score from 0-2.,Non-OADS,/arxiv_data1/oa_pdf/f0/0e/jos-17-76.PMC4325642.pdf
"38 http://j-stroke.orgCopyright © 2015  Korean Stroke Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which  permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/83/81/jos-17-38.PMC4325643.pdf
"The proportion of mRS scores of 0-1 was 42% on discharge, 50% at 3 months, and ReviewJournal of Stroke  201 5;17(1):38- 53 http://dx.doi.org/10.5853/jos.2015.17.1.38",Non-OADS,/arxiv_data1/oa_pdf/83/81/jos-17-38.PMC4325643.pdf
"1 / January 2015 http://dx.doi.org/10.5853/jos.2015.17.1.38 http://j-stroke.org  39Introduction In general, the term clinical registry  refers to a observational da - tabase of patients’ characteristics, treatments, and outcomes  without specified inclusion or exclusion criteria and therapeutic  approaches unrelated to purposes of the registry.1 Well-designed,  organized and performed clinical registry may provide relevant  data from real world experience and patients’ characteristics as  well as outcomes and safety of cases.",OADS,/arxiv_data1/oa_pdf/83/81/jos-17-38.PMC4325643.pdf
Stroke Treatment and Outcome Status in South Korea http://dx.doi.org/10.5853/jos.2015.17.1.38 40 http://j-stroke.orgjoined the CRCS-5 registry—Chungbuk National University  Hospital and Ulsan University Hospital.,Non-OADS,/arxiv_data1/oa_pdf/83/81/jos-17-38.PMC4325643.pdf
"1 / January 2015 http://dx.doi.org/10.5853/jos.2015.17.1.38 http://j-stroke.org  41pital, Seoul National University Bundang Hospital, Seoul Medical  Center, Soonchunhyang University Hospital Seoul, and Inje Uni - versity Ilsan Paik Hospital).",Non-OADS,/arxiv_data1/oa_pdf/83/81/jos-17-38.PMC4325643.pdf
"Data management and analysis of CRCS-5 registry Acute stroke cases were registered to the CRCS-5 web-based  database (http://www.stroke-crc.or.kr/ecrf), and the registration  process was required to be started within 48 hours of arrival.",OADS,/arxiv_data1/oa_pdf/83/81/jos-17-38.PMC4325643.pdf
Stroke Treatment and Outcome Status in South Korea http://dx.doi.org/10.5853/jos.2015.17.1.38 42 http://j-stroke.orgOverview of included cases Baseline characteristics The most recent database of the CRCS-5 registry as of Au - gust 2014 contained stroke cases admitted between April 2008  and November 2013.,OADS,/arxiv_data1/oa_pdf/83/81/jos-17-38.PMC4325643.pdf
1 / January 2015 http://dx.doi.org/10.5853/jos.2015.17.1.38 http://j-stroke.org  43CRCS-5 registry.,OADS,/arxiv_data1/oa_pdf/83/81/jos-17-38.PMC4325643.pdf
"Stroke Treatment and Outcome Status in South Korea http://dx.doi.org/10.5853/jos.2015.17.1.38 44 http://j-stroke.orgble, but the acute stroke treatment showed noticeable variability  across hospitals (T able 2).",Non-OADS,/arxiv_data1/oa_pdf/83/81/jos-17-38.PMC4325643.pdf
"1 / January 2015 http://dx.doi.org/10.5853/jos.2015.17.1.38 http://j-stroke.org  45#13) to 55 minutes (hospital #3), and the proportion of endo - vascular treatment was between 6% (hospital #10) and 64%  (hospital #2).",Non-OADS,/arxiv_data1/oa_pdf/83/81/jos-17-38.PMC4325643.pdf
Stroke Treatment and Outcome Status in South Korea http://dx.doi.org/10.5853/jos.2015.17.1.38 46 http://j-stroke.orgymptomatic ones) was detected in 27% of the cases.,Non-OADS,/arxiv_data1/oa_pdf/83/81/jos-17-38.PMC4325643.pdf
"1 / January 2015 http://dx.doi.org/10.5853/jos.2015.17.1.38 http://j-stroke.org  47Early neurological deteriorations A total of 14,730 cases admitted after January 2011 were avail - able to analyze for ENDs.",Non-OADS,/arxiv_data1/oa_pdf/83/81/jos-17-38.PMC4325643.pdf
"Stroke Treatment and Outcome Status in South Korea http://dx.doi.org/10.5853/jos.2015.17.1.38 48 http://j-stroke.org(10%), 2059 stroke progressions (69%), 171 symptomatic hem - orrhagic transformations (6%), 147 other (5%), 300 unknown  (10%), and 22 transient ischemic attacks (1%; missing informa - tion in 5 cases).",Non-OADS,/arxiv_data1/oa_pdf/83/81/jos-17-38.PMC4325643.pdf
"1 / January 2015 http://dx.doi.org/10.5853/jos.2015.17.1.38 http://j-stroke.org  49available, recurrent stroke occurred in 4.5%, vascular death in  3.0%, and composite events of recurrent stroke, myocardial in - farction and vascular death in 6.8% within 365 days of the index  stroke (T able 8).",Non-OADS,/arxiv_data1/oa_pdf/83/81/jos-17-38.PMC4325643.pdf
Stroke Treatment and Outcome Status in South Korea http://dx.doi.org/10.5853/jos.2015.17.1.38 50 http://j-stroke.orgTable 10.,Non-OADS,/arxiv_data1/oa_pdf/83/81/jos-17-38.PMC4325643.pdf
"1 / January 2015 http://dx.doi.org/10.5853/jos.2015.17.1.38 http://j-stroke.org  51tions of diabetes, dyslipidemia and atrial fibrillation were quite  low in China National Stroke Registry data.",Non-OADS,/arxiv_data1/oa_pdf/83/81/jos-17-38.PMC4325643.pdf
Stroke Treatment and Outcome Status in South Korea http://dx.doi.org/10.5853/jos.2015.17.1.38 52 http://j-stroke.orgCirc Cardiovasc Qual Outcome  2010;3:291-302.,Non-OADS,/arxiv_data1/oa_pdf/83/81/jos-17-38.PMC4325643.pdf
1 / January 2015 http://dx.doi.org/10.5853/jos.2015.17.1.38 http://j-stroke.org  5342.,Non-OADS,/arxiv_data1/oa_pdf/83/81/jos-17-38.PMC4325643.pdf
"Copyright © 2015  Korean Stroke Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which  permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/30/f4/jos-17-87.PMC4325644.pdf
"pISSN: 2287-6391 • eISSN: 2287-6405 http://j-stroke.org  87In vivo  Image of Cerebral Amyloid Angiopathy in  an Alzheimer’s Disease Mouse Model  Jinho Kim, Y ong Jeong Department of Bio and Brain Engineering, KAIST , Daejeon, KoreaLetter to the EditorJournal of Stroke  201 5;17(1):87- 88 http://dx.doi.org/10.5853/jos.2015.17.1.87 Dear Sir: We would like to share an in vivo  image of cerebral amyloid  angiopathy (CAA) in an Alzheimer’s disease (AD) mouse  model.",Non-OADS,/arxiv_data1/oa_pdf/30/f4/jos-17-87.PMC4325644.pdf
Cerebral Amyloid Angiopathy in Alzheimer’s Disease http://dx.doi.org/10.5853/jos.2015.17.1.87 88 http://j-stroke.org4.,Non-OADS,/arxiv_data1/oa_pdf/30/f4/jos-17-87.PMC4325644.pdf
86pISSN 2288-6575  • eISSN 2288-6796 http://dx.doi.org/10.4174/astr.2015.88.2.86 Annals of Surgical Treatment and ResearchORIGINAL ARTICLE Can intravenous patient-controlled analgesia be   omitted in patients undergoing laparoscopic surgery  for colorectal cancer?,Non-OADS,/arxiv_data1/oa_pdf/5b/fc/astr-88-86.PMC4325645.pdf
"All  articles are distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5b/fc/astr-88-86.PMC4325645.pdf
" Annals of Surgical Treatment and Research 55pISSN 2288-6575  • eISSN 2288-6796 http://dx.doi.org/10.4174/astr.2015.88.2.55 Annals of Surgical Treatment and ResearchORIGINAL ARTICLE Effects of combination therapy of docetaxel with  selenium on the human breast cancer cell lines  MDA-MB-231 and MCF-7 Sang O Park, Young Bum Yoo1, Yong Hun Kim2, Kwang Je Baek, Jung-Hyun Yang1, Pil Cho Choi3,   Jeong Hun Lee4, Kyeong Ryong Lee, Kyoung Sik Park1 Departments of Emergency Medicine and 1Surgery, Konkuk University Medical Center, Konkuk University School of Medicine,  Seoul, 2Department of Surgery, Konkuk University Chungju Hospital, Chungju, 3Department of Emergency Medicine, Kangbuk  Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, 4Department of Emergency Medicine, Dongguk  University Ilsan Hospital, Dongguk University College of Medicine, Goyang, Korea INTRODUCTION Breast cancer is the most common invasive cancer and is  the second most common cause of deaths in women.",Non-OADS,/arxiv_data1/oa_pdf/b7/f6/astr-88-55.PMC4325646.pdf
"All  articles are distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b7/f6/astr-88-55.PMC4325646.pdf
" Annals of Surgical Treatment and Research 69pISSN 2288-6575  • eISSN 2288-6796 http://dx.doi.org/10.4174/astr.2015.88.2.69 Annals of Surgical Treatment and ResearchORIGINAL ARTICLE A comparative analysis of endoscopic thyroidectomy  versus conventional thyroidectomy in clinically lymph node negative thyroid cancer Min Ji Cho, Kyoung Sik Park, Min Jeng Cho, Young Bum Yoo, Jung Hyun Yang Department of Surgery, Konkuk University School of Medicine, Seoul, Korea INTRODUCTION Thyroid cancer is the most common endocrine malignancy  and has been considered a disease with excellent prognosis [1].",Non-OADS,/arxiv_data1/oa_pdf/30/00/astr-88-69.PMC4325647.pdf
"All  articles are distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/30/00/astr-88-69.PMC4325647.pdf
"114pISSN 2288-6575  • eISSN 2288-6796 http://dx.doi.org/10.4174/astr.2015.88.2.114 Annals of Surgical Treatment and ResearchTECHNICAL ADVANCE Posterior triangle approach for lateral in-plane technique  during hemodialysis catheter insertion via the internal jugular vein Dan Song, Sangchul Yun, Sungwoo Cho Department of Surgery, Soonchunhyang University College of Medicine, Seoul, Korea INTRODUCTION The right internal jugular vein (IJV) is the preferred site for  hemodialysis catheter insertion.",Non-OADS,/arxiv_data1/oa_pdf/87/85/astr-88-114.PMC4325648.pdf
"All  articles are distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/87/85/astr-88-114.PMC4325648.pdf
" Annals of Surgical Treatment and Research 111pISSN 2288-6575  • eISSN 2288-6796 http://dx.doi.org/10.4174/astr.2015.88.2.111 Annals of Surgical Treatment and ResearchCASE REPORT A rare nonincisional lateral abdominal wall hernia Dong-Ju Kim, Jin-Woo Park Department of Surgery, Chungbuk National University College of Medicine, Cheongju, Korea INTRODUCTION Nonincisional lateral abdominal wall hernia (LAWH) is a very  rare condition, although incisional hernias along the lateral  abdominal wall incision can occur infrequently [1,2].",Non-OADS,/arxiv_data1/oa_pdf/80/c7/astr-88-111.PMC4325649.pdf
"All  articles are distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/80/c7/astr-88-111.PMC4325649.pdf
"92pISSN 2288-6575  • eISSN 2288-6796 http://dx.doi.org/10.4174/astr.2015.88.2.92 Annals of Surgical Treatment and ResearchORIGINAL ARTICLE Effect of IL-18 binding protein on hepatic ischemia- reperfusion injury induced by infrarenal aortic occlusion Mustafa Ozsoy, Yucel Gonul1, Ahmet Bal, Ziya Taner Ozkececi, Ruchan Bahadir Celep, Fahri Adali2,   Omer Hazman3, Ahmet Koçak4, Murat Tosun5 Departments of General Surgery, 1Anatomy, and 2Cardiovascular Surgery, Faculty of Medicine, Afyon Kocatepe University, Afyon,  3Department of Biochemistry, Faculty of Arts And Sciences, Afyon Kocatepe University, Afyon, 4Department of Histology and  Embryology, Faculty of Medicine, Dumlupinar University, Kutahya, 5Department of Histology and Embryology, Faculty of Medicine,  Afyon Kocatepe University, Afyon, Turkey INTRODUCTION Restoration of blood supply is the main factor for ischemic  organs to maintain their vitality.",Non-OADS,/arxiv_data1/oa_pdf/29/da/astr-88-92.PMC4325650.pdf
"All  articles are distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/29/da/astr-88-92.PMC4325650.pdf
" Annals of Surgical Treatment and Research 77pISSN 2288-6575  • eISSN 2288-6796 http://dx.doi.org/10.4174/astr.2015.88.2.77 Annals of Surgical Treatment and ResearchORIGINAL ARTICLE Astrocyte elevated gene-1 overexpression in hepatocellular  carcinoma: an independent prognostic factor    Hae Il Jung, Taesung Ahn, Sang Ho Bae, Jun Chul Chung1, Hyungjoo Kim2, Susie Chin3, Dongjun Jeong2,   Hyon Doek Cho4, Moon Soo Lee, Hyung Chul Kim1, Chang Ho Kim, Moo-Jun Baek Department of Surgery, Soonchunhyang University Cheonan Hospital, Cheonan, 1Department of Surgery, Soonchunhyang  University Bucheon Hospital, Bucheon, 2Department of Medical Science Research Institute, Soonchunhyang University, Cheonan,  3Department of Pathology, Soonchunhyang University Bucheon Hospital, Bucheon, 4Department of Pathology, Soonchunhyang  University Cheonan Hospital, Cheonan, Korea INTRODUCTION Hepatocellular carcinoma (HCC) is a common malignancy.",Non-OADS,/arxiv_data1/oa_pdf/42/1a/astr-88-77.PMC4325651.pdf
"All  articles are distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/42/1a/astr-88-77.PMC4325651.pdf
" Annals of Surgical Treatment and Research 63pISSN 2288-6575  • eISSN 2288-6796 http://dx.doi.org/10.4174/astr.2015.88.2.63 Annals of Surgical Treatment and ResearchORIGINAL ARTICLE Predictive factors of central lymph node metastasis in  papillary thyroid carcinoma Byong Hyon Ahn, Je Ryong Kim, Ho Chul Jeong, Jin Sun Lee, Eil Sung Chang, Yong Hun Kim1 Department of Surgery, Chungnam National University College of Medicine, Daejeon, 1Department of Surgery, Konkuk University  Chungju Hospital, Chungju, Korea INTRODUCTION Thyroid carcinoma accounts for approximately 1% of all  tumors and one third of all head and neck tumors.",Non-OADS,/arxiv_data1/oa_pdf/10/7d/astr-88-63.PMC4325652.pdf
"All  articles are distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/10/7d/astr-88-63.PMC4325652.pdf
"100pISSN 2288-6575  • eISSN 2288-6796 http://dx.doi.org/10.4174/astr.2015.88.2.100 Annals of Surgical Treatment and ResearchORIGINAL ARTICLE Effect of donor-specific antibodies and panel reactive  antibodies in living donor liver transplant recipients Seung Hwan Song1, Myoung Soo Kim1,2, Jung Jun Lee3, Man Ki Ju1,2, Jae Geun Lee1,2, Juhan Lee1,2,   Jin Sub Choi1,2, Gi Hong Choi1,2, Soon Il Kim1,2, Dong Jin Joo1,2 1Department of Surgery and 2The Research Institute for Transplantation, Yonsei University College of Medicine, Seoul,  3Department of Surgery, CHA Bundang Medical Center, CHA University, Seongnam, Korea INTRODUCTION Highly sensitized organ recipients are at greater risk of acute  rejection, vascular complications, and poor graft survival [1-3].",Non-OADS,/arxiv_data1/oa_pdf/da/a0/astr-88-100.PMC4325653.pdf
"All  articles are distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/da/a0/astr-88-100.PMC4325653.pdf
"106pISSN 2288-6575  • eISSN 2288-6796 http://dx.doi.org/10.4174/astr.2015.88.2.106 Annals of Surgical Treatment and ResearchCASE REPORT Transfusion free radical antegrade modular  pancreaticosplenectomy of metastatic neuroendocrine tumor of the pancreas in Jehovah’s Witness patient Young Bae Jeon*, Sangchul Yun*, Dongho Choi1 Department of Surgery, Soonchunhyang University College of Medicine, Cheonan, 1Department of Surgery, Hanyang University  College of Medicine, Seoul, Korea INTRODUCTION Pancreatic neuroendocrine tumors (PNETs) form a rare  subgroup of tumors found in the pancreas, where liver is  the most common site of metastasis [1].",Non-OADS,/arxiv_data1/oa_pdf/54/67/astr-88-106.PMC4325654.pdf
"All  articles are distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/54/67/astr-88-106.PMC4325654.pdf
"This is an Open Access article distributed under the terms of the  Creative Commons Attribution Non-Commercial License   (http://creativecommons.org/licenses/by-nc/4.0/), which   permits non-commercial re-use, distribution, and reproduction  in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b6/a5/hpu134.PMC4325666.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e7/17/deu344.PMC4325671.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/17/30/deu350.PMC4325673.pdf
"http://solutions.3m.com/wps/ portal/3M/en_US/PFOS/PFOA/Information/phase-out-technologies/(16 June 2014, date last accessed), 2014.",OADS,/arxiv_data1/oa_pdf/17/30/deu350.PMC4325673.pdf
"Agency for Toxic Substances and Disease Registry, 2009. http://www.atsdr.cdc.gov/ toxfaqs/tf.asp?id=1116&tid=237 (date last accessed, 16 June 2014).",OADS,/arxiv_data1/oa_pdf/17/30/deu350.PMC4325673.pdf
http://www2.dupont.com/PFOA2/en_US/index.,OADS,/arxiv_data1/oa_pdf/17/30/deu350.PMC4325673.pdf
"2010; http://www.hc-sc.gc.ca/ewh-semt/alt_ formats/hecs-sesc/pdf/pubs/contaminants/chms-ecms/report-rapport-eng.pdf (date last accessed, 16 June 2014).",OADS,/arxiv_data1/oa_pdf/17/30/deu350.PMC4325673.pdf
"2013; http://www.hc-sc.gc.ca/ewh-semt/pubs/ contaminants/chms-ecms-cycle2/index-eng.php , (date last accessed, 16 June 2014).",OADS,/arxiv_data1/oa_pdf/17/30/deu350.PMC4325673.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/29/97/tcrm-11-171.PMC4325830.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpTherapeutics and Clinical Risk Management 2015:11 171–188Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  171Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/TCRM.S7065 2Xerostomia induced by radiotherapy:  an overview of the physiopathology, clinical  evidence, and management of the oral damage Roberto Pinna1  Guglielmo Campus2  enzo Cumbo3  ida Mura1  egle Milia2 1Department of Biomedical Science,   2Department of Surgery, Microsurgery  and Medicine, University of Sassari,   Sassari, 3Department of Dental  Science, University of Palermo,   Palermo, italyBackground: The irradiation of head and neck cancer (HNC) often causes damage to the  salivary glands.",Non-OADS,/arxiv_data1/oa_pdf/29/97/tcrm-11-171.PMC4325830.pdf
"Major salivary  glands contribute to most of the secretion volume and electrolyte content of saliva  (the parotid, submandibular, and sublingual glands, which account for 90% of saliva  production), whereas minor salivary glands contribute little secretion volume and  most of the blood-group substance.10 Saliva components interact in related functions  in the following general areas: 1) bicarbonates, phosphates, and urea act to modulate pH and the buffering capacity  of saliva; 2) macromolecule proteins and mucins serve to cleanse, aggregate, and/or attach oral  microorganisms and contribute to the dental plaque metabolism;Correspondence: egle Milia Department of Surgery, Microsurgery  and Medicine, University of Sassari, viale  San Pietro 43/c, 07100 Sassari, italy   Tel +39 079 22 8437   Fax +39 079 27 2645   email emilia@uniss.i t Journal name: Therapeutics and Clinical Risk Management Article Designation: Review Y ear: 2015 Volume: 11 Running head verso: Pinna et al Running head recto: Xerostomia induced by radiotherapy DOI: http://dx.doi.org/10.2147/TCRM.S70652",Non-OADS,/arxiv_data1/oa_pdf/29/97/tcrm-11-171.PMC4325830.pdf
Available from: http://globocan.iarc.fr/ Default.aspx.,Non-OADS,/arxiv_data1/oa_pdf/29/97/tcrm-11-171.PMC4325830.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/29/97/tcrm-11-171.PMC4325830.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/29/97/tcrm-11-171.PMC4325830.pdf
Two months after publication it is available to  the public under an Attribution–Noncommercial–Share Alike 3.0 Unported Cre - ative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/b0/94/591.PMC4325831.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/94/04/594.PMC4325832.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/e1/c6/605.PMC4325833.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/f3/8d/622.PMC4325834.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/71/96/636.PMC4325835.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/71/ec/651.PMC4325836.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/ac/2d/659.PMC4325837.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported Cre - ative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/8f/37/674.PMC4325838.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/b9/74/685.PMC4325839.pdf
Two months after publication it  is available to the public under an Attribution–Noncommercial–Share Alike 3.0  Unported Creative Commons License (http://creativecommons.org/licenses/by- nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/f0/03/696.PMC4325840.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/35/20/711.PMC4325841.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/95/89/726.PMC4325842.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/f1/93/740.PMC4325843.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/f8/e0/751.PMC4325844.pdf
Two months after publication  it is available to the public under an Attribution–Noncommercial–Share Alike 3.0  Unported Creative Commons License (http://creativecommons.org/licenses/by- nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/1e/02/762.PMC4325845.pdf
"Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).Abbreviations used: ADBE, activity-dependent bulk endocytosis; CME, clathrin- mediated endocytosis; CN, calcineurin; PI(4,5)P 2, phosphatidylinositol-4,5-bis - phosphate; TGN, trans -Golgi network.",Non-OADS,/arxiv_data1/oa_pdf/75/7c/769.PMC4325846.pdf
"Images were ana - lyzed with CalMorph (http://scmd.gi.k.u-tokyo.ac.jp/datamine/ calmorph/; Ohtani et al., 2004), and actin polarity was calculated for  small- and medium-budded cells as the ratio of actin brightness in  the bud to actin brightness in the mother cell.",OADS,/arxiv_data1/oa_pdf/75/7c/769.PMC4325846.pdf
Two months after publication it  is available to the public under an Attribution–Noncommercial–Share Alike 3.0  Unported Creative Commons License (http://creativecommons.org/licenses/by- nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/1c/20/786.PMC4325847.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/7b/63/797.PMC4325848.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/22/59/805.PMC4325849.pdf
"Proteins were  identified by searching the protein sequence database from D. dis - coideum  (version 02/04/2013 from dictyBase, http://dictyBase.org/;  Eichinger et al., 2005) supplemented with frequently observed con - taminates and reverse sequences.",OADS,/arxiv_data1/oa_pdf/22/59/805.PMC4325849.pdf
The mass spectrome - try proteomics data were deposited at the ProteomeXchange  Consortium (http://proteomecentral.proteomexchange.org) via the  PRIDE partner repository with the data set identifier PXD001555.,OADS,/arxiv_data1/oa_pdf/22/59/805.PMC4325849.pdf
"This open-access article is distributed under the terms of the Creative Commons Attribution Non-Commercial License (CC BY-NC) (http://creativecommons.org/licenses/by-nc/4.0/), which permits reuse, distribution and reproduction of the article, provided that the original work is  properly cited and the reuse is restricted to noncommercial purposes.",Non-OADS,/arxiv_data1/oa_pdf/92/4e/prm-20-15.PMC4325885.pdf
"This open-access article is distributed under the terms of the Creative Commons Attribution Non-Commercial License (CC BY-NC) (http://creativecommons.org/licenses/by-nc/4.0/), which permits reuse, distribution and reproduction of the article, provided that the original work is  properly cited and the reuse is restricted to noncommercial purposes.",Non-OADS,/arxiv_data1/oa_pdf/8d/c0/prm-20-23.PMC4325886.pdf
"This open-access article is distributed under the terms of the Creative Commons Attribution Non-Commercial License (CC BY-NC) (http://creativecommons.org/licenses/by-nc/4.0/), which permits reuse, distribution and reproduction of the article, provided that the original work is  properly cited and the reuse is restricted to noncommercial purposes.",Non-OADS,/arxiv_data1/oa_pdf/40/fd/prm-20-29.PMC4325887.pdf
"This open-access article is distributed under the terms of the Creative Commons Attribution Non-Commercial License (CC BY-NC) (http://creativecommons.org/licenses/by-nc/4.0/), which permits reuse, distribution and reproduction of the article, provided that the original work is  properly cited and the reuse is restricted to noncommercial purposes.",Non-OADS,/arxiv_data1/oa_pdf/d7/6f/prm-20-39.PMC4325889.pdf
"This open-access article is distributed under the terms of the Creative Commons Attribution Non-Commercial License (CC BY-NC) (http://creativecommons.org/licenses/by-nc/4.0/), which permits reuse, distribution and reproduction of the article, provided that the original work is  properly cited and the reuse is restricted to noncommercial purposes.",Non-OADS,/arxiv_data1/oa_pdf/4f/30/prm-20-48.PMC4325891.pdf
"However, the most effective strategy is a urine test, if the patient  agrees (see the Guidelines, http://nationalpaincentre.mcmaster.ca/ opioid/).",Non-OADS,/arxiv_data1/oa_pdf/4e/cb/prm-20-7.PMC4325893.pdf
"The use of an evidence- based approach is mandatory in all health disciplines and, in recent  years, CAM research has made significant progress in providing more information on efficacy and safety, partly due to more open-minded government attitudes (http://nccam.nih.gov).",Non-OADS,/arxiv_data1/oa_pdf/4e/cb/prm-20-7.PMC4325893.pdf
"This open-access article is distributed under the terms of the Creative Commons Attribution Non-Commercial License (CC BY-NC) (http://creativecommons.org/licenses/by-nc/4.0/), which permits reuse, distribution and reproduction of the article, provided that the original work is properly cited and the reuse is restricted to noncommercial purposes.",Non-OADS,/arxiv_data1/oa_pdf/9f/12/prm-20-e1.PMC4325894.pdf
"<http://ipe.utoronto.ca/sites/default/files/2012CoreCompetenciesDiagram.pdf> (Accessed on November 12, 2012).25.",OADS,/arxiv_data1/oa_pdf/95/33/prm-20-e12.PMC4325895.pdf
"<http://avigaili.wix.com/olav#!vibroacoustic-solutions> (Accessed November 10, 2013).",Non-OADS,/arxiv_data1/oa_pdf/44/1e/prm-20-e21.PMC4325896.pdf
"This open-access article is distributed under the terms of the Creative Commons Attribution Non-Commercial License (CC BY-NC) (http://creativecommons.org/licenses/by-nc/4.0/), which permits reuse, distribution and reproduction of the article, provided that the original work is  properly cited and the reuse is restricted to noncommercial purposes.",Non-OADS,/arxiv_data1/oa_pdf/75/fe/prm-20-e28.PMC4325897.pdf
"This open-access article is distributed under the terms of the Creative Commons Attribution Non-Commercial License (CC BY-NC) (http://creativecommons.org/licenses/by-nc/4.0/), which permits reuse, distribution and reproduction of the article, provided that the original work is  properly cited and the reuse is restricted to noncommercial purposes.",Non-OADS,/arxiv_data1/oa_pdf/07/dc/prm-20-e8.PMC4325899.pdf
See http://creativecommons.org/licenses/by-nc/2.0/de/ NIH Public Access Author Manuscript Demogr Res .,Non-OADS,/arxiv_data1/oa_pdf/79/d5/nihms658530.PMC4326020.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/ by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/91/24/main.PMC4326062.pdf
"http://dx.doi.org/10.1016/j.gendis.2014.09.009 2352-3042/Copyright ª2014, Chongqing Medical University.",Non-OADS,/arxiv_data1/oa_pdf/91/24/main.PMC4326062.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).HOSTED BY Available online at www.sciencedirect.com ScienceDirect journal homepage: http://ees.elsevier.com/gendis/default.asp Genes &Diseases (2014) 1, 214e226",Non-OADS,/arxiv_data1/oa_pdf/91/24/main.PMC4326062.pdf
"http://dx.doi.org/10.1016/j.gendis.2014.09.004 2352-3042/Copyright ª2014, Chongqing Medical University.",Non-OADS,/arxiv_data1/oa_pdf/e9/83/main.PMC4326072.pdf
"Production and hosting by Elsevier B.V. All rights reserved.HOSTED BY Available online at www.sciencedirect.com ScienceDirect journal homepage: http://ees.elsevier.com/gendis/default.asp Genes &Diseases (2014) 1, 149e161",Non-OADS,/arxiv_data1/oa_pdf/e9/83/main.PMC4326072.pdf
2014. http://dx.doi.org/10.1002/term.1918 .,Non-OADS,/arxiv_data1/oa_pdf/e9/83/main.PMC4326072.pdf
"For reprints and permission queries, please visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.6White et al The Orthopaedic Journal of Sports Medicine",Non-OADS,/arxiv_data1/oa_pdf/b6/2c/10.1177_2325967113496967.PMC4326084.pdf
http://www.oecd.org/unit- edstates/43800977.pdf (Accessed: 17 Nov 2012).,Non-OADS,/arxiv_data1/oa_pdf/1f/5a/main.PMC4326114.pdf
http://www.census.gov/prod/2008pubs/p60–235.pdf (Accessed: 7 Dec 2012).,OADS,/arxiv_data1/oa_pdf/1f/5a/main.PMC4326114.pdf
"http://www.healthcare.gov/law/full/index.html (Accessed: 21 Nov 2012).Table 2 Age-standardized death rates (per 100,000) for all  amenable causes in 1999 to 2006/2007 for men ag ed 0–641 Country 1999 2007 France 47.25 37.13 Germany 60.66 49.53 United Kingdom 72.71 53.01 United States 78.17 68.81 Table 3 Comparison of Life Expectancy and Infant Mortality in 2007 6,7 Country Life Expectancy   (years)Infant Mortality (deaths per 1,000 live births) German 80.0 3.9 France 80.9 3.8 United Kingdom 79.9 4.8 United States 77.9 6.8Table 1 Reduction of Amenable Mortality People Aged  0–74 between 1999–2006/20071 Country Men (%) Women (%) United Kingdom 36.9 31.9 France 27.7 23.4 German 24.3 22.7 United States 18.5 17.5Fig 1.",Non-OADS,/arxiv_data1/oa_pdf/1f/5a/main.PMC4326114.pdf
An in depth investigation into the causes of prescribing errors by foundation trainees  in relation to their medical education-EQUIP study 2009: Available from: http://www.gmc-uk.org/about/research/research_commissioned_4.asp.,Non-OADS,/arxiv_data1/oa_pdf/dc/52/main.PMC4326115.pdf
http://www.nice.,Non-OADS,/arxiv_data1/oa_pdf/b4/c2/main.PMC4326116.pdf
http://publications.nice.org.uk/lipid-modifi-cation-cg67.,Non-OADS,/arxiv_data1/oa_pdf/b4/c2/main.PMC4326116.pdf
ANNALS OF MEDICINE AND SURGERY Annals of Medicine and Surgery 2013; 2(1): 32–35 www.annalsjournal.com Page 35http://www.guardian.co.uk/commentisfree/2011/oct/31/caesarean-sections-lifestyle-choice  (Accessed 14th Nov 2012).,Non-OADS,/arxiv_data1/oa_pdf/9e/4c/main.PMC4326117.pdf
The Social Costs of Litigation: Centre for Policy Studies 2012 [online]  http://www.cps.org.uk/files/reports/original/120905122753-thesocialcostoflitigation.pdf (accessed 14 Nov 2012).,Non-OADS,/arxiv_data1/oa_pdf/9e/4c/main.PMC4326117.pdf
Available at:  http://www.youtube.com/ watch?v=JzlvgtPIof4 (accessed 6 February 2013).,Non-OADS,/arxiv_data1/oa_pdf/3b/c8/main.PMC4326118.pdf
http://www.ncbi.nlm.nih.gov/books/NBK63696/ (Accessed: 6 Sept 2012).,Non-OADS,/arxiv_data1/oa_pdf/fc/ff/main.PMC4326119.pdf
http://www.health.gov.au/internet/main/publishing.nsf/Content/obesityguidelines-guidelines-adults.htm (accessed: 6 Sept 2012).,Non-OADS,/arxiv_data1/oa_pdf/fc/ff/main.PMC4326119.pdf
http://www.cdc.gov/nchs/healthy_people/hp2010/hp2010_final_review.htm  (accessed: 6 Sept 2012).,Non-OADS,/arxiv_data1/oa_pdf/fc/ff/main.PMC4326119.pdf
http://www.ncbi.nlm.nih.gov/books/NBK65294/ (accessed: 6 Sept 2012).,Non-OADS,/arxiv_data1/oa_pdf/fc/ff/main.PMC4326119.pdf
http://www.ncbi.nlm.nih.gov/books/NBK2003/ (accessed: 6 Sept 2012).,Non-OADS,/arxiv_data1/oa_pdf/fc/ff/main.PMC4326119.pdf
http://www.screening.nhs.uk/policydb.php  (accessed: 6 Sept 2012).,Non-OADS,/arxiv_data1/oa_pdf/fc/ff/main.PMC4326119.pdf
http://www.nice.org.uk/nicemedia/live/11000/30364/30364.pdf (accessed: 6 Sept 2012).,Non-OADS,/arxiv_data1/oa_pdf/fc/ff/main.PMC4326119.pdf
http://www.wpro.who.int/nutrition/documents/docs/Redefiningobesity.pdf (accessed 6 Sept 2012).,Non-OADS,/arxiv_data1/oa_pdf/fc/ff/main.PMC4326119.pdf
http://www.healthypeople.gov/2020/topicsobjectives2020/default.aspx.,Non-OADS,/arxiv_data1/oa_pdf/fc/ff/main.PMC4326119.pdf
http://www.heart.org/idc/groups/heart-public/@wcm/@private/@hcm/documents/downloadable/ucm_316262.pdf (Accessed: 6 November 2012).,Non-OADS,/arxiv_data1/oa_pdf/98/72/main.PMC4326120.pdf
"2 The Kaiser Family Foundation, December 2010 http://www.kff.org/uninsured/upload/ 7451- 06.pdf.",Non-OADS,/arxiv_data1/oa_pdf/e8/70/main.PMC4326121.pdf
http://www.commonwealthfund.org/Publications/Fund-Reports/ 2012/Oct/Health-Care-in-the-2012-Presidential-Election.aspx?page=all [Accessed on 26 November 2012].,Non-OADS,/arxiv_data1/oa_pdf/e8/70/main.PMC4326121.pdf
2011. http://www.vtethicsnetwork.org/health- carerights.html [Accessed on 3rd August 2012].,Non-OADS,/arxiv_data1/oa_pdf/e8/70/main.PMC4326121.pdf
2012. http://www.healthcare.procon.org  [Accessed 3rd August 2012].,Non-OADS,/arxiv_data1/oa_pdf/e8/70/main.PMC4326121.pdf
"v.  Sebelius, Secretary of Health and human services, et al., http://www.supremecourt.gov/opinions/11pdf/11-393c3a2.pdf.",Non-OADS,/arxiv_data1/oa_pdf/e8/70/main.PMC4326121.pdf
http://www.histansoc.org.uk/timeline.html (Accessed: 1 Oct 2012).,Non-OADS,/arxiv_data1/oa_pdf/f2/ed/main.PMC4326122.pdf
http://www.oximetry.org/pulseox/history.,OADS,/arxiv_data1/oa_pdf/f2/ed/main.PMC4326122.pdf
http://www.nice.org.uk/nicemedia/live/ 13504/59368/59368.pdf (Accessed: 28 Dec 2012).,Non-OADS,/arxiv_data1/oa_pdf/f2/ed/main.PMC4326122.pdf
http://guidance.nice.org.uk/MTG3 (Accessed: 28 December 2012).,Non-OADS,/arxiv_data1/oa_pdf/f2/ed/main.PMC4326122.pdf
http://www.rcoa.ac.uk/about-the- college/history-of-anaesthesia (Accessed: 10 Dec 2012).,Non-OADS,/arxiv_data1/oa_pdf/f2/ed/main.PMC4326122.pdf
http://www.ncepod.org.uk/about.htm# (Accessed: 28 Dec 2012).,Non-OADS,/arxiv_data1/oa_pdf/f2/ed/main.PMC4326122.pdf
http://www.npsa.nhs.,Non-OADS,/arxiv_data1/oa_pdf/f2/ed/main.PMC4326122.pdf
http://www.patientsafetyfirst.nhs.uk/ Content.aspx?path=/interventions/Perioperativecare/ (Accessed: 9 Dec 2011).,Non-OADS,/arxiv_data1/oa_pdf/f2/ed/main.PMC4326122.pdf
2012 [online] http://www.joint- commission.org/facts_about_the_universal_protocol/ (Accessed: 1 Oct 2012).,Non-OADS,/arxiv_data1/oa_pdf/f2/ed/main.PMC4326122.pdf
2003  [online] http://www.reproline.jhu.edu/english/2mnh/2obs_care/EmOC/Participants/week_2/ 22_CL_CesareanSection.html (Accessed 11/01/2012).,Non-OADS,/arxiv_data1/oa_pdf/f2/ed/main.PMC4326122.pdf
http://www.youtube.com/watch?,Non-OADS,/arxiv_data1/oa_pdf/f2/ed/main.PMC4326122.pdf
http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/@dh/@en/docu-ments/ digitalasset/dh_4082232.pdf (Accessed: 11 Dec 2012).,OADS,/arxiv_data1/oa_pdf/f2/ed/main.PMC4326122.pdf
http://www.health.gov/dietaryguidelines/dga2005/document/ (Accessed: 13 Dec 2012).,Non-OADS,/arxiv_data1/oa_pdf/d4/3e/main.PMC4326124.pdf
http://www.nhs.uk/Change4Life/Pages/ change-for-life.aspx (Accessed: 13 Dec 2012).,Non-OADS,/arxiv_data1/oa_pdf/d4/3e/main.PMC4326124.pdf
http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_129001 (Accessed: 13 Dec 2012).,Non-OADS,/arxiv_data1/oa_pdf/d4/3e/main.PMC4326124.pdf
http://www.moveeattreat.org (Accessed: 13 Dec 2012).14 National Health Service.,Non-OADS,/arxiv_data1/oa_pdf/d4/3e/main.PMC4326124.pdf
http://www.nhs.uk/Livewell/ Goodfood/Pages/eatwell-plate.aspx (Accessed: 13 Dec 2012).,Non-OADS,/arxiv_data1/oa_pdf/d4/3e/main.PMC4326124.pdf
http://www.ebbp.org/course_outlines/randomized_controlled_trials/ (Accessed: 14th August 2012).,Non-OADS,/arxiv_data1/oa_pdf/aa/a3/main.PMC4326125.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/50/a8/main.PMC4326179.pdf
"Because human cells derive energy using electron transfer from donor species to oxygen, andContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/redoxRedox Biology http://dx.doi.org/10.1016/j.redox.2015.01.006 2213-2317/ &2015 The Authors.",OADS,/arxiv_data1/oa_pdf/50/a8/main.PMC4326179.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/50/a8/main.PMC4326179.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/50/a8/main.PMC4326179.pdf
http://dx.doi.org/10.1016/S0140-6736(13)62365-X 24581668 .,OADS,/arxiv_data1/oa_pdf/50/a8/main.PMC4326179.pdf
"Handy, J. Loscalzo, Redox regulation in the extracellular environment, Circulation Journal 72 (1) (2008) 1 –16.http://dx.doi.org/ 10.1253/circj.72.1 18159092 .",Non-OADS,/arxiv_data1/oa_pdf/50/a8/main.PMC4326179.pdf
http://dx.doi.org/10.1016/S0891-5849(99)00275-0 10719244 .,OADS,/arxiv_data1/oa_pdf/50/a8/main.PMC4326179.pdf
http://dx.doi.org/10.1089/ neu.2008-0816 19317602 .,Non-OADS,/arxiv_data1/oa_pdf/50/a8/main.PMC4326179.pdf
http://dx.doi.org/10.1016/j.bbrc.2007.07.078 17662690 .,OADS,/arxiv_data1/oa_pdf/50/a8/main.PMC4326179.pdf
http://dx.doi.org/10.1021/bi010595q 11502194 .,Non-OADS,/arxiv_data1/oa_pdf/50/a8/main.PMC4326179.pdf
http://dx.doi.org/ 10.2144/000113801 22313409 .,Non-OADS,/arxiv_data1/oa_pdf/50/a8/main.PMC4326179.pdf
http://dx.doi.org/10.1016/0891-5849(91) 90192-6 1937131 .,Non-OADS,/arxiv_data1/oa_pdf/50/a8/main.PMC4326179.pdf
"[12] G. Barrera, Oxidative stress and lipid peroxidation products in cancer pro- gression and therapy, ISRN Oncology 2012 (2012) 137289. http://dx.doi.org/ 10.5402/2012/137289 23119185 .",Non-OADS,/arxiv_data1/oa_pdf/50/a8/main.PMC4326179.pdf
http://dx.doi.org/10.3390/cancers2020338 24281073 .,Non-OADS,/arxiv_data1/oa_pdf/50/a8/main.PMC4326179.pdf
"Mattson, Modi ﬁcation of ion homeostasis by lipid peroxidation: roles in neuronal degeneration and adaptive plasticity, Trends in Neurosciences 21 (2) (1998) 53 –57.http://dx.doi.org/10.1016/S0166-2236(97)01188-0 9498297 .",OADS,/arxiv_data1/oa_pdf/50/a8/main.PMC4326179.pdf
http://dx.doi.org/10.1016/ S0306-4522(97)00065-1 9276486 .,OADS,/arxiv_data1/oa_pdf/50/a8/main.PMC4326179.pdf
http://dx.doi.org/10.1016/j.taap.2014.04.026 24832492 .,OADS,/arxiv_data1/oa_pdf/50/a8/main.PMC4326179.pdf
http://dx.doi.org/ 10.1073/pnas.95.9.4924 9560204 .,Non-OADS,/arxiv_data1/oa_pdf/50/a8/main.PMC4326179.pdf
http://dx.doi.org/10.1203/00006450-200205000-00005 11978879 .,Non-OADS,/arxiv_data1/oa_pdf/50/a8/main.PMC4326179.pdf
http://dx.doi.org/10.1089/ 089771503767870005 12965056 .,Non-OADS,/arxiv_data1/oa_pdf/50/a8/main.PMC4326179.pdf
http://dx.doi.org/ 10.1097/TA.0b013e318069178a 17693848 .,Non-OADS,/arxiv_data1/oa_pdf/50/a8/main.PMC4326179.pdf
http://dx.doi.org/10.1016/j.freeradbiomed.2014.04.002 24726861 .,OADS,/arxiv_data1/oa_pdf/50/a8/main.PMC4326179.pdf
http://dx.doi.org/10.1097/00003246-199504000-00011 7712754 .,Non-OADS,/arxiv_data1/oa_pdf/50/a8/main.PMC4326179.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/50/a8/main.PMC4326179.pdf
"[26] H.F. Galley, Oxidative stress and mitochondrial dysfunction in sepsis, British Journal of Anaesthesia 107 (1) (2011) 57 –64.http://dx.doi.org/10.1093/bja/ aer093 21596843 .D.",Non-OADS,/arxiv_data1/oa_pdf/50/a8/main.PMC4326179.pdf
"Murphy, How mitochondria produce reactive oxygen species, Biochem- ical Journal 417 (1) (2009) 1 –13.http://dx.doi.org/10.1042/BJ20081386 19061483 .",OADS,/arxiv_data1/oa_pdf/50/a8/main.PMC4326179.pdf
http://dx.doi.org/ 10.1073/pnas.95.20.11715 9751731 .,Non-OADS,/arxiv_data1/oa_pdf/50/a8/main.PMC4326179.pdf
http://dx.doi.org/10.1113/ex- pphysiol.2006.033506 16857720 .,Non-OADS,/arxiv_data1/oa_pdf/50/a8/main.PMC4326179.pdf
"Lu, Association between oxidative stress and outcome in different subtypes of acute ischemic stroke, BioMed Research International 2014 (2014) 256879. http://dx.doi.org/10.1155/ 2014/256879 24895559 .",Non-OADS,/arxiv_data1/oa_pdf/50/a8/main.PMC4326179.pdf
http://dx.doi.org/10.1097/ WNF.0b013e3182309418 21897213 .,Non-OADS,/arxiv_data1/oa_pdf/50/a8/main.PMC4326179.pdf
http://dx.doi.org/10.1161/01.STR.0000105391.62306.2E 14671251 .,Non-OADS,/arxiv_data1/oa_pdf/50/a8/main.PMC4326179.pdf
http://dx.doi.org/10.1038/sj.ejcn.1602248 16091766 .,Non-OADS,/arxiv_data1/oa_pdf/50/a8/main.PMC4326179.pdf
http://dx.doi.org/10.1042/CS20040134 15279619 .,Non-OADS,/arxiv_data1/oa_pdf/50/a8/main.PMC4326179.pdf
http://dx.doi.org/10.3171/ jns.1998.89.5.0748 9817412 .,OADS,/arxiv_data1/oa_pdf/50/a8/main.PMC4326179.pdf
http://dx.doi.org/10.1161/01.CIR.96.7.2414 9337218 .,Non-OADS,/arxiv_data1/oa_pdf/50/a8/main.PMC4326179.pdf
http://dx.doi.org/10.1161/01.CIR.99.1.1219884388 .,Non-OADS,/arxiv_data1/oa_pdf/50/a8/main.PMC4326179.pdf
"[39] C. Di Filippo, S. Cuzzocrea, F. Rossi, R. Marfella, M. D ’Amico, Oxidative stress as the leading cause of acute myocardial infarction in diabetics, Cardiovascular Drug Reviews 24 (2) (2006) 77 –87.http://dx.doi.org/10.1111/j.1527- 3466.2006.00077.x 16961722 .",Non-OADS,/arxiv_data1/oa_pdf/50/a8/main.PMC4326179.pdf
http://dx.doi.org/10.1152/physrev.00018.2010 21742790 .,Non-OADS,/arxiv_data1/oa_pdf/50/a8/main.PMC4326179.pdf
http://dx.doi.org/10.1172/JCI65268 23426181 .,Non-OADS,/arxiv_data1/oa_pdf/50/a8/main.PMC4326179.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/50/a8/main.PMC4326179.pdf
"Gormaz, The effectiveness of antioxidant vitamins C and E in reducing myocardial infarct size in patients subjected to percutaneous cor- onary angioplasty (PREVEC Trial): study protocol for a pilot randomized double-blind controlled trial, Trials 15 (2014) 192. http://dx.doi.org/10.1186/ 1745-6215-15-192 24885600 .",Non-OADS,/arxiv_data1/oa_pdf/50/a8/main.PMC4326179.pdf
http://dx.doi.org/10.1038/nature13909 25383517 .,Non-OADS,/arxiv_data1/oa_pdf/50/a8/main.PMC4326179.pdf
http://dx.doi.org/10.3109/10715769409056590 7834052 .,Non-OADS,/arxiv_data1/oa_pdf/50/a8/main.PMC4326179.pdf
http://dx.doi.org/10.1097/00004630- 199705000-00018 9169953 [Discussion 268].,Non-OADS,/arxiv_data1/oa_pdf/50/a8/main.PMC4326179.pdf
http://dx.doi.org/10.1097/ SHK.0b013e3182236eba 21610569 .D.,Non-OADS,/arxiv_data1/oa_pdf/50/a8/main.PMC4326179.pdf
"It was shown that Myco- bacterium tuberculosis (M.tb) senses host-derived CO produced by HO-1 induction during macrophages infection [20], and COContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/redoxRedox Biology http://dx.doi.org/10.1016/j.redox.2015.01.012 2213-2317/ &2015 Elsevier B.V..",OADS,/arxiv_data1/oa_pdf/d2/37/main.PMC4326180.pdf
http://dx.doi.org/10.1111/j.1600-0463.2006.apm_390.x 16725007 .,Non-OADS,/arxiv_data1/oa_pdf/d2/37/main.PMC4326180.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d2/37/main.PMC4326180.pdf
http://dx.doi.org/10.1165/rcmb.2009-0276TR 20081053 .,Non-OADS,/arxiv_data1/oa_pdf/d2/37/main.PMC4326180.pdf
"http://dx.doi.org/10.1016/j.arbres.2011.03.007 , English Version.",OADS,/arxiv_data1/oa_pdf/d2/37/main.PMC4326180.pdf
http://dx.doi.org/10.1016/S0140-6736 (13)60632-7 23541540 .,OADS,/arxiv_data1/oa_pdf/d2/37/main.PMC4326180.pdf
http://dx.doi.org/10.2478/s11756-012- 0058-1 .,Non-OADS,/arxiv_data1/oa_pdf/d2/37/main.PMC4326180.pdf
http://dx.doi.org/10.1126/science.3029864 3029864 .,Non-OADS,/arxiv_data1/oa_pdf/d2/37/main.PMC4326180.pdf
http://dx.doi.org/10.1152/physrev.00011.2005 16601269 .,Non-OADS,/arxiv_data1/oa_pdf/d2/37/main.PMC4326180.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d2/37/main.PMC4326180.pdf
http://dx.doi.org/ 10.1007/s10495-006-0016-x 17219054 .,Non-OADS,/arxiv_data1/oa_pdf/d2/37/main.PMC4326180.pdf
http://dx.doi.org/10.1084/jem.192.7.1015 11015442 .,Non-OADS,/arxiv_data1/oa_pdf/d2/37/main.PMC4326180.pdf
http://dx.doi.org/ 10.1016/j.biocel.2006.03.013 16697692 .,OADS,/arxiv_data1/oa_pdf/d2/37/main.PMC4326180.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d2/37/main.PMC4326180.pdf
http://dx.doi.org/10.1182/ blood-2007-07-104042 18202225 .,Non-OADS,/arxiv_data1/oa_pdf/d2/37/main.PMC4326180.pdf
http://dx.doi.org/10.1038/mi.2011.3 21307848 .,Non-OADS,/arxiv_data1/oa_pdf/d2/37/main.PMC4326180.pdf
http://dx.doi.org/10.1016/j.chom.2008.03.007 18474359 .,OADS,/arxiv_data1/oa_pdf/d2/37/main.PMC4326180.pdf
http://dx.doi.org/10.1074/jbc.,Non-OADS,/arxiv_data1/oa_pdf/d2/37/main.PMC4326180.pdf
"Shiloh, Cor, a novel carbon monoxide resistance gene, is essential for Mycobacterium tuberculosis pathogenesis, MBio 4 (6) (2013) , http://dx.doi.org/10.1128/mBio.00721-13 24255121 .",Non-OADS,/arxiv_data1/oa_pdf/d2/37/main.PMC4326180.pdf
http://dx.doi.org/10.1128/IAI.68.10.5619-5627.2000 10992462 .,Non-OADS,/arxiv_data1/oa_pdf/d2/37/main.PMC4326180.pdf
http://dx.doi.org/ 10.1128/AAC.00655-09 19917753 .,Non-OADS,/arxiv_data1/oa_pdf/d2/37/main.PMC4326180.pdf
"[25] R.-H. Shih, C.-M. Yang, Induction of heme oxygenase-1 attenuates lipopoly- saccharide-induced cyclooxygenase-2 expression in mouse brain endothelialcells, J. Neuroin ﬂammation 7 (2010) 86. http://dx.doi.org/10.1186/1742-2094- 7-86 21118574 .",Non-OADS,/arxiv_data1/oa_pdf/d2/37/main.PMC4326180.pdf
http://dx.doi.org/10.1096/fj.11- 190017 22490782 .,Non-OADS,/arxiv_data1/oa_pdf/d2/37/main.PMC4326180.pdf
http://dx.doi.org/ 10.1128/IAI.00251-13 23630967 .,Non-OADS,/arxiv_data1/oa_pdf/d2/37/main.PMC4326180.pdf
http://dx.doi.org/10.1074/jbc.M110.138636 20833713 .,Non-OADS,/arxiv_data1/oa_pdf/d2/37/main.PMC4326180.pdf
http://dx.doi.org/10.1165/rcmb.2006-0340TR 16990612 .,Non-OADS,/arxiv_data1/oa_pdf/d2/37/main.PMC4326180.pdf
http://dx.doi.org/10.1128/AAC.01519-12 22964249 .,Non-OADS,/arxiv_data1/oa_pdf/d2/37/main.PMC4326180.pdf
http://dx.doi.org/10.1128/AAC.01543-13 24060870 .,Non-OADS,/arxiv_data1/oa_pdf/d2/37/main.PMC4326180.pdf
http://dx.doi.org/10.1002/ hep.23921 21105106 .,Non-OADS,/arxiv_data1/oa_pdf/d2/37/main.PMC4326180.pdf
http://dx.doi.org/ 10.1002/hep.23339 20044809 .,Non-OADS,/arxiv_data1/oa_pdf/d2/37/main.PMC4326180.pdf
"Reversal of the usualnonfusion pattern and observations on bacterial survival, Journal of Experi-mental Medicine 142 (1) (1975) 1 –16.http://dx.doi.org/10.1084/jem.142.1.1 807671 .",Non-OADS,/arxiv_data1/oa_pdf/d2/37/main.PMC4326180.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d2/37/main.PMC4326180.pdf
http://dx.doi.org/ 10.1084/jem.181.1.257 7807006 .,Non-OADS,/arxiv_data1/oa_pdf/d2/37/main.PMC4326180.pdf
http://dx.doi.org/10.1128/JCM.39.2.816-819.2001 11158161 .,Non-OADS,/arxiv_data1/oa_pdf/d2/37/main.PMC4326180.pdf
http://dx.doi.org/10.1084/jem.192.7.1015 11015442 .,Non-OADS,/arxiv_data1/oa_pdf/d2/37/main.PMC4326180.pdf
http://dx.doi.org/10.1038/74680 10742149 .,Non-OADS,/arxiv_data1/oa_pdf/d2/37/main.PMC4326180.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/d2/37/main.PMC4326180.pdf
http://dx.doi.org/ 10.1128/IAI.00251-13 23630967 .,Non-OADS,/arxiv_data1/oa_pdf/d2/37/main.PMC4326180.pdf
http://dx.doi.org/10.1038/ labinvest.2012.125 22964851 .,OADS,/arxiv_data1/oa_pdf/d2/37/main.PMC4326180.pdf
Frontiers in Pharmacology 3 (2012) 30. http://dx.doi.org/10.3389/fphar.2012.00030 22438843 .,Non-OADS,/arxiv_data1/oa_pdf/d2/37/main.PMC4326180.pdf
http://dx.doi.org/10.1074/jbc.M310661200 15123630 .,Non-OADS,/arxiv_data1/oa_pdf/d2/37/main.PMC4326180.pdf
http://dx.doi.org/10.1161/HY- PERTENSIONAHA.107.092296 17679649 .,Non-OADS,/arxiv_data1/oa_pdf/d2/37/main.PMC4326180.pdf
"[53] C. Vilchèze, T. Hartman, B. Weinrick, W.R. Jacobs Jr., Mycobacterium tu- berculosis is extraordinarily sensitive to killing by a vitamin C-induced Fenton reaction, Nature Communications 4 (2013) 1881. http://dx.doi.org/10.1038/ ncomms2898 23695675 .",Non-OADS,/arxiv_data1/oa_pdf/d2/37/main.PMC4326180.pdf
http://dx.doi.org/10.1016/j.free- radbiomed.2010.08.026 20807564 .,OADS,/arxiv_data1/oa_pdf/d2/37/main.PMC4326180.pdf
http://dx.doi.org/10.1165/rcmb.2008-0138OC 19097985 .,Non-OADS,/arxiv_data1/oa_pdf/d2/37/main.PMC4326180.pdf
http://dx.doi.org/ 10.1074/jbc.M412687200 15637067 .,Non-OADS,/arxiv_data1/oa_pdf/d2/37/main.PMC4326180.pdf
http://dx.doi.org/ 10.1002/hep.23339 20044809 .,Non-OADS,/arxiv_data1/oa_pdf/d2/37/main.PMC4326180.pdf
http://dx.doi.org/10.1002/ hep.23921 21105106 .,Non-OADS,/arxiv_data1/oa_pdf/d2/37/main.PMC4326180.pdf
"Young, Ammonia inhibits phagosome –lysosome fusion in macrophages, Nature 286 (5768) (1980) 79 –80.http://dx.doi.org/ 10.1038/286079a0 6993961 .",Non-OADS,/arxiv_data1/oa_pdf/d2/37/main.PMC4326180.pdf
http://dx.doi.org/ 10.1084/jem.158.2.477 6193224 .,Non-OADS,/arxiv_data1/oa_pdf/d2/37/main.PMC4326180.pdf
http://dx.doi.org/10.1091/mbc.E02- 12-0780 12925769 .M.Y.,Non-OADS,/arxiv_data1/oa_pdf/d2/37/main.PMC4326180.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d6/49/main.PMC4326181.pdf
"Experimental studies have shown an important role of mitochondrial reactive oxygen species in the development of endothelial dysfunction, hypertension andContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/redoxRedox Biology http://dx.doi.org/10.1016/j.redox.2014.12.012 2213-2317/ &2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/d6/49/main.PMC4326181.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d6/49/main.PMC4326181.pdf
http://dx.doi.org/10.1016/S0140-6736(05)17741-1 15652604 .,OADS,/arxiv_data1/oa_pdf/d6/49/main.PMC4326181.pdf
"Titze, Vascular in ﬂammatory cells in hy- pertension, Frontiers in Physiology 3 (2012) 128. http://dx.doi.org/10.3389/ fphys.2012.00128 22586409 .",Non-OADS,/arxiv_data1/oa_pdf/d6/49/main.PMC4326181.pdf
http://dx.doi.org/ 10.1016/j.ahj.2011.05.010 21835296 .,OADS,/arxiv_data1/oa_pdf/d6/49/main.PMC4326181.pdf
"Gongora, T.J. Guzik, J. Widder, Oxidative stress and hy- pertension, Journal of the American Society of Hypertension 1 (1) (2007) 30–44.http://dx.doi.org/10.1016/j.jash.2006.11.006 20409831 .",Non-OADS,/arxiv_data1/oa_pdf/d6/49/main.PMC4326181.pdf
http://dx.doi.org/10.1089/ars.2012.4918 24053613 .,Non-OADS,/arxiv_data1/oa_pdf/d6/49/main.PMC4326181.pdf
http://dx.doi.org/10.1172/JCI14453 11714732 .,Non-OADS,/arxiv_data1/oa_pdf/d6/49/main.PMC4326181.pdf
http://dx.doi.org/10.1152/japplphysiol.00513.2006 17023572 .,Non-OADS,/arxiv_data1/oa_pdf/d6/49/main.PMC4326181.pdf
http://dx.doi.org/10.1161/01.,Non-OADS,/arxiv_data1/oa_pdf/d6/49/main.PMC4326181.pdf
http://dx.doi.org/10.1016/S0169-409X(99)00069-1 10699318 .,OADS,/arxiv_data1/oa_pdf/d6/49/main.PMC4326181.pdf
http://dx.doi.org/10.1146/annurev.pharm- tox.47.120505.105110 17014364 .,Non-OADS,/arxiv_data1/oa_pdf/d6/49/main.PMC4326181.pdf
"Sivitz, Reactive oxygen and targeted antioxidant administration in endothelial cell mitochondria, Journal of Biological Chemistry 281 (52) (2006) 39766 – 39775. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/d6/49/main.PMC4326181.pdf
http://dx.doi.org/10.1089/ars.2007.1693 17854275 .,Non-OADS,/arxiv_data1/oa_pdf/d6/49/main.PMC4326181.pdf
http://dx.doi.org/10.1074/ jbc.271.42.26026 8824242 .,Non-OADS,/arxiv_data1/oa_pdf/d6/49/main.PMC4326181.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/d6/49/main.PMC4326181.pdf
"[18] V. Mildaziene, R. Baniene, A. Marcinkeviciute, Z. Nauciene, A. Kalvenas, A. Zimkus, Tetraphenylphosphonium inhibits oxidation of physiological sub- strates in heart mitochondria, Molecular and Cellular Biochemistry 174 (1 –2) (1997) 67 –70.http://dx.doi.org/10.1023/A:1006812128286 9309667 .",Non-OADS,/arxiv_data1/oa_pdf/d6/49/main.PMC4326181.pdf
http://dx.doi.org/10.1016/j.freeradbiomed.2005.04.016 16085176 .,OADS,/arxiv_data1/oa_pdf/d6/49/main.PMC4326181.pdf
http://dx.doi.org/ 10.1016/j.freeradbiomed.2007.12.036 18206669 .,OADS,/arxiv_data1/oa_pdf/d6/49/main.PMC4326181.pdf
"Nepomnyashchikh, Nitroxyl antioxidant tppa-tempo in-creases the ef ﬁcacy of antitumor therapy on the model of transplantable mouse tumor, Bulletin of Experimental Biology and Medicine 150 (1) (2010) 75–78.http://dx.doi.org/10.1007/s10517-010-1073-2 21161057 .",Non-OADS,/arxiv_data1/oa_pdf/d6/49/main.PMC4326181.pdf
http://dx.doi.org/10.1161/CIR- CULATIONAHA.105.538934 16230485 .,Non-OADS,/arxiv_data1/oa_pdf/d6/49/main.PMC4326181.pdf
http://dx.doi.org/10.1161/01.HYP.25.5.1111 7737724 .,Non-OADS,/arxiv_data1/oa_pdf/d6/49/main.PMC4326181.pdf
http://dx.doi.org/10.1161/01.ATV.0000259298.11129.a2 17272743 .,Non-OADS,/arxiv_data1/oa_pdf/d6/49/main.PMC4326181.pdf
"Murphy, Antioxidant properties of mito-TEMPOl and its hydroxylamine, Free Radical Research 43 (1) (2009) 4–12.http://dx.doi.org/10.1080/10715760802582183 19058062 .",Non-OADS,/arxiv_data1/oa_pdf/d6/49/main.PMC4326181.pdf
http://dx.doi.org/ 10.1016/0005-2728(79)90065-3 228716 .,OADS,/arxiv_data1/oa_pdf/d6/49/main.PMC4326181.pdf
http://dx.doi.org/10.3317/jraas.2003.014 12806586 .,Non-OADS,/arxiv_data1/oa_pdf/d6/49/main.PMC4326181.pdf
http://dx.doi.org/10.1073/ pnas.0501719102 15824309 .,Non-OADS,/arxiv_data1/oa_pdf/d6/49/main.PMC4326181.pdf
http://dx.doi.org/ 10.1016/S0076-6879(05)96052-7 16291267 .,OADS,/arxiv_data1/oa_pdf/d6/49/main.PMC4326181.pdf
"This Open Access article is distributed under the terms of the Creative Commons License Attribution-Non-Commercial Share Alike (http://creativecommons.org/licenses/by-nc-sa/4.0/).HUMAN GENE THERAPY 26:69–81 (February 2015) Mary Ann Liebert, Inc.DOI: 10.1089/hum.2014.106 69",Non-OADS,/arxiv_data1/oa_pdf/2e/46/hum.2014.106.PMC4326268.pdf
Examination of the Factor IX MutationDatabase reveals that individuals with missense mutations arising from a single nucleotide variance from wild-type factor IX essentially do not develop inhibitors in the settingof exogenous protein replacement; a single patient with amissense substitution complicated by inhibitor is described among the 1095 unique F9variants and 3713 individual cases in the database 37(http://www.factorix.org/).,Non-OADS,/arxiv_data1/oa_pdf/2e/46/hum.2014.106.PMC4326268.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution- Noncommercial 3.0 Unported License (http://creativecommons.org/licenses/by-nc/3.0/), permitting all non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Libyan J Med 2015, 10: 26229 - http://dx.doi.org/10.3402/ljm.v10.26229 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/39/d3/LJM-10-26229.PMC4326401.pdf
"2 (page number not for citation purpose)Citation: Libyan J Med 2015, 10: 26229 - http://dx.doi.org/10.3402/ljm.v10.26229",Non-OADS,/arxiv_data1/oa_pdf/39/d3/LJM-10-26229.PMC4326401.pdf
"Rating of perceived exertion (RPE) scores (mean9SD, n/C3012) obtained following the 30-sec Wingate test, after the 5-min (5WU) and the 15-min (15WU) warm- up, and before (BR) and during (R2) Ramadan.£Signiﬁcant difference in comparison with BR; *signiﬁcant difference incomparison with the 5-min warm-up.Warm-up duration and Ramadan Citation: Libyan J Med 2015, 10: 26229 - http://dx.doi.org/10.3402/ljm.v10.26229 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/39/d3/LJM-10-26229.PMC4326401.pdf
"4 (page number not for citation purpose)Citation: Libyan J Med 2015, 10: 26229 - http://dx.doi.org/10.3402/ljm.v10.26229",Non-OADS,/arxiv_data1/oa_pdf/39/d3/LJM-10-26229.PMC4326401.pdf
"2007; 41: 398 /C1400.Warm-up duration and Ramadan Citation: Libyan J Med 2015, 10: 26229 - http://dx.doi.org/10.3402/ljm.v10.26229 5 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/39/d3/LJM-10-26229.PMC4326401.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/76/f5/main.PMC4326466.pdf
http://dx.doi.org/10.1016/j.nicl.2015.01.014 2213-1582/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/76/f5/main.PMC4326466.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/76/f5/main.PMC4326466.pdf
"Diffusion imaging analysis All analyses were performed using the Functional MRI of the Brain (FMRIB) software library (FSL v5.0.2.1, http://www.fmrib.ox.ac.uk/fsl ) (Smith et al., 2004 ).",OADS,/arxiv_data1/oa_pdf/76/f5/main.PMC4326466.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/76/f5/main.PMC4326466.pdf
http://dx.doi.org/10.1093/brain/awp25719914928 .,Non-OADS,/arxiv_data1/oa_pdf/76/f5/main.PMC4326466.pdf
http://dx.doi.org/10.1016/j.jalz.2011.03.008 .,OADS,/arxiv_data1/oa_pdf/76/f5/main.PMC4326466.pdf
http://dx.doi.org/10.1001/archneur.64.10.148217923631 .,Non-OADS,/arxiv_data1/oa_pdf/76/f5/main.PMC4326466.pdf
http://dx.doi.org/10.1212/01.WNL.0000120548.,Non-OADS,/arxiv_data1/oa_pdf/76/f5/main.PMC4326466.pdf
"Aging 25 (1), 5 –18.http://dx.doi.org/ 10.1016/j.neurobiolaging.2003.03.00114675724 .Basser, P.J., Jones, D.K., 2002.",Non-OADS,/arxiv_data1/oa_pdf/76/f5/main.PMC4326466.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/76/f5/main.PMC4326466.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/76/f5/main.PMC4326466.pdf
"Aging 33 (1), 61 –74.http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/76/f5/main.PMC4326466.pdf
http://dx.doi.org/10.1007/BF003088091759558 .,Non-OADS,/arxiv_data1/oa_pdf/76/f5/main.PMC4326466.pdf
http://dx.doi.org/10.1212/WNL.57.9.166911706109 .,Non-OADS,/arxiv_data1/oa_pdf/76/f5/main.PMC4326466.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/76/f5/main.PMC4326466.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/76/f5/main.PMC4326466.pdf
http://dx.doi.org/10.1093/brain/awg19612821520 .,Non-OADS,/arxiv_data1/oa_pdf/76/f5/main.PMC4326466.pdf
http://dx.doi.org/10.1016/j.neurobiolaging.,OADS,/arxiv_data1/oa_pdf/76/f5/main.PMC4326466.pdf
"21 (1), 83–92.http://dx.doi.org/10.1097/WCO.0b013e3282f4594b18180656 .",Non-OADS,/arxiv_data1/oa_pdf/76/f5/main.PMC4326466.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/76/f5/main.PMC4326466.pdf
"Aging 22 (4),529 –539.http://dx.doi.org/ 10.1016/S0197-4580(01)00230-511445252 .",OADS,/arxiv_data1/oa_pdf/76/f5/main.PMC4326466.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/76/f5/main.PMC4326466.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/76/f5/main.PMC4326466.pdf
"13 (6), 614 –629.http://dx.doi.org/ 10.1016/S1474-4422(14)70090-024849862 .",OADS,/arxiv_data1/oa_pdf/76/f5/main.PMC4326466.pdf
http://dx.doi.org/ 10.1016/j.tins.2011.05.00521696834 .,OADS,/arxiv_data1/oa_pdf/76/f5/main.PMC4326466.pdf
http://dx.doi.org/ 10.1016/j.neurobiolaging.2004.11.00615917103 .,OADS,/arxiv_data1/oa_pdf/76/f5/main.PMC4326466.pdf
"Neuroimage 36 (1), 1 –7.http://dx.doi.org/10.1016/j.neuroimage.2007.02.",OADS,/arxiv_data1/oa_pdf/76/f5/main.PMC4326466.pdf
http://dx.doi.org/10.1016/0022-3956(75)90026-61202204 .,OADS,/arxiv_data1/oa_pdf/76/f5/main.PMC4326466.pdf
http://dx.doi.org/10.1093/brain/awp13219477964 .,Non-OADS,/arxiv_data1/oa_pdf/76/f5/main.PMC4326466.pdf
http://dx.doi.org/10.1136/jnnp.73.5.50812397142 .,Non-OADS,/arxiv_data1/oa_pdf/76/f5/main.PMC4326466.pdf
http://dx.doi.org/10.1007/ s11682-008-9055-y20596297 .,Non-OADS,/arxiv_data1/oa_pdf/76/f5/main.PMC4326466.pdf
http://dx.doi.org/10.1016/ j.neuroimage.2011.05.09021722740 .,OADS,/arxiv_data1/oa_pdf/76/f5/main.PMC4326466.pdf
http://dx.doi.org/10.1073/ pnas.030862710115070770 .,Non-OADS,/arxiv_data1/oa_pdf/76/f5/main.PMC4326466.pdf
http://dx.doi.org/ 10.1007/s00259-009-1060-x19224210 .,Non-OADS,/arxiv_data1/oa_pdf/76/f5/main.PMC4326466.pdf
http://dx.doi.org/10.1006/nimg.2002.,OADS,/arxiv_data1/oa_pdf/76/f5/main.PMC4326466.pdf
http://dx.doi.org/10.1016/j.neurobiolaging.2011.06.02721872362 .,OADS,/arxiv_data1/oa_pdf/76/f5/main.PMC4326466.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/76/f5/main.PMC4326466.pdf
"Neuroimage 73, 239 – 254.http://dx.doi.",OADS,/arxiv_data1/oa_pdf/76/f5/main.PMC4326466.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/76/f5/main.PMC4326466.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/76/f5/main.PMC4326466.pdf
http://dx.doi.org/10.1002/jmri.107611276097 .,Non-OADS,/arxiv_data1/oa_pdf/76/f5/main.PMC4326466.pdf
http://dx.doi.org/10.1016/j.neurobiolaging.,OADS,/arxiv_data1/oa_pdf/76/f5/main.PMC4326466.pdf
http://dx.doi.org/10.1016/ j.jalz.2011.03.005 .,OADS,/arxiv_data1/oa_pdf/76/f5/main.PMC4326466.pdf
http://dx.doi.org/10.1016/j.neurobiolaging.,OADS,/arxiv_data1/oa_pdf/76/f5/main.PMC4326466.pdf
http://dx.doi.org/10.1523/ JNEUROSCI.2317-11.201121917806 .,Non-OADS,/arxiv_data1/oa_pdf/76/f5/main.PMC4326466.pdf
"Regionally-speci ﬁc diffusion tensor imaging in mild cognitive impairmentand Alzheimer 3sd i s e a s e .N e u r o i m a g e4 6( 1 ) ,4 7 –55.http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/76/f5/main.PMC4326466.pdf
"42 (1), 85 –94.http://dx.doi.org/10.1002/ana.4104201149225689 .",Non-OADS,/arxiv_data1/oa_pdf/76/f5/main.PMC4326466.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/76/f5/main.PMC4326466.pdf
http://dx.doi.org/10.1016/j.neurobiolaging.2014.,OADS,/arxiv_data1/oa_pdf/76/f5/main.PMC4326466.pdf
http://dx.doi.org/10.1002/ana.1066912953266 .,Non-OADS,/arxiv_data1/oa_pdf/76/f5/main.PMC4326466.pdf
http://dx.doi.org/10.1016/j.nicl.2013.,OADS,/arxiv_data1/oa_pdf/76/f5/main.PMC4326466.pdf
"Aging 31 (1), 25 –33.http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/76/f5/main.PMC4326466.pdf
http://dx.doi.org/10.1001/archneur.56.3.30310190820 .,Non-OADS,/arxiv_data1/oa_pdf/76/f5/main.PMC4326466.pdf
http://dx.doi.org/10.1016/j.nicl.2014.02.00124936411 .,OADS,/arxiv_data1/oa_pdf/76/f5/main.PMC4326466.pdf
http://dx.doi.org/10.1016/j.neuroimage.2004.10.,OADS,/arxiv_data1/oa_pdf/76/f5/main.PMC4326466.pdf
http://dx.doi.org/10.1136/jnnp.,OADS,/arxiv_data1/oa_pdf/76/f5/main.PMC4326466.pdf
http://dx.doi.org/10.1109/42.,Non-OADS,/arxiv_data1/oa_pdf/76/f5/main.PMC4326466.pdf
http://dx.doi.org/10.1093/brain/ awt06523539189 .,Non-OADS,/arxiv_data1/oa_pdf/76/f5/main.PMC4326466.pdf
"3 (1), 43. http://dx.doi.org/10.1186/ 2191-219X-3-4323731789 .",Non-OADS,/arxiv_data1/oa_pdf/76/f5/main.PMC4326466.pdf
http://dx.doi.org/10.1212/01.wnl.0000279336.36610.f717984454 .,Non-OADS,/arxiv_data1/oa_pdf/76/f5/main.PMC4326466.pdf
"Psychiatry 55 (10), 967 –972.http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/76/f5/main.PMC4326466.pdf
http://dx.doi.org/10.1016/j.neuroimage.2008.05.,OADS,/arxiv_data1/oa_pdf/76/f5/main.PMC4326466.pdf
http://dx.doi.org/10.1016/j.neuroimage.2006.02.,OADS,/arxiv_data1/oa_pdf/76/f5/main.PMC4326466.pdf
http://dx.doi.org/10.1016/j.neuroimage.,OADS,/arxiv_data1/oa_pdf/76/f5/main.PMC4326466.pdf
"Neuroimage 44 (1), 83 –98.http://dx.doi.org/10.1016/j.neuroimage.2008.",OADS,/arxiv_data1/oa_pdf/76/f5/main.PMC4326466.pdf
http://dx.doi.org/10.2174/15672050979014710619747154 .,Non-OADS,/arxiv_data1/oa_pdf/76/f5/main.PMC4326466.pdf
http://dx.doi.org/10.1016/j.neurobiolaging.2009.04.01419428143 .,OADS,/arxiv_data1/oa_pdf/76/f5/main.PMC4326466.pdf
http://dx.doi.org/10.1038/nrn273319812579 .,Non-OADS,/arxiv_data1/oa_pdf/76/f5/main.PMC4326466.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/76/f5/main.PMC4326466.pdf
http://dx.doi.org/10.1093/brain/ awq20320688814 .,Non-OADS,/arxiv_data1/oa_pdf/76/f5/main.PMC4326466.pdf
http://dx.doi.org/10.1093/brain/awt09423649697 .,Non-OADS,/arxiv_data1/oa_pdf/76/f5/main.PMC4326466.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/76/f5/main.PMC4326466.pdf
http://dx.doi.org/10.1002/hbm.2032417133390 .,Non-OADS,/arxiv_data1/oa_pdf/76/f5/main.PMC4326466.pdf
http://dx.doi.org/10.1016/j.neuroimage.,OADS,/arxiv_data1/oa_pdf/76/f5/main.PMC4326466.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/76/f5/main.PMC4326466.pdf
http://dx.doi.org/10.1097/01.wnr.0000174061.41897.ee16056124 .,Non-OADS,/arxiv_data1/oa_pdf/76/f5/main.PMC4326466.pdf
"Neurology 68 (1), 13 –19.http://dx.doi.org/10.1212/01.wnl.0000250326.",Non-OADS,/arxiv_data1/oa_pdf/76/f5/main.PMC4326466.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/76/f5/main.PMC4326466.pdf
"Neuroimage 53 (1), 16 –25.http://dx.doi.org/10.1016/ j.neuroimage.2010.05.06820595067 .492 F. Rémy et al.",OADS,/arxiv_data1/oa_pdf/76/f5/main.PMC4326466.pdf
Society for Endocrinology competency framework1–17 4:W1 http://www.endocrineconnections.org DOI: 10.1530/EC-14-0134/C2092015 Society for Endocrinology Published by Bioscientiﬁca Ltd This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 4.0International License .,Non-OADS,/arxiv_data1/oa_pdf/1f/6b/ec-04-W1.PMC4326532.pdf
Society for Endocrinology competency framework2–17 4:W2 http://www.endocrineconnections.org DOI: 10.1530/EC-14-0134/C2092015 Society for Endocrinology Published by Bioscientiﬁca Ltd This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 4.0International License .,Non-OADS,/arxiv_data1/oa_pdf/1f/6b/ec-04-W1.PMC4326532.pdf
Society for Endocrinology competency framework3–17 4:W3 http://www.endocrineconnections.org DOI: 10.1530/EC-14-0134/C2092015 Society for Endocrinology Published by Bioscientiﬁca Ltd This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 4.0International License .,Non-OADS,/arxiv_data1/oa_pdf/1f/6b/ec-04-W1.PMC4326532.pdf
Society for Endocrinology competency framework4–17 4:W4 http://www.endocrineconnections.org DOI: 10.1530/EC-14-0134/C2092015 Society for Endocrinology Published by Bioscientiﬁca Ltd This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 4.0International License .,Non-OADS,/arxiv_data1/oa_pdf/1f/6b/ec-04-W1.PMC4326532.pdf
Society for Endocrinology competency framework5–17 4:W5 http://www.endocrineconnections.org DOI: 10.1530/EC-14-0134/C2092015 Society for Endocrinology Published by Bioscientiﬁca Ltd This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 4.0International License .,Non-OADS,/arxiv_data1/oa_pdf/1f/6b/ec-04-W1.PMC4326532.pdf
Society for Endocrinology competency framework6–17 4:W6 http://www.endocrineconnections.org DOI: 10.1530/EC-14-0134/C2092015 Society for Endocrinology Published by Bioscientiﬁca Ltd This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 4.0International License .,Non-OADS,/arxiv_data1/oa_pdf/1f/6b/ec-04-W1.PMC4326532.pdf
Society for Endocrinology competency framework7–17 4:W7 http://www.endocrineconnections.org DOI: 10.1530/EC-14-0134/C2092015 Society for Endocrinology Published by Bioscientiﬁca Ltd This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 4.0International License .,Non-OADS,/arxiv_data1/oa_pdf/1f/6b/ec-04-W1.PMC4326532.pdf
Society for Endocrinology competency framework8–17 4:W8 http://www.endocrineconnections.org DOI: 10.1530/EC-14-0134/C2092015 Society for Endocrinology Published by Bioscientiﬁca Ltd This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 4.0International License .,Non-OADS,/arxiv_data1/oa_pdf/1f/6b/ec-04-W1.PMC4326532.pdf
Society for Endocrinology competency framework9–17 4:W9 http://www.endocrineconnections.org DOI: 10.1530/EC-14-0134/C2092015 Society for Endocrinology Published by Bioscientiﬁca Ltd This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 4.0International License .,Non-OADS,/arxiv_data1/oa_pdf/1f/6b/ec-04-W1.PMC4326532.pdf
Society for Endocrinology competency framework10–17 4:W10 http://www.endocrineconnections.org DOI: 10.1530/EC-14-0134/C2092015 Society for Endocrinology Published by Bioscientiﬁca Ltd This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 4.0International License .,Non-OADS,/arxiv_data1/oa_pdf/1f/6b/ec-04-W1.PMC4326532.pdf
Society for Endocrinology competency framework11–17 4:W11 http://www.endocrineconnections.org DOI: 10.1530/EC-14-0134/C2092015 Society for Endocrinology Published by Bioscientiﬁca Ltd This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 4.0International License .,Non-OADS,/arxiv_data1/oa_pdf/1f/6b/ec-04-W1.PMC4326532.pdf
Society for Endocrinology competency framework12–17 4:W12 http://www.endocrineconnections.org DOI: 10.1530/EC-14-0134/C2092015 Society for Endocrinology Published by Bioscientiﬁca Ltd This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 4.0International License .,Non-OADS,/arxiv_data1/oa_pdf/1f/6b/ec-04-W1.PMC4326532.pdf
Society for Endocrinology competency framework13–17 4:W13 http://www.endocrineconnections.org DOI: 10.1530/EC-14-0134/C2092015 Society for Endocrinology Published by Bioscientiﬁca Ltd This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 4.0International License .,Non-OADS,/arxiv_data1/oa_pdf/1f/6b/ec-04-W1.PMC4326532.pdf
Society for Endocrinology competency framework14–17 4:W14 http://www.endocrineconnections.org DOI: 10.1530/EC-14-0134/C2092015 Society for Endocrinology Published by Bioscientiﬁca Ltd This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 4.0International License .,Non-OADS,/arxiv_data1/oa_pdf/1f/6b/ec-04-W1.PMC4326532.pdf
Society for Endocrinology competency framework15–17 4:W15 http://www.endocrineconnections.org DOI: 10.1530/EC-14-0134/C2092015 Society for Endocrinology Published by Bioscientiﬁca Ltd This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 4.0International License .,Non-OADS,/arxiv_data1/oa_pdf/1f/6b/ec-04-W1.PMC4326532.pdf
Society for Endocrinology competency framework16–17 4:W16 http://www.endocrineconnections.org DOI: 10.1530/EC-14-0134/C2092015 Society for Endocrinology Published by Bioscientiﬁca Ltd This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 4.0International License .,Non-OADS,/arxiv_data1/oa_pdf/1f/6b/ec-04-W1.PMC4326532.pdf
"London, UK: UK Central Council for Nursing, Midwifery and Health Visiting (available at: http://www.nmc-uk.org/ Documents/Archived%20Publications/UKCC%20Archived%20 Publications/Code%20of%20Professional%20Conduct% 20June%201992.PDF ), 1992.",Non-OADS,/arxiv_data1/oa_pdf/1f/6b/ec-04-W1.PMC4326532.pdf
"London, UK: Nursing and Midwifery Council (available at: http://www.nmc-uk.org/Docu- ments/Standards/The-code-A4-20100406.pdf ), 2008.",Non-OADS,/arxiv_data1/oa_pdf/1f/6b/ec-04-W1.PMC4326532.pdf
"London: RCN (available at: http://www.rcn.org.uk/ __data/assets/pdf_ﬁle/0003/146478/003207.pdf ), 2012.",Non-OADS,/arxiv_data1/oa_pdf/1f/6b/ec-04-W1.PMC4326532.pdf
"London, UK: Royal College of Nursing (available at: http://www.rcn.org.uk/ __data/assets/pdf_ﬁle/0006/544704/003_264.pdf ), 2013.",Non-OADS,/arxiv_data1/oa_pdf/1f/6b/ec-04-W1.PMC4326532.pdf
Society for Endocrinology competency framework17–17 4:W17 http://www.endocrineconnections.org DOI: 10.1530/EC-14-0134/C2092015 Society for Endocrinology Published by Bioscientiﬁca Ltd This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 4.0International License .,Non-OADS,/arxiv_data1/oa_pdf/1f/6b/ec-04-W1.PMC4326532.pdf
"The cell line from patients affected by Parkinson’sdisease were obtained from the ‘Cell Line and DNA Biobank from Patients affectedby Genetic Diseases’ (Istituto G. Gaslini) and the ‘Parkinson Institute Biobank’(Milan, http://www.parkinsonbiobank.com/), members of the Telethon Network ofGenetic Biobanks ((http://www.biobanknetwork.org, project no.",Non-OADS,/arxiv_data1/oa_pdf/04/21/cdd2014139a.PMC4326570.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Differentiation website (http://www.nature.com/cdd)AMBRA1 regulates mitophagy F Strappazzon et al 432 Cell Death and Differentiation",Non-OADS,/arxiv_data1/oa_pdf/04/21/cdd2014139a.PMC4326570.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/Oxidative stress and autophagy interplay G Filomeni et al 388 Cell Death and Differentiation",Non-OADS,/arxiv_data1/oa_pdf/95/ae/cdd2014150a.PMC4326572.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Differentiation website (http://www.nature.com/cdd)DAPK2 promotes autophagy by mTORC1 suppression Y Ber et al 475 Cell Death and Differentiation",Non-OADS,/arxiv_data1/oa_pdf/17/05/cdd2014177a.PMC4326577.pdf
"All normalized and non-normalized microarray data have been submitted to the GEO database (accessionnumber GSE59995, reviewer link: http://www.ncbi.nlm.nih.",OADS,/arxiv_data1/oa_pdf/1c/e1/10549_2015_Article_3281.PMC4326655.pdf
"Table 1 Gene ontology and pathways negatively correlating with DC-SCRIPT expression Category GO term # of genes % Benjamini pvalue GOTERM-BP-FAT Cell cycle 24 16 8.87E -05 GOTERM-BP-FAT DNA metabolic process 23 16 8.94E -07 GOTERM-BP-FAT Cell cycle process 19 13 4.93E -04 GOTERM-BP-FAT Cell cycle phase 18 12 5.10E -05 GOTERM-BP-FAT M phase 17 11 1.60E -05 GOTERM-BP-FAT DNA replication 15 10 9.34E -07 GOTERM-BP-FAT Cell division 14 9 4.76E -04 Database Term # of genes % pvalue Reactome Cell cycle mitotic 18 12 3.75E -06 Reactome Cell cycle checkpoints 10 7 6.87E -05 KEGG Cell cycle 8 5 6.64E -04 KEGG Oxidative phosphorylation 8 5 8.40E -04 Genes negatively correlating with DC-SCRIPT expression were used as input for the online Functional Annotation Tool at the DAVID Bioinformatics Resources (National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD; http://david.abcc.",OADS,/arxiv_data1/oa_pdf/1c/e1/10549_2015_Article_3281.PMC4326655.pdf
"In early 2012, I moved my blog to a  WordPress platform and gave it a new name, Scholarly Open  Access , found at http://scholarlyoa.com.",Non-OADS,/arxiv_data1/oa_pdf/b3/20/main.PMC4326692.pdf
Retrieved from: http://scholarlyoa.com/2013/04/02/bogus-peer-review/.,Non-OADS,/arxiv_data1/oa_pdf/b3/20/main.PMC4326692.pdf
http://dx.doi.org/10.7710/2162- 3309.1052.,Non-OADS,/arxiv_data1/oa_pdf/b3/20/main.PMC4326692.pdf
http://www.levesoninquiry.org.uk/wp-content/uploads/2012/07/Second-submission-to-Inquiry-from-Guidelines-for-science-and-health-reporting-31.05.12.pdf (Accessed: 04 Dec 2012).,Non-OADS,/arxiv_data1/oa_pdf/55/bf/main.PMC4326693.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/",Non-OADS,/arxiv_data1/oa_pdf/49/e9/aps2014135a.PMC4326792.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ Supplementary Information accompanies this paper on International Journal of Obesity website (http://www.nature.com/ijo)Cardiometabolic regulation by apelin in obesity C Alfarano et al 320 International Journal of Obesity (2015) 312 –320 © 2015 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/6b/65/ijo2014122a.PMC4326962.pdf
Available from: http://www.nppaindia.,Non-OADS,/arxiv_data1/oa_pdf/7e/cf/JRPP-4-1.PMC4326966.pdf
"Available from: https://www.hsph.harvard.edu/wp-content/Table  1: Differences in medication pricing upon recent exclusion from drug price control list: A few examples Drug category Generic name INR (USD)* Difference in INR (%) Current price Earlier price Anti‑cancer Gefitinib 11,500 (187.21) 5900 (96.04) 5600 (94.91) Imatinib 108,000 (1758.10) 8500 (138.37) 99,500 (1170.58) Tamoxifen 200 (3.25) 45 (0.732) 155 (344.44) Cardiovascular drugs Ramipril 128 (2.08) 92 (1.50) 36 (39.13) Clopidogrel 1615 (26.24) 147 (2.39) 1468 (998.63) Metoprolol 164 (2.66) 78 (1.26) 86 (110.25) Hypoglycemic agents Glimepiride 208 (3.38) 98 (1.59) 110 (112.24) Insulin 159 (2.58) 140 (2.58) 19 (13.57) Antibiotics Moxifloxacin 399 (6.50) 250 (4.07) 149 (59.6) Ofloxacin 173 (2.82) 34 (0.55) 139 (408.82) Cholesterol‑lowering agents Atorvastatin 97 (1.58) 62 (1.01) 35 (56.45) Anti‑rabies vaccine Anti‑rabies vaccine 7000 (113.93) 2670 (43.45) 4330 (162.17) Eye drops Latanoprost 1187 (19.31) 450 (7.32) 737 (163.77) Latanoprost/timolol 1348 (21.94) 515 (8.34) 833 (161.74) Others Immunoglobulin 3500 (56.96) 2200 (35.80) 1300 (59.09) Dexamethasone 21 (0.34) 10 (16.27) 11 (110) Omeprazole 97 (1.57) 50 (0.81) 47 (94) *Prices are given for a brand of the given generic.",Non-OADS,/arxiv_data1/oa_pdf/7e/cf/JRPP-4-1.PMC4326966.pdf
Available from:  http://www.ajaymakenblog.wordpress.com/.,Non-OADS,/arxiv_data1/oa_pdf/7e/cf/JRPP-4-1.PMC4326966.pdf
Available  from: http://www.who.int/drugresistance/WHO_Global_ Strategy_English.pdf.,Non-OADS,/arxiv_data1/oa_pdf/11/f9/JRPP-4-37.PMC4326970.pdf
SUPPLEMENTARY MATERIAL is linked to the online version of the paper at http://www.nature.com/mi ACKNOWLEDGMENTS Part of this study was supported by the NIH grant AI095255 and a SeniorResearch Award from Crohn’s and Colitis Foundation of America.,Non-OADS,/arxiv_data1/oa_pdf/40/51/mi201467a.PMC4326974.pdf
"To view a copy of this license,visit http://creativecommons.org/licenses/by-nc-nd/3.0/ARTICLES 306 VOLUME 8 NUMBER 2 |MARCH 2015 |www.nature.com/mi",Non-OADS,/arxiv_data1/oa_pdf/40/51/mi201467a.PMC4326974.pdf
"SUPPLEMENTARY MATERIAL is linked to the online version of the paper at http://www.nature.com/mi ACKNOWLEDGMENTS We thank Robert J. Newman for help with vector construction, Xin Rairdan for performing blastocyst injections, and Alfred Wong for excellent mouse colony management.",Non-OADS,/arxiv_data1/oa_pdf/f0/05/mi201479a.PMC4326976.pdf
"To view a copy of this license,visit http://creativecommons.org/licenses/by-nc-nd/3.0/ARTICLES 428 VOLUME 8 NUMBER 2 |MARCH 2015 |www.nature.com/mi",Non-OADS,/arxiv_data1/oa_pdf/f0/05/mi201479a.PMC4326976.pdf
2013;2013:  http://dx.doi.org/  10.1155/2013/639725.,Non-OADS,/arxiv_data1/oa_pdf/0b/4a/RPS-9-385.PMC4326978.pdf
"Detecting the hot spot areas of the protein by  Aggrescan   In order to predict the areas of protein  which are susceptible to self-aggregation,               the Aggrescan program was used  (http://bioinf.uab.es/aggrescan).",OADS,/arxiv_data1/oa_pdf/35/d4/RPS-9-431.PMC4326981.pdf
"This is an Open Access article distributed under the terms o f the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use , distribution, and reproduction in any medium, provided the original work is prop erly cited.",Non-OADS,/arxiv_data1/oa_pdf/d0/04/msu326.PMC4327153.pdf
"Finally, our results suggest that the ESP Exome VariantServer (EVS; http://evs.gs.washington.edu/EVS/ , last accessed December 1, 2014) will be a valuable resource for screening orprioritization of causal Mendelian or de novo variants(O’Roak et al.",OADS,/arxiv_data1/oa_pdf/d0/04/msu326.PMC4327153.pdf
"PLINK’s LD pruning method removes SNPs with a window approach where, with our parameters, allpairwise SNPs are compared in a 50 SNP window and one of the SNPs is removed if they are found to have an r 2greater than 0.5, ﬁnally the window is s hifted 5 SNPs and the process is repeated ( http://pngu.mgh.harvard.edu/~purcell/plink/ summary.shtml#prune , last accessed December 1, 2014).",Non-OADS,/arxiv_data1/oa_pdf/d0/04/msu326.PMC4327153.pdf
"Filtered sets of annotated variants andtheir allele frequencies are available at http://evs.gs.washing- ton.edu/EVS/ , SNVs have been deposited in dbSNP ( http:// www.ncbi.nlm.nih.gov/snp ) and genotypes and phenotypes from a large subset of individuals are also available viadbGaP ( http://www.ncbi.nlm.nih.gov/gap ) using the following accession information: NHLBI GO-ESP: Women’s Health Initiative Exome Sequencing Project (WHI), pht00 2246.v2.p2, phs000281.v2.p2; NHLBI GO-ESP: Lung CohortsExome Sequencing Project (Cys tic Fibrosis), ESP_LungGO_ CF_PA_Culture_Data, pht002227.v1.p1, phs000254.v1.p1; NHLBI GO-ESP: Early-Onset Myocardial Infarction (Broad EOMI), pht001437.v1.p1, phs000279.v1.p1; NHLBI GO-ESP:Lung Cohorts Exome Sequencing Project (Pulmonary Arterial Hypertension), PAH_Subject_Phenotypes_Baseline_ Measures, pht002277.v1.p1, phs000290.v1.p1; NHLBI GO-ESP:Lung Cohorts Exome Sequencing Project (Lung Health Studyof Chronic Obstructive Pulmonary Disease), pht002272.v1.p1, phs000291.v1.p1; NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (ARIC), phs000398; NHLBI GO-ESP:Heart Cohorts Exome Sequencing Project (CARDIA),phs000399; NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (CHS), phs000400; NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (FHS), phs000401; NHLBIGO-ESP: Heart Cohorts Exome Sequencing Project (Jackson Heart Study), phs000402; NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (MESA), phs000403; NHLBI GO-ESP: Heart Cohorts Exome Seq uencing Project (SWISS), phs000327.",Non-OADS,/arxiv_data1/oa_pdf/d0/04/msu326.PMC4327153.pdf
"This is an Open Access article distributed under the terms o f the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use , distribution, and reproduction in any medium, provided the original work is prop erly cited.",Non-OADS,/arxiv_data1/oa_pdf/1d/1e/msu328.PMC4327155.pdf
"This is an Open Access article distributed under the terms o f the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use , distribution, and reproduction in any medium, provided the original work is prop erly cited.",Non-OADS,/arxiv_data1/oa_pdf/19/04/msu337.PMC4327157.pdf
"We ﬁrst selected models of sequence evolution for eachcodon using MrModelTest v2.3 ( https://www.abc.se/ ~nylander/mrmodeltest2/mrmodeltest2.html , last accessed December 15, 2014) to determin e the model favored by the 764Junqueira-de-Azevedo et al.",OADS,/arxiv_data1/oa_pdf/19/04/msu337.PMC4327157.pdf
"Tracer v1.5 ( http://beast.bio.ed.ac.uk/Tracer ,l a s t accessed December 15, 2014) was used to estimate effectivesample sizes for all parameters (with a minimum of 200deemed acceptable) and to construct plots of ln( L)a g a i n s t generation to verify the point of convergence (burnin), withall trees generated prior to this point (the ﬁrst 25%) discarded.",OADS,/arxiv_data1/oa_pdf/19/04/msu337.PMC4327157.pdf
"This is an Open Access article distributed under the terms o f the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use , distribution, and reproduction in any medium, provided the original work is prop erly cited.",Non-OADS,/arxiv_data1/oa_pdf/cf/ea/msu343.PMC4327159.pdf
"A major focus of the Parasitic Plant Genome Project (PPGP; http://ppgp.huck.psu.edu/ ,l a s t accessed December 18, 2014) is th e identiﬁcation of genes related to haustorial initiation and development through a comparative transcriptomics approach of multiple stages of parasite growth and development in Orobanchaceae, theyoungest (estimated at 32 My) and one of the largest andmost diverse extant lineages of parasitic plants ( Naumann et al.",OADS,/arxiv_data1/oa_pdf/cf/ea/msu343.PMC4327159.pdf
"2008 ) (http://fgp.bio.psu.edu/tribedb/10_genomes/ , last accessed December 18, 2014).",OADS,/arxiv_data1/oa_pdf/cf/ea/msu343.PMC4327159.pdf
The UCO list was obtained from the Compositae genome project ( http://compgenomics.ucdavis.,OADS,/arxiv_data1/oa_pdf/cf/ea/msu343.PMC4327159.pdf
"edu/compositae_reference.php , last accessed December 18, 2014) and the COSII gene list was obtained from SolGenomics ( http://solgenomics.net/documents/markers/ cosii.xls , last accessed December 18, 2014).",OADS,/arxiv_data1/oa_pdf/cf/ea/msu343.PMC4327159.pdf
"The single copy gene list containing 970 single copy orthogroups from PlantTribes2.0 ( http://fgp.bio.psu.edu/tribedb/10_genomes/ , last accessed Decem ber 18, 2014) was identiﬁed as single copy in the seven angiosperm genomes included in the clas- siﬁcation: Arabidopsis thaliana Columbia (version 7), Carica 769Comparative Transcriptome Analyses .doi:10.1093/molbev/msu343 MBE",OADS,/arxiv_data1/oa_pdf/cf/ea/msu343.PMC4327159.pdf
"Assembly, Cleaning, and Annotation (Including Gene Family Classification) Duplicate reads in the Illumina sequence data were removed with CLC Assembly Cell version 3.2.0 ( http://www.clcbio.",OADS,/arxiv_data1/oa_pdf/cf/ea/msu343.PMC4327159.pdf
"The predicted protein sequences were used for BLASTP ( E value = 1e-5) searches against Swissprot, TAIR10, and trEMBL databases to assign putative fu nctional annotations in the form of human readable descriptions using the automatedassignment of human readable descriptions (AHRD) pipeline (https://github.com/groupschoof/AHRD , last accessed December 18, 2014).",OADS,/arxiv_data1/oa_pdf/cf/ea/msu343.PMC4327159.pdf
"Supplementary Material Supplementary ﬁgures S1–S3 ,tables S1 and S2,a n dd a t a S1–S23 are available at Molecular Biology and Evolution online ( http://www.mbe.oxfordjournals.org/ )a n dt h eP P G P website through the link provided ( http://ppgp.huck.psu.",Non-OADS,/arxiv_data1/oa_pdf/cf/ea/msu343.PMC4327159.pdf
"Acknowledgments Sequence data are archived at National Center for Biotechnology Information BioProject ID SRP001053, and athttp://ppgp.huck.psu.edu .",OADS,/arxiv_data1/oa_pdf/cf/ea/msu343.PMC4327159.pdf
"This is an Open Access article distributed under the terms o f the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use , distribution, and reproduction in any medium, provided the original work is prop erly cited.",Non-OADS,/arxiv_data1/oa_pdf/a7/63/msu394.PMC4327160.pdf
Supplementary Material Supplementary tables S1–S5 and ﬁgures S1–S14 are available atMolecular Biology and Evolution online ( http://www.mbe.,Non-OADS,/arxiv_data1/oa_pdf/a7/63/msu394.PMC4327160.pdf
Available from: http://beast.bio.ed.ac.uk/Tracer .,OADS,/arxiv_data1/oa_pdf/a7/63/msu394.PMC4327160.pdf
2004; Disponívelem URL: http://www.datasus.gov.br/cgi/tabcgi.exe?ibge/cni/popsp.def.,OADS,/arxiv_data1/oa_pdf/71/b7/1678-7757-jaos-14-03-0167.PMC4327191.pdf
Available at: URL:http://www.forp.usp.br/restauradora/depart.htm.,Non-OADS,/arxiv_data1/oa_pdf/82/60/1678-7757-jaos-14-05-0351.PMC4327227.pdf
Available at: http://www.ibge.gov.br/população/ indicadoressociaismínimos.,Non-OADS,/arxiv_data1/oa_pdf/5d/fc/1678-7757-jaos-14-05-0382.PMC4327232.pdf
1997; Available at: http://www.abori.org.br/rbo/.,Non-OADS,/arxiv_data1/oa_pdf/03/0e/1678-7757-jaos-15-05-0420.PMC4327263.pdf
"Available from: http://www.extremetech.com/article2/0,1697,1152062,00.asp.",Non-OADS,/arxiv_data1/oa_pdf/aa/6f/1678-7757-jaos-14-06-0410.PMC4327292.pdf
[cited 2006 Aug 28].Available from:http://snap.lbl.gov/pubdocs/CCDpaper_rev2.pdf#search=%22ccd%20depletion%20zone%22.,OADS,/arxiv_data1/oa_pdf/aa/6f/1678-7757-jaos-14-06-0410.PMC4327292.pdf
Available from:http://www.ing.iac.es/~smt/redsense/deep_depletion.PDF#search=%22ccd%20depletion%20zone%22.,OADS,/arxiv_data1/oa_pdf/aa/6f/1678-7757-jaos-14-06-0410.PMC4327292.pdf
Available from:http://www.olympusmicro.com/primer/digitalimaging/concepts/concepts.html.,Non-OADS,/arxiv_data1/oa_pdf/aa/6f/1678-7757-jaos-14-06-0410.PMC4327292.pdf
[cited 2006 Aug 28].Available from: http://www.microscopyu.com/tutorials/java/digitalimaging/signaltonoise/index.html.,OADS,/arxiv_data1/oa_pdf/aa/6f/1678-7757-jaos-14-06-0410.PMC4327292.pdf
Available from: http://www.bythom.com/ccds.htm.,Non-OADS,/arxiv_data1/oa_pdf/aa/6f/1678-7757-jaos-14-06-0410.PMC4327292.pdf
"Available from: http://www.mit.tut.fi/staff/Hytti/Noise_characterization.pdf#search=%22dark%20current%20digital%20camera%22 21- Schulze RK, Rosing ST, D’Hoedt B.",OADS,/arxiv_data1/oa_pdf/aa/6f/1678-7757-jaos-14-06-0410.PMC4327292.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution- NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b9/e5/dau084.PMC4327340.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/5d/3a/ccid-8-047.PMC4327394.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pClinical, Cosmetic and Investigational Dermatology 2015:8 47–52Clinical, Cosmetic and Investigational Dermatology Dove press submit your manuscript | www.dovepress.co m Dove press  47RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CCID.S6911 8Noninvasive skin tightening: focus on new  ultrasound techniques Sabrina Guillen Fabi Goldman, Butterwick, Fitzpatrick,   Groff and Fabi, Cosmetic Laser  Dermatology, San Diego, CA, USA Correspondence: Sabrina Guillen Fabi   Goldman, Butterwick, Fitzpatrick,   Groff and Fabi, Cosmetic Laser  Dermatology, 9339 Genesee Avenue,  Suite 300, San Diego, CA 92121, USA   Tel +1 858 657 1003   Fax +1 858 657 9294   email sfabi@clderm.co mAbstract:  Microfocused ultrasound (MFU) has been recently developed to meet the ever- growing public demand for achieving significant, noninvasive skin lifting and tightening.",Non-OADS,/arxiv_data1/oa_pdf/5d/3a/ccid-8-047.PMC4327394.pdf
"Clinical, Cosmetic and Investigational Dermatology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-cosmetic-and-investigational-dermatology-journa lClinical, Cosmetic and Investigational Dermatology is an interna - tional, peer-reviewed, open access, online journal that focuses on  the latest clinical and experimental research in all aspects of skin  disease and cosmetic interventions.",Non-OADS,/arxiv_data1/oa_pdf/5d/3a/ccid-8-047.PMC4327394.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/5d/3a/ccid-8-047.PMC4327394.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/75/c8/nss-7-033.PMC4327395.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pNature and Science of Sleep 2015:7 33–42Nature and Science of Sleep Dove press submit your manuscript | www.dovepress.co m Dove press  33OrigiNal reSearchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NSS.S7704 5The relationship between sleep habits, anxiety,  and depression in the elderly Marie-France leblanc1 Sophie Desjardins1 alain Desgagné2 1Department of Psychology, Université  du Québec à Trois-rivières, Trois- rivières, Qc , canada;  2Department of  Mathematics, Université du Québec à  Montréal, Montréal, Qc , canada correspondence: Sophie Desjardins   Département de psychologie, Université  du Québec à Trois-rivières, cP  500,  Trois-rivières, Qc, canada g9a  5h7  Tel +1 819 376 5011  Fax +1 819 376 5195  email sophie.desjardins@uqtr.c aPurpose:  The objective of this study is to determine which sleep-related behaviors are most  often used by the elderly according to the presence or absence of anxiety and mood disorders.",Non-OADS,/arxiv_data1/oa_pdf/75/c8/nss-7-033.PMC4327395.pdf
Available from:  http://www.statcan.gc.ca/pub/82-617-x/index-fra.ht m.  6.,OADS,/arxiv_data1/oa_pdf/75/c8/nss-7-033.PMC4327395.pdf
Available from: http://search.proquest.,Non-OADS,/arxiv_data1/oa_pdf/75/c8/nss-7-033.PMC4327395.pdf
Available from: http://doxa.u-pec.fr/theses/th0243099.pd f.  21.,Non-OADS,/arxiv_data1/oa_pdf/75/c8/nss-7-033.PMC4327395.pdf
A vailable  from: http://search.proquest.com.bibli o proxy.uqtr.ca/docview/305256013/ fulltextPDF/14118C93B8A3B377580/1?accountid =14725.,Non-OADS,/arxiv_data1/oa_pdf/75/c8/nss-7-033.PMC4327395.pdf
Available from: http://search.proquest.com.,Non-OADS,/arxiv_data1/oa_pdf/75/c8/nss-7-033.PMC4327395.pdf
"Nature and Science of Sleep Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/nature-and-science-of-sleep-journa lNature and Science of Sleep is an international, peer-reviewed, open  access journal covering all aspects of sleep science and sleep medicine,  including the neurophysiology and functions of sleep, the genetics of  sleep, sleep and society, biological rhythms, dreaming, sleep disorders and  therapy, and strategies to optimize healthy sleep.",Non-OADS,/arxiv_data1/oa_pdf/75/c8/nss-7-033.PMC4327395.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/75/c8/nss-7-033.PMC4327395.pdf
Available from: http://www.statcan.gc.ca/pub/89-519 -x/89-519-x2006001-fra.pd f.  45.,OADS,/arxiv_data1/oa_pdf/75/c8/nss-7-033.PMC4327395.pdf
Available from: http://search.proquest.com.bibli oproxy.,Non-OADS,/arxiv_data1/oa_pdf/75/c8/nss-7-033.PMC4327395.pdf
Available from: http://search.proquest.,Non-OADS,/arxiv_data1/oa_pdf/75/c8/nss-7-033.PMC4327395.pdf
Available from: http://www.theses.ulaval.,Non-OADS,/arxiv_data1/oa_pdf/75/c8/nss-7-033.PMC4327395.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/5b/a9/mder-8-119.PMC4327396.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pMedical Devices: Evidence and Research 2015:8 119–129Medical Devices: Evidence and Research Dove press submit your manuscript | www.dovepress.co m Dove press  119ORIGINAL RESEARCHopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/MDER.S7280 6Detectability and acceptability of continuous pulse  signals for the MemoPatch® device, an electronic  skin patch intended to deliver tactile medication  reminder signals Ivo Abraham1–3 Jan De Geest2 Wim De Geest2 Elke De Troy4 Karen MacDonald3 1Center for Health Outcomes  and PharmacoEconomic Research,   University of Arizona, T ucson, AZ,   USA;  2TheraSolve, Diepenbeek,   Belgium;  3Matrix45, T ucson, AZ, USA;   4Jessa Ziekenhuis, Hasselt, Belgium Correspondence: Ivo Abraham   Center for Health Outcomes and  PharmacoEconomic Research,   University of Arizona,  1291 N Martin,   Tucson, AZ  85721, USA   Tel +1 202 487 3982  Fax +1 708 575 8504  Email iabraham@matrix45.co mBackground:  Unintended forgetfulness is the most common cause of medication  nonadherence.",Non-OADS,/arxiv_data1/oa_pdf/5b/a9/mder-8-119.PMC4327396.pdf
Submit your manuscript here:  http://www.dovepress.com/medical-devices-evidence-and-research-journa l Medical Devices: Evidence and Research 2015:8submit your manuscript | www.dovepress.co m Dove press Dove press Dove pres s 129Continuous pulse signals for the MemoPatch® device Disclosure The authors report no conflicts of interest in this work.,Non-OADS,/arxiv_data1/oa_pdf/5b/a9/mder-8-119.PMC4327396.pdf
"Available from: http://www.prnewswire.com/ news-releases/prescription-drug-compliance-a-significant-challenge- for-many-patients-according-to-new-national-survey-54370352.htm l.  Accessed November 29, 2014.",Non-OADS,/arxiv_data1/oa_pdf/5b/a9/mder-8-119.PMC4327396.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ed/d5/ndt-11-317.PMC4327397.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2015:11 317–320Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  317Case repor Topen access to scientific and medical research open access Full T ext article http: //dx.doi.org/10.2147/NDT .S7333 3Diffuse cerebral vasospasm after resection  of schwannoma: a case report Ji Qi Liwei Zhang Wang Jia Junting Zhang Zhen Wu Department of Neurosurgery, Beijing  Tiantan Hospital, Capital Medical  University, Beijing, people’s republic  of ChinaBackground:  The etiology of vasospasm after brain tumor resection remains unclear.",Non-OADS,/arxiv_data1/oa_pdf/ed/d5/ndt-11-317.PMC4327397.pdf
"6, road Tiantanxili,  Beijing 100050, people’s republic of  China Tel +86 133 8121 8298 Fax +86 21 6408 5875 email zlwtt@aliyun.co m Journal name: Neuropsychiatric Disease and Treatment Article Designation: Case report Y ear: 2015 Volume: 11 Running head verso: Qi et al Running head recto: Diffuse cerebral vasospasm after schwannoma resection DOI: http://dx.doi.org/10.2147/NDT.S73333",Non-OADS,/arxiv_data1/oa_pdf/ed/d5/ndt-11-317.PMC4327397.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/ed/d5/ndt-11-317.PMC4327397.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/ed/d5/ndt-11-317.PMC4327397.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/29/c2/ndt-11-297.PMC4327398.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2015:11 297–310Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  297Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/NDT .S7822 6Neuroprotective strategies against  calpain-mediated neurodegeneration Aysegul Yildiz-Unal1 Sirin Korulu2 Arzu Karabay3 1Department of Molecular Biology  and Genetics, Faculty of Science,   Muğla Sıtkı Koçman University,   Kötekli, Mu ğla, T urkey; 2Department  of Molecular Biology and Genetics,   istanbul Arel University, istanbul  T urkey; 3Department of Molecular  Biology and Genetics, Faculty of  Science and Letters, istanbul T echnical  University, Maslak, Istanbul, T urkeyAbstract:  Calpains are calcium-dependent proteolytic enzymes that have deleterious effects on  neurons upon their pathological over-activation.",Non-OADS,/arxiv_data1/oa_pdf/29/c2/ndt-11-297.PMC4327398.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/29/c2/ndt-11-297.PMC4327398.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/29/c2/ndt-11-297.PMC4327398.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/39/3c/cpaa-7-019.PMC4327399.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pClinical Pharmacology: Advances and Applications 2015:7 19–27Clinical Pharmacology: Advances and Applications Dove press submit your manuscript | www.dovepress.co m Dove press  19OriginAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CPAA.S7218 5heparin requirements for full anticoagulation   are higher for patients on dabigatran than   for those on warfarin – a model-based study Thomas edrich1,2 gyorgy Frendl2 gregory Michaud3 ioannis Ch Paschalidis4 1Department of Anesthesiology,  Perioperative Medicine and general  intensive Care Medicine, salzburg  general hospital and Paracelsus  Private Medical University, salzburg,  Austria, 2Department of Anesthesiology,  Perioperative and Pain Medicine,  3Department of Medicine, Division  of Cardiology, Brigham and Women’s  hospital, harvard Medical school,  4Department of electrical and  Computer engineering, Division of  systems engineering, Boston University,  Boston, MA, UsA Correspondence: Thomas edrich   Department of Anesthesiology,  Perioperative Medicine and general  intensive Care Medicine, salzburg  general hospital and Paracelsus  Private Medical University, Muellner  hauptstrasse 48, salzburg, Austria 5020   Tel +43 662 4482 2701   Fax +43 662 4482 2780   email t.edrich@salk.a tPurpose:  Dabigatran (D) is increasingly used for chronic anticoagulation in place of warfarin  (W).",Non-OADS,/arxiv_data1/oa_pdf/39/3c/cpaa-7-019.PMC4327399.pdf
"Clinical Pharmacology: Advances and Applications Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-pharmacology-advances-and-applications-journa lClinical Pharmacology: Advances and Applications is an international,  peer-reviewed, open access journal publishing original research, reports,  reviews and commentaries on all areas of drug experience in humans.",Non-OADS,/arxiv_data1/oa_pdf/39/3c/cpaa-7-019.PMC4327399.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/39/3c/cpaa-7-019.PMC4327399.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/35/23/ijnrd-8-007.PMC4327400.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nephrology and Renovascular Disease 2015:8 7–12International Journal of Nephrology and Renovascular Disease Dove press submit your manuscript | www.dovepress.co m Dove press  7ORIGINAL RESEARCHopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJNRD.S7434 9Low-dose synthetic adrenocorticotropic  hormone-analog therapy for nephrotic patients:  results from a single-center pilot study Paolo Lorusso Anna Bottai Emanuela Mangione Maurizio Innocenti Adamasco Cupisti Maria Francesca Egidi Nephrology Transplant Dialysis Unit  (AOUP), Department of Clinical and  Experimental Medicine, University of  Pisa, Pisa, Italy Correspondence: Paolo Lorusso   Nephrology Transplant Dialysis Unit  (AOUP), Department of Clinical and  Experimental Medicine, University of Pisa,  2 Via Paradisa, Pisa 56126, Italy   Tel +39 050 997275-6   Fax +39 050 997285   Email p.lorusso@ao-pisa.toscana.i tIntroduction:  This report describes our experience using a low-dose synthetic adrenocorti - cotropic hormone (ACTH) analog for patients affected by nephrotic syndrome who had not  responded to or had relapsed after steroid and immunosuppressive treatments.",Non-OADS,/arxiv_data1/oa_pdf/35/23/ijnrd-8-007.PMC4327400.pdf
"International Journal of Nephrology and Renovascular Disease Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nephrology-and-renovascular-disease-journa lThe International Journal of Nephrology and Renovascular Disease is  an international, peer-reviewed open-access journal focusing on the  pathophysiology of the kidney and vascular supply.",Non-OADS,/arxiv_data1/oa_pdf/35/23/ijnrd-8-007.PMC4327400.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/35/23/ijnrd-8-007.PMC4327400.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b0/dd/ndt-11-321.PMC4327401.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2015:11 321–332Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  321OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S7739 1Medium-to-high prevalence of screening-detected  parkinsonism in the urban area of T ehran, iran:  data from a community-based door-to-door study seyed-Mohammad  Fereshtehnejad1,2 Mahdiyeh shafieesabet3 arash rahmani4 ahmad Delbari1,5 Johan lökk1,6 1Division of clinical geriatrics,   Department of Neurobiology,   care sciences, and society (NVs),   Karolinska institutet, stockholm,   sweden; 2Firoozgar clinical research  Development center (FcrDc),   Firoozgar hospital, 3Medical student  research committee (M src),   Faculty of Medicine, 4Mental health  research center, T ehran institute  of Psychiatry, school of Behavioral  sciences and Mental health, iran  University of Medical sciences, T ehran,   iran; 5iranian research center on  aging, University of social Welfare  and rehabilitation, T ehran, iran;   6Department of geriatric Medicine,   Karolinska University hospital,   stockholm, swedenIntroduction:  Parkinsonism occurs in all ethnic groups worldwide; however, there are wide  variations in the prevalence rates reported from different countries, even for neighboring  regions.",Non-OADS,/arxiv_data1/oa_pdf/b0/dd/ndt-11-321.PMC4327401.pdf
"PD incidence and prevalence increase with age,3 which makes it an impending  public health issue in rapidly aging societies, especially less developed countries that correspondence: seyed-Mohammad  Fereshtehnejad Division of clinical geriatrics,  Department of Neurobiology, care  sciences and society (NVs), Karolinska  Institutet, Novum – 5th floor, Stockholm  14186, sweden Tel +46 73 930 2627 Fax +46 8 5858 5470 email sm.fereshtehnejad@ki.s e Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2015 Volume: 11 Running head verso: Fereshtehnejad et al Running head recto: Prevalence of parkinsonism in Iran DOI: http://dx.doi.org/10.2147/NDT.S77391",Non-OADS,/arxiv_data1/oa_pdf/b0/dd/ndt-11-321.PMC4327401.pdf
Available from: http://www.amar.org.ir/Default.,Non-OADS,/arxiv_data1/oa_pdf/b0/dd/ndt-11-321.PMC4327401.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/b0/dd/ndt-11-321.PMC4327401.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/b0/dd/ndt-11-321.PMC4327401.pdf
"In brief, all libraries were aligned to the Canis lupus familiaris genome using SOAPaligner v.2.21 (http://soap.genomics.org.cn/soapaligner.html) and readsthat mapped to the genome removed.",OADS,/arxiv_data1/oa_pdf/5b/99/ncomms7145.PMC4327413.pdf
"Genome assembly.Pre-processed genomic PE-libraries (insert sizes 170-, 500- and 800-bp) and J-libraries (insert sizes: 2-, 5 -and 10-kb) were assembled and scaffolded using the program SOAPdenovo2 v.2.04 (http://soap.genomics.org.cn/ soapdenovo.html) using a k-mer of 43.",OADS,/arxiv_data1/oa_pdf/5b/99/ncomms7145.PMC4327413.pdf
"ES proteins were pre- dicted using the programs Phobius (http://www.ebi.ac.uk/Tools/pfa/phobius/), SignalP (http://www.cbs.dtu.dk/services/SignalP/) and TMHMM (http://www.",OADS,/arxiv_data1/oa_pdf/5b/99/ncomms7145.PMC4327413.pdf
The ﬁnal annotation for the protein-coding gene set of T. canis is available for download at http://bioinfosecond.vet.unimelb.edu.au/ Tcanis.,OADS,/arxiv_data1/oa_pdf/5b/99/ncomms7145.PMC4327413.pdf
Structural modelling was conducted using the program Phyre (http://www.sbg.bio.ic.ac.uk/phyre2/).,OADS,/arxiv_data1/oa_pdf/5b/99/ncomms7145.PMC4327413.pdf
canis was conducted using the program edgeR (http://www.bioconductor.org/ packages/release/bioc/html/edgeR.html).,OADS,/arxiv_data1/oa_pdf/5b/99/ncomms7145.PMC4327413.pdf
"Hubs of these gene clusters were identiﬁed using functional gene networking ( C. elegans ; http://geneorienteer.org/) and weighted gene co-expression network analysis 67,68.",OADS,/arxiv_data1/oa_pdf/5b/99/ncomms7145.PMC4327413.pdf
Network connectivity data for C. elegans were obtained using WormNet v.2 (http://www.functionalnet.org/wormnet/cgi-perl/WormNet.v2_ nga_form.cgi).,OADS,/arxiv_data1/oa_pdf/5b/99/ncomms7145.PMC4327413.pdf
Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/5b/99/ncomms7145.PMC4327413.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article : Zhu, X.-Q.",Non-OADS,/arxiv_data1/oa_pdf/5b/99/ncomms7145.PMC4327413.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms7145 8 NATURE COMMUNICATIONS | 6:6145 | DOI: 10.1038/ncomms7145 | www.nature.com/naturecommunications &2015 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/5b/99/ncomms7145.PMC4327413.pdf
"In order to register a clinical trial, please access one the following addresses: · Register in the *Clinicaltrials.gov*: URL: http:// prsinfo.clinicaltrials.gov/ · Register in the *International Standard Randomized Controlled Trial Number (ISRCTN)*: URL: http://www.controlled-trials.com/ Carlos F. Santos, DDS, PhD, Associate Professor Editor-in-ChiefJournal of Applied Oral Science",Non-OADS,/arxiv_data1/oa_pdf/8b/b2/1678-7757-jaos-15-04-000i.PMC4327423.pdf
Disponível em: http://www.cfo.org.br/download/pdf/relatorio_SB_brasil_2003.pdf.,Non-OADS,/arxiv_data1/oa_pdf/7d/75/1678-7757-jaos-15-04-0253.PMC4327425.pdf
"Ribeirão Preto: School of Dentistry, http://www.forp.usp.br/restauradora/gmc/gmc.html#gmc.",Non-OADS,/arxiv_data1/oa_pdf/e7/3a/1678-7757-jaos-14-02-0088.PMC4327448.pdf
"Disponívelem: http://www.usp.br/prc/revista/pp2.html.14- Hanaoka Y , Inoue M, Tsai TH, Minaguchi K. Fundamental and practical study for DNA analysis using tooth as a source of DNA.Nihon Hoigaku Zasshi.",Non-OADS,/arxiv_data1/oa_pdf/07/40/1678-7757-jaos-15-03-0156.PMC4327460.pdf
Disponível em:http://www.ghente.org/doc_juridicos.,Non-OADS,/arxiv_data1/oa_pdf/07/40/1678-7757-jaos-15-03-0156.PMC4327460.pdf
Disponívelem: http://www.saude.gov.br.,Non-OADS,/arxiv_data1/oa_pdf/89/7e/1678-7757-jaos-15-03-0175.PMC4327463.pdf
"Ribeirão Preto: School of Dentistry, http://www.forp.usp.br/restauradora/gmc/gmc.html#gmc.",Non-OADS,/arxiv_data1/oa_pdf/1b/aa/1678-7757-jaos-14-04-0233.PMC4327478.pdf
"Disponívelem < http://www.saude.sp.gov.br> 10- Cunha RF, Delbem ACB, Percinoto C, Saito TE.",Non-OADS,/arxiv_data1/oa_pdf/1b/aa/1678-7757-jaos-14-04-0233.PMC4327478.pdf
ISO Store at http://www.iso.ch/iso/en/prods-services/ISOstore/store.html.,OADS,/arxiv_data1/oa_pdf/68/61/1678-7757-jaos-15-06-0506.PMC4327500.pdf
"Available from: http://dx.doi.org/10.1111/j.1747-4477.2009.00168.x 3- Barato-Filho F, Leonardi DP, Zielak JC, Vanni JR, Sayão-Maia SM, Sousa-Neto MD.",OADS,/arxiv_data1/oa_pdf/b2/28/1678-7757-jaos-17-06-0590.PMC4327519.pdf
"For information on the Cochrane Collaboration, see: www.cochrane.org Please visit our website: http://bahrain.cochrane.org/en/ index.html www.fob.usp.br/jaos or www.scielo.br/jaos 1- Director of The Cochrane Collaboration - The Bahrain Branch of the UK Cochrane Centre Received: May 5, 2008 Accepted: May 5, 2008Zbys Fedorowicz1J Appl Oral Sci.",OADS,/arxiv_data1/oa_pdf/bf/41/1678-7757-jaos-16-04-0236.PMC4327530.pdf
Available from: http://www.whocollab.od.mah.se/sicdata.html.,Non-OADS,/arxiv_data1/oa_pdf/19/8a/1678-7757-jaos-16-04-0286.PMC4327539.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/34/d8/ndt-11-311.PMC4327563.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2015:11 311–315Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  311Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/NDT .S6130 9The emerging role of bexarotene in the treatment  of Alzheimer’s disease: current evidence Babak T ousi Cleveland Clinic Lou Ruvo Center  for Brian Health, Neurological  institute, Cleveland, OH, USAAbstract:  In 2012, a novel approach to the treatment of Alzheimer’s disease was introduced,  heralding a wave of excitement in the field of dementia.",Non-OADS,/arxiv_data1/oa_pdf/34/d8/ndt-11-311.PMC4327563.pdf
"The therapies that target amyloid processing in Alzheimer’s Correspondence: Babak Tousi Cleveland Clinic Lou Ruvo Center  for Brian Health, Neurological institute,   9500 euclid Ave U-10 Cleveland, OH  44195, USA Tel +1 216 521 2228 email b abak.tousi@ccf.or g Journal name: Neuropsychiatric Disease and Treatment Article Designation: Review Y ear: 2015 Volume: 11 Running head verso: Tousi Running head recto: Bexarotene and Alzheimer’s disease DOI: http://dx.doi.org/10.2147/NDT.S61309",Non-OADS,/arxiv_data1/oa_pdf/34/d8/ndt-11-311.PMC4327563.pdf
